Parthenogenic activation of human oocytes for the production of human embryonic stem cells

Abstract

Methods of producing human stem cells are disclosed for parthenogenetically activating human oocytes by manipulation of O2 tension, including manipulation of Ca2+ under high O2 tension and contacting oocytes with serine threonine kinase inhibitors under low O2 tension, isolating inner cell masses (ICMs) from the activated oocytes, and culturing the cells of the isolated ICMs under high O2 tension. Moreover, methods are described for the production of stems cells from activated oocytes in the absence of non-human animal products, including the use of human feeder cells/products for culturing ICM/stem cells. Stem cells produced by the disclosed methods are also described.

Description

BACKGROUND OF THE INVENTION

1. Field of the Invention

The present invention relates generally to embryonic stems cells, and more specifically to a process for obtaining human embryonic stem cells using parthenogenically activated oocytes.

2. Background Information

Human embryonic stem cells (ES) cells are pluripotent cells that can differentiate into a large array of cell types. When injected into immune-deficient mice, embryonic stem cells form differentiated tumors (teratomas). However, embryonic stem cells that are induced in vitro to form embryoid bodies (EBs) provide a source of embryonic stem cell lines that are amenable to differentiation into multiple cell types characteristic of several tissues under certain growth conditions. For example, ES cells become differentiated into neurons in the presence of nerve growth factor and retinoic acid.

Human ES cells and their differentiated progeny are important sources of normal human cells for therapeutic transplantation and for drug testing and development. Required by both of these goals is the provision of sufficient cells that are differentiated into tissue types suitable for a patient's needs or the appropriate pharmacological test. Associated with this is a need for an efficient and reliable method of producing differentiated cells from embryonic stem cells.

Currently, human embryonic stem cells (hES) are derived from three sources: blastocysts remaining after infertility treatments and donated for research, blastocysts generated from donated gametes (oocytes and sperm), and the products of nuclear transfer (NT). Cadaveric fetal tissue is the only source of human embryonic germ cells (hEG). hES and hEG cells offer remarkable scientific and therapeutic possibilities, involving potential for generating more specialized cells or tissues. Ethical concerns about the sources of hES and hEG cells, however, and fears that use of NT for research could lead to use of NT to produce a human being, have fostered a great deal of public discussion and debate.

Parthenogenic activation of mammalian oocytes may be used as an alternative to fertilization by sperm/NT to prepare oocytes for embryonic stem cell generation. Parthenogenic activation is the production of embryonic cells, with or without eventual development into an adult, from a female gamete in the absence of any contribution from a male gamete.

Parthenogenetic activation of mammalian oocytes has been induced in a number of ways. Using an electrical stimulus to induce activation is of particular interest because electrofusion is part of the current nuclear transfer procedure. Parthenogenetic activation in vitro by electrical stimulation with electrofusion apparatus used for embryonic cell-oocyte membrane fusion has been reported.

Mouse oocytes have been activated by exposure to Ca⁺²—Mg⁺² free medium, medium containing hyaluronidase, exposure to ethanol, Ca⁺² ionophores or chelators, inhibitors of protein synthesis, and electrical stimulation. These procedures have led to high rates of parthenogenic activation and development of mouse oocytes, but did not activate and/or lead to a lower development rate of young bovine oocytes. Further, fertilization and parthenogenic activation of mouse oocytes is also dependent on post ovulatory aging.

Activation of bovine oocytes has been reported by ethanol, electrical stimulation, exposure to room temperature, and a combination of electrical stimulation and protein inhibition with cycloheximide. While these processes are thought to raise intracellular Ca⁺², they are most successful when the oocytes have been aged for more than 28 hours.

SUMMARY OF THE INVENTION

The present invention is based on the seminal discovery that certain conditions are optimal for parthenogenically activating human oocytes.

In one embodiment, a method of producing human stem cells is provided including parthenogenetically activating an oocyte, where activation includes contacting the oocyte with an ionophore at high oxygen (O₂) tension and contacting the oocyte with a serine-threonine kinase inhibitor under low O₂ tension, cultivating the activated oocyte at low O₂ tension until blastocyst formation, transferring the blastocyst to a layer of feeder cells, and culturing the transferred blastocyst under high O₂ tension, mechanically isolating an inner cell mass (ICM) from trophectoderm of the blastocyst, and culturing the cells of the ICM on a layer of feeder cells, where culturing the ICM cells is carried out under high O₂ tension. Preferably, the oocyte is human.

In a related aspect, low O₂ tension is maintained by incubation in a gas mixture environment comprising an O₂ concentration of about 2% O₂ to about 5% O₂, where the gas mixture environment further comprises about 5% CO₂ and about 90% nitrogen (N₂) to 93% N₂.

In another embodiment, a method of activating human metaphase II oocytes is provided including incubating human metaphase II oocytes in in vitro fertilization (IVF) media under high O₂ tension, activating by incubating the cells in IVF media comprising an ionophore under high O₂ tension, and subsequently incubating the cells in IVF media comprising a serine-threonine kinase inhibitor (STKI) under low O₂ tension, and incubating the STKI treated cells until blastocyst formation under low O₂ tension, where inner cell masses (ICM) obtained from the blastocyst produce culturable stem cells. High O₂ tension may be maintained by incubating the cells in a gas mixture environment having about 5% CO₂, about 20% O₂, and about 75% N₂.

In a related aspect, the O₂ tension for the incubating steps subsequent to activation is maintained by incubating the cells in a gas mixture environment comprising an O₂ concentration of about 2% O₂ to about 5% O₂, where the gas mixture environment further includes about 5% CO₂ and about 90% N₂ to about 93% N₂.

In another related aspect, the IVF media is essentially free of non-human products.

In a further related aspect, isolated oocytes prepared by the invention methods are provided, including isolated inner cell masses (ICM) prepared from such oocytes and corresponding stem cells isolated therefrom.

In another embodiment, human parthenogenic activation of mammalian oocytes resulting in embryogenic stem cells and their differentiated progeny is provided. Such cells and progeny are substantially isogenic to the oocyte donor, thus allowing for autologous transplantation of cells relative to the oocyte donor, and rejection by the oocyte donor's immune system is typically avoided.

In a related aspect, a cell bank of hES cell lines derived from parthenogenically activated oocytes is provided.

In one embodiment, a method for producing human stem cells from a cryopreserved oocyte or parthenote is provided, including microinjecting into the cytoplasm of the oocyte or parthenote a cryopreservation agent, freezing the oocyte or parthenote to a cryogenic temperature to cause it to enter a dormant state, storing the oocyte or parthenote in the dormant state, thawing the oocyte or parthenote, parthenogenically activating the oocyte, where the activation includes contacting the oocyte with an ionophore at high O₂ tension and contacting the oocyte with a serine-threonine kinase inhibitor under low O₂ tension, cultivating the parthenote or activated oocyte under low O₂ tension until blastocyst formation, isolating an inner cell mass (ICM) from the trophectoderm of the blastocyst, and culturing the cells of the ICM on a layer of feeder cells, where culturing is carried out under high O₂ tension.

In another embodiment, autologous stem cells derived from parthenogenetically activated oocytes from a human donor are provided. In one aspect, the stem cells possess a substantially identical haplotype as the donor cell. In a related aspect, stem cells are substantially identical genetically to the donor cell.

In one aspect, a stem cell is identified as a full sibling of the donor according to single nucleotide polymorphism (SNP) markers. In another aspect, a stem cell is genomically imprinted according to donor origin.

In one embodiment, a differentiated cell derived from a stem cell obtained from a parthenogenetically activated oocyte from a human donor is disclosed. In a related aspect, the differentiated cell includes, but is not limited to, a neuronal cell, a cardiac cell, a smooth muscle cell, a striated muscle cell, an endothelial cell, an osteoblast, an oligodendrocyte, a hematopoietic cell, an adipose cell, a stromal cell, a chondrocyte, an astrocyte, a dendritic cell, a keratinocyte, a pancreatic islet, a lymphoid precursor cell, a mast cell, a mesodermal cell, and an endodermal cell. In a further related aspect, the differentiated cell expresses one or more markers, including but not limited to, neurofiliment 68, NCAM, beta III-tubulin, GFAP, alpha-actinin, desmin, PECAM-1, VE-Cadherin, alpha-fetoprotein, or a combination thereof.

In another embodiment, a cell line comprising autologous stem cells is disclosed, where the stem cells are derived from parthenogenetically activated oocytes from a human donor. In one aspect, the cells do not express SSEA-1. In another aspect, the cells of the cell line give rise to ectodermal, mesodermal, and endodermal germ lines.

In one embodiment, a cell bank is disclosed including cryopreserved parthenotes, where the parthenotes are derived from parthenogenetically activated oocytes from one or more human donors. In a related aspect, the parthenotes have been cultivated under low O₂ tension until blastocyst formation.

In one embodiment, a cell bank is disclosed including cryopreserved autologous stem cells, where the stem cells are derived from parthenogenetically activated oocytes from one or more human donors.

In another embodiment, a method of treating a subject in need thereof, comprising administering a cellular composition comprising differentiated cells, wherein the differentiated cells are derived from a stem cell obtained from a parthenogenetically activated oocyte from a human donor. In one aspect, the differentiated cell is selected from the group consisting of a neuronal cell, cardiac cell, smooth muscle cell, striated muscle cell, endothelial cell, osteoblast, oligodendrocyte, hematopoietic cell, adipose cell, stromal cell, chondrocyte, astrocyte, dendritic cell, keratinocyte, pancreatic islet, lymphoid precursor cell, mast cell, mesodermal cell, and endodermal cell.

In a related aspect, the subject presents a disease selected from the group consisting of Parkinson's disease, Huntington's disease, Alzheimer's disease, ALS, spinal cord defects or injuries, multiple sclerosis, muscular dystrophy, cystic fibrosis, liver disease, diabetes, heart disease, retinal disease (such as macular degeneration and retinitis pigmentosa), cartilage defects or injuries, burns, foot ulcers, vascular disease, urinary tract disease, AIDS, and cancer.

In one embodiment, a method of generating cloned human embryonic stem cells is disclosed, including removing a first pronuclei from a previously fertilized human oocyte, transferring a second pro-nuclei into the enucleated oocyte, where the second pro-nuclei is derived from a donor oocyte or an oocyte from the mother of the donor, or a parthenogenetically activated oocyte, where the pro-nuclei of the oocyte has been replaced by the nucleus of a donor somatic cell prior to activation, and cultivating the resulting oocyte until blastocyst formation, where an inner cell mass from the blastocyst contains the embryonic stem cells.

Exemplary methods and compositions according to this invention are described in greater detail below.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1A shows a micrograph of the surface marker expression of alkaline phosphatase for the parthenogenically derived hES cells.

FIG. 1B shows a micrograph of the expression for the surface marker Oct4.

FIG. 1C shows a micrograph of the expression for the surface marker SSEA-1.

FIG. 1D shows a micrograph of the expression for the surface marker SSEA-3.

FIG. 1E shows a micrograph of the expression for the surface marker SSEA-4.

FIG. 1F shows a micrograph of the expression for the surface marker TRA-1-60.

FIG. 1G shows a micrograph of the expression for the surface marker TRA-1-81.

FIG. 2A shows the analysis of telomerase activity for the parthenogenically derived hES cells. 500, 1000, and 10000 (units) of extract was used to perform the analysis. ΔH-heat treated test extract (negative control); positive control-telomerase positive cells; CHAPS-lysis buffer; TSR8-control template.

FIG. 2B shows a micrograph of embryoid body formation from parthenogenically derived hES cells, 9 day culture.

FIG. 2C shows a micrograph of embryoid body formation from parthenogenically derived hES cells, 10 day culture.

FIG. 2D illustrates the karyotype of parthenogenically derived hES cells.

FIG. 2E shows the results from DNA finger printing analysis of parthenogenically derived hES cells. 1—DNA from the blood of the oocyte donor; 2—DNA from the parthenogenic hES cells derived from the same donor; 3—DNA from human feeder fibroblasts.

FIG. 3 shows a Northern blot characterizing the expression of genes associated with genomic imprinting. DNA probes: SNRPN, Peg1_—2, Peg1_A, H19, and GAPDH (as an internal control). NSF, neonatal skin fibroblasts; hES, human embryonic stem cell line derived from fertilized oocytes; 1, phESC-1; 2, phESC-3, 3, phESC-4, 4, phESC-5; 5, phESC-6; 6 phESC-7. NSF RT−, hES RT−, 1 RT− are negative controls.

FIG. 4 shows the differentiation of phESC into derivatives of all three germ layers. Ectoderm differentiation is presented by positive immunocytochemical staining for neuron specific markers 68 (A), NCAM (B), beta III-tubulin (C) and glial cell marker GFAP (D, M). Differentiated cells were positive for mesodermal markers: muscle specific alpha actinin (G) and desmin (J), endothelial markers PECAM-1 (E) and VE-Cadherin (F). Endoderm differentiation is presented by positive staining for alpha-fetoprotein (H, L). The phESC produce pigmented epithelial-like cells (I, K). Magnification (I)×100; (A-H, J-M),×400.

FIG. 5 shows the characterization of phESC lines for specific markers. Undifferentiated colonies of phESC on human feeder layer cells (A-F), negative staining for SSEA-1 (G-L), expression of cell surface markers SSEA-3 (M-R), SSEA-4 (S—X). Magnification (A) to (E)×100; (F)×200; (G) to (X)×400. Alkaline phosphatase positive staining of phESC colonies on feeder cells (A-F), OCT-4 (G-L), TRA-1-60 (K—R) and TRA-1-81 (S—X). Magnification (A, B, O, R)×100; (C—F, M, S, X)×200; (G-L, N, P, Q, T-W)×400.

FIG. 6 demonstrates that phESC cells possess high levels of telomerase activity by comparison with positive control cells: “+”-extract from 500 cells; “−”-heat treated cell extract with inactivated telomerase; “Control +”-telomerase positive cell extract (applied with TRAPEZE Kit); “B”-CHAPS lysis buffer, primer-dimer/PCR contamination control; TSR8-telomerase quantitative control template (0.1 and 0.2 amole/μl); “M”-marker, DNA ladder.

FIG. 7 shows the G-banded karyotyping of phESC lines. The phESC-1 (A), phESC-3 (B), phESC-4 (C), phESC-5 (D) and phESC-6 (E) lines have normal 46, XX karyotype. The phESC-7 line has 47, XXX karyotype (F).

DETAILED DESCRIPTION OF THE INVENTION

Before the present composition, methods, and culturing methodologies are described, it is to be understood that this invention is not limited to particular compositions, methods, and experimental conditions described, as such compositions, methods, and conditions may vary. It is also to be understood that the terminology used herein is for purposes of describing particular embodiments only, and is not intended to be limiting, since the scope of the present invention will be limited only in the appended claims.

As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural references unless the context clearly dictates otherwise. Thus, for example, references to “the method” includes one or more methods, and/or steps of the type described herein which will become apparent to those persons skilled in the art upon reading this disclosure and so forth.

“Differentiation” refers to a change that occurs in cells to cause those cells to assume certain specialized functions and to lose the ability to change into certain other specialized functional units. Cells capable of differentiation may be any of totipotent, pluripotent or multipotent cells. Differentiation may be partial or complete with respect to mature adult cells.

Gynogenesis refers to the production of an embryo containing a discernible trophectoderm and inner cell mass that results upon activation of a cell, such as an oocyte, or other embryonic cell type, containing mammalian DNA of all female origin, preferably human female origin, e.g., human or non-human primate oocyte DNA. Such female mammalian DNA may be genetically modified, e.g., by insertion, deletion or substitution of at least one DNA sequence, or may be unmodified. For example, the DNA may be modified by the insertion or deletion of desired coding sequences, or sequences that promote or inhibit embryogenesis. Typically, such an embryo will be obtained by in vitro activation of an oocyte that contains DNA of all female origin. Gynogenesis is inclusive of parthenogenesis which is defined below. It also includes activation methods where the spermatozoal DNA does not contribute to the DNA in the activated oocyte.

In a related aspect, oocytes are obtained from superovulating subjects prepared for IVF. “Superovulation” techniques, such as treatment of a female subject with hormones, used in IVF are designed to stimulate the ovaries to produce several eggs (oocytes) rather than the usual single egg as in a natural cycle.

The medications required to boost egg production may include, but are not limited to the following: Lupron (gonadotropin releasing hormone-agonist), Orgalutran, Antagon or Cetrotide (gonadotropin releasing hormone-antagonist), Follistim, Bravelle or Gonal-F (FSH, follicle stimulating hormone), Repronex (combination of FSH and LH, luteinizing hormone), and Pregnyl or Novarel (hCG, human chorionic gonadotropin).

In a related aspect, collection of eggs can be performed under transvaginal ultrasound guidance. To accomplish this, a needle is inserted (e.g., under IV sedation) through the vaginal wall into the ovaries using ultrasound to locate each follicle. The follicular fluid is drawn up into a test tube to obtain the eggs.

“Parthenogenesis” (“parthenogenically activated” and “parthenogenetically activated” is used interchangeably) the process by which activation of the oocyte occurs in the absence of sperm penetration, and refers to the development of an early stage embryo comprising trophectoderm and inner cell mass that is obtained by activation of an oocyte or embryonic cell, e.g., blastomere, comprising DNA of all female origin. In a related aspect, a “parthenote” refers to the resulting cell obtained by such activation. In another related aspect, “blastocyst” refers to a cleavage stage of a fertilized or activated oocyte comprising a hollow ball of cells made of outer trophoblast cells and an inner cell mass (ICM). In a further related aspect, “blastocyst formation” refers to the process, after oocyte fertilization or activation, where the oocyte is subsequently cultured in media for a time to enable it to develop into a hollow ball of cells made of outer trophoblast cells and ICM (e.g., 5 to 6 days).

In one embodiment, the process of creating cloned human embryonic stem cell line by parthenogenetically activated oocytes is disclosed. While pathogenesis is not an uncommon form of reproduction in nature, mammals are not known to be capable of this form of reproduction. However, a 10% rate of spontaneous parthenogenesis can be found in oocytes from females of the inbred mouse strain LT/Sv (Ozil and Huneau, Development (2001) 128:917-928; Vrana et al., Proc Natl Acad Sci USA (2003) 100(Suppl 1):11911-11916; Berkowitz and Goldstein, New Eng J Med (1996) 335(23):1740-1748). Oocytes from placental mammals can be induced to undergo parthenogenesis in vitro; however, embryonic development is unsuccessful.

Following parthenogenic activation of mammalian oocytes and transfer of the activated oocyte into a surrogate mother, there is limited embryonic survival: ten days in mice; 21 days in sheep; 29 days in pigs; and 11.5 days in rabbits (Kure-bayashi et al., Theriogenology (2000) 53:1105-1119; Hagemann et al., Mol Reprod Dev (1998) 50:154-162; Surani and Barton, Science (1983) 222:1034-1036). The reason for this arrested development is likely due to genetic imprinting. It has been shown that maternal and paternal genomes are epigentically different and that both sets are required for successful embryonic development (Surani, Cell (1998) 93:309-312; Sasaki et al., (1992) 6:1843-1856). In parthenotes, all of the genetic material should be of maternal origin, a therefore should lack paternal imprinting. Paternal imprinting is thought to be responsible for extra-embryo tissue development, thus the development of trophoblastic tissue following fertilization of an enucleated oocyte (Stevens, Nature (1978) 276:266-267). In animals, therefore, enucleated zygotes may be useful for nuclear transfer with subsequent parthenogenic activation.

Mammalian parthenotes undergo only limited development with eventual death of the embryo. In Macac fascicularis, only 14 percent of oocytes in stage II metaphase following in vitro Parthenogenetic activation developed to the blastocyst stage following 8 days of culture (Monk, Genes Dev (1988) 2:921-925). Similarly, 12 percent of human oocytes that were parthenogenetically activated in vitro following nuclear transfer developed to the blastocyst state (Monk, 1988). In both cases, one stem cell line was created.

Embryos formed in spontaneously activated parthenotes in virgin females of the LT/Sv inbred mouse strain die within a few days. When nuclear transfer is performed from cells comprising the inner cell mass (ICM) of these embryos into fertilized enucleated C57BL/6j mouse oocytes, cloned mice with the LT/Sv genome are obtained (Kaufman et al., Nature (1977) 265:53-55). Thus, the use of a fertilized oocyte allows for full-term development of a parthenote. In one aspect, a fertilized enucleated human oocyte can be used to support development of a parthenogenetic embryo containing a donor's nuclei until the blastocyst stage.

In one embodiment, the pronuclei of a donor's oocyte or from the oocyte of the mother of a donor, following parthenogenetic activation, can be transferred into a fertilized human oocyte from which the male and female pronuclei have been extracted.

In another embodiment, a two stage process is disclosed for generating human stem cells including transferring the nucleus of a donor's somatic cell into a donor oocyte, where the oocyte is subsequently activated by parthenogenesis and transferring the pronuclei of the activated oocyte into a fertilized oocyte, where the male and female pronuclei have been extracted.

In another embodiment, the nucleus from a donor's somatic cell can be transferred into a fertilized enucleated human oocyte with subsequent parthenogenetic activation. The three embodiments above are illustrated by the following flow diagrams:

Case 1
Female patient →	Remove oocyte →	Parthenogenetic →	Remove →	Add pronuclei to
		activation	pronuclei	enucleated fertilized
				oocyte
Male patient →	Obtain oocyte from →	Parthenogenetic →	Remove →	Add pronuclei to
	patient's mother	activation	pronuclei	enucleated fertilized
				oocyte
Case 2
Obtain donor →	Remove →	Add nucleus from →	Parthenogenetic →	Remove →	Add pronuclei
oocyte	pronuclei	patient's somatic	activation	pronuclei	to enucleated
		cell using nuclear			fertilized
		transfer			oocyte
Case 3
Obtain donor oocyte →	Fertilize →	Remove nucleus →	Add patient's →	Parthenogenetic
			somatic cell	activation
			nucleus

“Pluripotent cell” refers to a cell derived from an embryo produced by activation of a cell containing DNA of all female or male origin that can be maintained in vitro for prolonged, theoretically indefinite period of time in an undifferentiated state, that can give rise to different differentiated tissue types, i.e., ectoderm, mesoderm, and endoderm. The pluripotent state of the cells is preferably maintained by culturing inner cell mass or cells derived from the inner cell mass of an embryo produced by androgenetic or gynogenetic methods under appropriate conditions, for example, by culturing on a fibroblast feeder layer or another feeder layer or culture that includes leukemia inhibitory factor (LIF). The pluripotent state of such cultured cells can be confirmed by various methods, e.g., (i) confirming the expression of markers characteristic of pluripotent cells; (ii) production of chimeric animals that contain cells that express the genotype of the pluripotent cells; (iii) injection of cells into animals, e.g., SCID mice, with the production of different differentiated cell types in vivo; and (iv) observation of the differentiation of the cells (e.g., when cultured in the absence of feeder layer or LIF) into embryoid bodies and other differentiated cell types in vitro.

“Diploid cell” refers to a cell, e.g., an oocyte or blastomere, having a diploid DNA content of all male or female origin.

“Haploid cell” refers to a cell, e.g., an oocyte or blastomere, having a haploid DNA content, where the haploid DNA is of all male or female origin.

Activation refers to a process where a fertilized or unfertilized oocyte, for example, but not limited to, in metaphase II of meiosis, undergoes a process typically including separation of the chromatid pairs, extrusion of the second polar body, resulting in an oocyte having a haploid number of chromosomes, each with one chromatid. Activation includes methods whereby a cell containing DNA of all male or female origin is induced to develop into an embryo that has a discernible inner cell mass and trophectoderm, which is useful for producing pluripotent cells but which is itself is likely to be incapable of developing into a viable offspring. Activation may be carried out, for example, under one of the following conditions: (1) conditions that do not cause second polar body extrusion; (ii) conditions that cause polar body extrusion but where the polar body extrusion is inhibited; or (iii) conditions that inhibit first cell division of the haploid oocyte.

“Metaphase II” refers to a stage of cell development where the DNA content of a cell consists of a haploid number of chromosomes with each chromosome represented by two chromatids.

In one embodiment, metaphase II oocytes are activated by incubating oocytes under various O₂ tension gas environments. In a related aspect, the low O₂ tension gas environment is created by a gas mixture comprising an O₂ concentration of about 2%, 3%, 4%, or 5%. In a further related aspect, the gas mixture comprises about 5% CO₂. Further, the gas mixture comprises about 90% N₂, 91% N₂, or 93% N₂. This gas mixture is to be distinguished from 5% CO₂ air, which is approximately about 5% CO₂, 20% O₂, and 75% N₂.

“O₂ tension” refers to the partial pressure (pressure exerted by a single component of a gas mixture) of oxygen in a fluid (i.e., liquid or gas). Low tension is when the partial pressure of oxygen (pO₂) is low and high tension is when the pO₂ is high.

“Defined-medium conditions” refer to environments for culturing cells where the concentration of components therein required for optimal growth are detailed. For example, depending on the use of the cells (e.g., therapeutic applications), removing cells from conditions that contain xenogenic proteins is important; i.e., the culture conditions are animal-free conditions or free of non-human animal proteins. In a related aspect, “in vitro fertilization (IVF) media” refers to a nutrient system which contains chemically defined substances on or in which fertilized oocytes can be grown.

“Extracellular matrix (ECM) substrates” refer to a surface beneath cells which supports optimum growth. For example, such ECM substrates include, but are not limited to, Matrigel, laminin, gelatin, and fibronectin substrates. In a related aspect, such substrates may comprise collagen IV, entactin, heparin sulfate proteoglycan, to include various growth factors (e.g., bFGF, epidermal growth factor, insulin-like growth factor-1, platelet derived growth factor, nerve growth factor, and TGF-β-1).

“Embryo” refers to an embryo that results upon activation of a cell, e.g., oocyte or other embryonic cells containing DNA of all male or female origin, which optionally may be modified, that comprises a discernible trophectoderm and inner cell mass, which cannot give rise to a viable offspring and where the DNA is of all male or female origin. The inner cell mass or cells contained therein are useful for the production of pluripotent cells as defined previously.

“Inner cell mass (ICM)” refers to the inner portion of an embryo which gives rise to fetal tissues. Herein, these cells are used to provide a continuous source of pluripotent cells in vitro. Further, the ICM includes the inner portion of the embryo that results from androgenesis or gynogenesis, i.e., embryos that result upon activation of cells containing DNA of all male or female origin. Such DNA, for example, will be human DNA, e.g., human oocyte or spermatozoal DNA, which may or may not have been genetically modified.

“Trophectoderm” refers to another portion of early stage embryo which gives rise to placental tissues, including that tissue of an embryo that results from androgenesis or gynogenesis, i.e., embryos that result from activation of cells that contain DNA of all male or female origin, e.g., human ovarian or spermatozoan.

“Differentiated cell” refers to a non-embryonic cell that possesses a particular differentiated, i.e., non-embryonic, state. The three earliest differentiated cell types are endoderm, mesoderm, and ectoderm.

“Substantially identical” refers to a quality of sameness regarding a particular characteristic that is so close as to be essentially the same within the ability to measure difference (e.g., by HLA typing, SNP analysis, and the like).

“Histocompatible” refers to the extent to which an organism will tolerate a graft of a foreign tissue.

“Genomic imprinting” refers to the mechanism by which a number of genes throughout the genome are monoallelically expressed according to their parental origin.

“Homoplasmy,” including grammatical variations thereof, refers to the presence of the same type of the mitochondrial DNA (mtDNA) within a cell or individual.

“Heteroplasmy,” including grammatical variations thereof, refers to the presence of a mixture of more than one type of mitochondrial DNA (mtDNA) within a cell or individual.

“Uniparental” refers to one or more cells or individuals from which another arises and to which it remains subsidiary.

“Mechanically isolating” refers to the process of separating cell aggregates by physical forces. For example, such a process would exclude the use of enzymes (or other cell cleavage products) which might contain non-human materials.

In the native environment, immature oocytes (eggs) from the ovary undergo a process of maturation which results in the progression through meiosis to metaphase II of meiosis. The oocytes then arrest at metaphase II. In metaphase II, the DNA content of the cell consists of a haploid number of chromosomes, each represented by two chromatids.

Such oocytes may be maintained indefinitely by cryopreserving by, for example, but not limited to, microinjection with a sugar.

In one embodiment, a method for producing human stem cells from a cryopreserved oocyte or parthenote is provided, including microinjecting into the cytoplasm of the oocyte or parthenote a cryopreservation agent, freezing the oocyte or parthenote to a cryogenic temperature to cause it to enter a dormant state, storing the oocyte or parthenote in the dormant state, thawing the oocyte or parthenote, parthenogenically activating the oocyte under high O₂ tension in the presence or an ionophore followed by contacting the oocyte with a serine-threonine kinase inhibitor under low O₂ tension, culturing the activated oocyte or parthenote until blastocyst formation, isolating an inner cell mass (ICM) from the blastocyst, and culturing the cells of the ICM on a layer of human feeder cells, where culturing the ICM cells is carried out under high O₂ tension.

In one aspect, oocytes obtained as described are transferred to modified, isotonic IVF covered with embryo-tested mineral oil (Sigma), or any other suitable medium. If desired, the oocytes may be incubated with an extracellular sugar at the same concentration as the amount planned for microinjection. For example, to inject 0.1 M sugar, oocytes may be equilibrated in DMEM/F-12 with 0.1 M sugar. In one aspect, the cryopreservation agent comprises a lower Na⁺ concentration than standard DMEM (i.e., Na⁺ low media). In a related aspect, the cryopreservation agent comprises a higher K⁺ concentration than standard DMEM (i.e., K⁺ high). In a further related aspect, the cryopreservation agent comprises both a lower Na⁺ and higher K⁺ concentration than standard DMEM (i.e., Na⁺ low/K⁺ high media). In one aspect, the cryopreservation agent comprises an organic buffer, including but not limited to, HEPES. In another aspect, the cryopreservation agent comprises moieties that inhibit apoptotic protein (e.g., capases).

Alternatively, the oocytes may be optionally equilibrated with any other substantially non-permeable solute, such a NaCl, to decrease their cell volume prior to microinjection. This initial decrease in cell volume may result in a smaller final volume of the microinjected oocytes compared to oocytes not incubated in a hypertonic media prior to microinjection. This smaller final volume may minimize any potential adverse effect from the swelling of the oocytes. This general procedure for the preparation of cells for microinjection may also be used for other cell types (e.g., activated oocytes, hES cells, and the like).

The oocytes are then microinjected with a cryopreservation agent. Microinjection equipment and procedures are well characterized in the art and microinjection equipment known for use in injecting small molecules into cells may be used with the invention. In an exemplary microinjection step, oocytes can be microinjected at a pressure of 10 psi for 30 milliseconds. Another example of a standard microinjection technique is the method described by Nakayama and Yanagimachi (Nature Biotech. 16:639-642, 1998).

A cryopreservation agent useful in this process includes any chemical that has cryo-protective properties and is ordinarily non-permeable. In particular, the cryopreservation agent can include sugars either alone or mixed together with other traditional cryopreservation agents. Carbohydrate sugars such as trehalose, sucrose, fructose, and raffinose, may be microinjected to concentrations less than or equal to about 1.0 M, and more preferably, less than or equal to about 0.4 M. In one aspect, the concentration is between 0.05 and 0.20 M, inclusive. Additionally, an extracellular sugar or traditional cryopreservation agent may be added prior to storage. If the cells were incubated in a hypertonic solution prior to microinjection, the substantially non-permeable solute may be allowed to remain in the media after microinjection or may be removed from the media by washing the cells with media containing a lower concentration, or none, of this solute.

Certain sugars or polysaccharides which ordinarily do not permeate cell membranes because they are too large to pass through the membrane have superior physiochemical and biological properties for cryopreservation purposes. While these sugars ordinarily do not permeate cell membranes on their own, using the method as described, these ordinarily non-permeating sugars may be microinjected intracellularly to result in a beneficial effect.

Non-permeating sugars having a stabilizing or preserving effect on cells that are especially useful as the cryopreservation agent in the present method include sucrose, trehalose, fructose, dextran, and raffinose. Among these sugars, trehalose, a non-reducing disaccharide of glucose, has been shown to be exceptionally effective in stabilizing cell structures at low concentrations. The addition of extracellular glycolipids or glycoproteins may also stabilize the cell membrane.

Following the microinjection of the cryopreservation agent, the cells are prepared for storage. A variety of methods for freezing and/or drying may be employed to prepare the cells for storage. In particular, three approaches are described herein: vacuum or air drying, freeze drying, and freeze-thaw protocols. Drying processes have the advantage that the stabilized biological material may be transported and stored at ambient temperatures.

Typically, oocytes loaded with 1 to 2M DMSO are cooled at a very slow cooling rate (0.3 to 0.5° C./min) to an intermediate temperature (−60° C. to −80° C.) before plunging in liquid nitrogen for storage. The sample can then be stored at this temperature.

The suspended material can then be stored at cryopreservation temperatures, for example, by leaving the vials in liquid nitrogen (LN₂), for the desired amount of time.

Protocols for vacuum or air drying and for freeze drying proteins are well characterized in the art (Franks et al., “Materials Science and the Production of Shelf-Stable Biologicals,” BioPharm, October 1991, p. 39; Shalaev et al., “Changes in the Physical State of Model Mixtures during Freezing and Drying: Impact on Product Quality,” Cryobiol. 33, 14-26 (1996)) and such protocols may be used to prepare cell suspensions for storage with the method as described. In addition to air drying, other convective drying methods that may be used to remove water from cell suspensions include the convective flow of nitrogen or other gases.

An exemplary evaporative vacuum drying protocol useful with the method of the invention may include placing 20 μl each into wells on 12 well plates and vacuum drying for 2 hours at ambient temperature. Of course, other drying methods could be used, including drying the cells in vials. Cells prepared in this manner may be stored dry, and rehydrated by diluting in DMEM or any other suitable media.

A method of the invention using freeze drying to prepare the cells for storage begins with freezing the cell suspension. While methods of freezing known in the art may be employed, the simple plunge freezing method described herein for the freeze-thaw method may also be used for the freezing step in the freeze drying protocol.

After freezing, a two stage drying process may be employed. In the first stage, energy of sublimation is added to vaporize frozen water. Secondary drying is performed after the pure crystalline ice in the sample has been sublimated. Freeze dried cells can be stored and hydrated in the same manner as described above for vacuum drying. Viable cells may then be recovered.

After the recovery of cells from a frozen or dried state, any external cryopreservation agent may be optionally removed from the culture media. For example, the media may be diluted by the addition of the corresponding media with a lower concentration of cryopreservation agent. For example, the recovered cells may be incubated for approximately five minutes in media containing a lower concentration of sugar than that used for cell storage. For this incubation, the media may contain the same sugar that was used as the cryopreservation agent; a different cryopreservation agent, such as galactose; or any other substantially non-permeable solute. To minimize any osmotic shock induced by the decrease in the osmolarity of the media, the concentration of the extracellular cryopreservation agent may be slowly decreased by performing this dilution step multiple times, each time with a lower concentration of cryopreservation agent. These dilution steps may be repeated until there is no extracellular cryopreservation agent present or until the concentration of cryopreservation agent or the osmolarity of the media is reduced to a desired level.

The parthenogenetically activated oocytes, blastocysts, ICM, and autologous stem cells can be stored or “banked” in a manner that allows the cells to be revived as needed in the future. An aliquot of the parthenogenetically activated oocytes and autologous stem cells can be removed at any time, to be grown into cultures of many undifferentiated cells and then differentiated into a particular cell type or tissue type, and may then be used to treat a disease or to replace malfunctioning tissues in a subject. Since the cells are parthenogenetically derived from the donor, the cells can be stored so that an individual or close relative can have access to cells for an extended period of time.

In one embodiment, a cell bank is provided for storing parthenogenetically activated oocytes, blastocysts, ICM, and/or autologous stem cell samples. In another embodiment, methods for administering such a cell bank are provided. U.S. Published Patent Application No. 20030215942, which is incorporated by reference herein in its entirety, provides an example of a stem cell bank system.

Using methods such as those described above, the isolation and in vitro propagation of parthenogenetically activated oocytes, blastocysts, ICM, and autologous stem cell samples and their cryopreservation facilitates the establishment of a “bank” of transplantable human stem cells. Because it is possible to store smaller aliquots of cells, the banking procedure could take up a relatively small space. Therefore, the cells of many individuals could be stored or “banked” on a short term or long term basis, with relatively little expense.

In one embodiment, a portion of the sample is made available for testing, either before or after processing and storage.

This invention also provides methods of recording or indexing the parthenogenetically activated oocyte, blastocyst, ICM, and/or autologous stem cell samples so that when a sample needs to be located, it can be easily retrieved. Any indexing and retrieval system can be used to fulfill this purpose. Any suitable type of storage system can be used so that the parthenogenetically activated oocytes, blastocysts, ICM, and/or autologous stem cells can be stored. The samples can be designed to store individual samples, or can be designed to store hundreds, thousands, and even millions of different cell samples.

The stored parthenogenetically activated oocyte, blastocyst, ICM, and/or autologous stem cell samples can be indexed for reliable and accurate retrieval. For example, each sample can be marked with alphanumeric codes, bar codes, or any other method or combinations thereof. There may also be an accessible and readable listing of information enabling identification of each parthenogenetically activated oocyte, blastocyst, ICM, and/or autologous stem cell sample and its location in the bank and enabling identification of the source and/or type the cell sample, which is outside of the bank. This indexing system can be managed in any way known in the art, e.g., manually or non-manually, e.g. a computer and conventional software can be used.

In one embodiment, the cell samples are organized using an indexing system so that the sample will be available for the donor's use whenever needed. In other embodiments, the cell samples can be utilized by individuals related to the original donor. Once recorded into the indexing system, the cell sample can be made available for matching purposes, e.g., a matching program will identify an individual with matching type information and the individual will have the option of being provided the matching sample.

The storage banking system can comprise a system for storing a plurality of records associated with a plurality of individuals and a plurality of cell samples. Each record may contain type information, genotypic information or phenotypic information associated with the cell samples or specific individuals. In one embodiment, the system will include a cross-match table that matches types of the samples with types of individuals who wish to receive a sample.

In one embodiment, the database system stores information for each parthenogenetically activated oocyte, blastocyst, ICM, and/or autologous stem cell sample in the bank. Certain information is stored in association with each sample. The information may be associated with a particular donor, for example, an identification of the donor and the donor's medical history. For example, each sample may be HLA typed and the HLA type information may be stored in association with each sample. The information stored may also be availability information. The information stored with each sample is searchable and identifies the sample in such a way that it can be located and supplied to the client immediately.

Accordingly, embodiments of the invention utilize computer-based systems that contain information such as the donor, date of submission, type of cells submitted, types of cell surface markers present, genetic information relating to the donor, or other pertinent information, and storage details such as maintenance records and the location of the stored samples, and other useful information.

The term “a computer-based system” refers to the hardware, software, and any database used to store, search, and retrieve information about the stored cells. The computer-based system preferably includes the storage media described above, and a processor for accessing and manipulating the data. The hardware of the computer-based systems of this embodiment comprises a central processing unit (CPU) and a database. A skilled artisan can readily appreciate that any one of the currently available computer-based systems are suitable.

In one embodiment, the computer system includes a processor connected to a bus that is connected to a main memory (preferably implemented as RAM) and a variety of secondary storage devices, such as a hard drive and removable medium storage device. The removable medium storage device can represent, for example, a floppy disk drive, a DVD drive, an optical disk drive, a compact disk drive, a magnetic tape drive, etc. A removable storage medium, such as a floppy disk, a compact disk, a magnetic tape, etc. containing control logic and/or data recorded therein can be inserted into the removable storage device. The computer system includes appropriate software for reading the control logic and/or the data from the removable medium storage device once inserted in the removable medium storage device. Information relating to the parthenogenetically activated oocyte, blastocyst, ICM, and/or autologous stem cell can be stored in a well known manner in the main memory, any of the secondary storage devices, and/or a removable storage medium. Software for accessing and processing these data (such as search tools, compare tools, etc.) reside in main memory during execution.

As used herein, “a database” refers to memory that can store any useful information relating to the parthenogenetically activated oocyte and/or autologous stem cell collections and the donors.

The data relating to the stored parthenogenetically activated oocyte, blastocyst, ICM, and/or autologous stem cell can be stored and manipulated in a variety of data processor programs in a variety of formats. For example, the data can be stored as text in a word processing file, such as Microsoft WORD or WORDPERFECT, an ASCII file, an html file, or a pdf file in a variety of database programs familiar to those of skill in the art, such as DB2, SYBASE, or ORACLE.

A “search program” refers to one or more programs that are implemented on the computer-based system to search for details or compare information relating to the cryopreserved samples within a database. A “retrieval program” refers to one or more programs that can be implemented on the computer-based system to identify parameters of interest in the database. For example, a retrieval program can be used to find samples that fit a particular profile, samples having specific markers or DNA sequences, or to find the location of samples corresponding to particular individuals.

There is no upper limit on the number of cell samples that can be stored in one cell bank. In one embodiment, hundreds of products from different individuals will be stored at one bank or storage facility. In another embodiment, up to millions of products may be stored in one storage facility. A single storage facility may be used to store parthenogenetically activated oocyte and/or autologous stem cell samples, or multiple storage facilities may be used.

In some embodiments of the present invention, the storage facility may have a means for any method of organizing and indexing the stored cell samples, such as, for example, automated robotic retrieval mechanisms and cell sample manipulation mechanisms. The facility may include micromanipulation devices for processing cell samples. Known conventional technologies can be used for efficient storage and retrieval of the cell samples. Exemplary technologies include but are not limited to Machine Vision, Robotics, Automated Guided Vehicle System, Automated Storage and Retrieval Systems, Computer Integrated Manufacturing, Computer Aided Process Planning, Statistical Process Control, and the like.

The type information or other information associated with the individual in need of a sample may be recorded into a system that can be used to identify an appropriate matching product, such as, for example, a database system, an indexing system, and the like. Once recorded in the system, a match can be made between the type of the individual and a donor cell sample. In preferred embodiments, the donor sample is from the same individual as the individual in need of the sample. However, similar but not identical donor/recipient matches can also be used. The matching sample is available for the individual possessing the matching type identifier. In one embodiment of this invention, the individual's identification information is stored in connection with the cell sample. In some embodiments, the matching process occurs around the time of harvesting the sample, or can occur at any time during processing, storage, or when a need arises. Accordingly, in some embodiments of the invention, the matching process occurs before the individual is in actual need of the cell sample.

When the parthenogenetically activated oocyte, blastocyst, ICM, and/or autologous stem cell sample is needed by an individual, it may be retrieved and made available for research, transplantation or other purposes within minutes, if desired. The sample may also be further processed to prepare it for transplantation or other needs.

Normally, the oocyte is ovulated at this stage and fertilized by the sperm. The sperm initiates the completion of meiosis in a process called activation. During activation, the pairs of chromatids separate, the second polar body is extruded, and the oocyte retains a haploid number of chromosomes, each with one chromatid. The sperm contributes the other haploid complement of chromosomes to make a full diploid cell with single chromatids. The chromosomes then progress through DNA synthesis during the first cell cycle. These cells then develop into embryos.

By contrast, embryos described herein are developed by artificial activation of cells, typically mammalian oocytes or blastomeres containing DNA of all male or female origin. As discussed in the background of the invention, many methods have been reported in the literature for artificial activation of unfertilized oocytes. Such methods include physical methods, e.g., mechanical methods such as pricking, manipulation or oocytes in culture, thermal methods such as cooling and heating, repeated electric pulses, enzymatic treatments, such as trypsin, pronase, hyaluronidase, osmotic treatments, ionic treatments such as with divalent cations and calcium ionophores, such as ionomycin and A23187, the use of anesthetics such as ether, ethanol, tetracaine, lignocaine, procaine, phenothiazine, tranquilizers such as thioridazine, trifluoperazine, fluphenazine, chlorpromazine, the use of protein synthesis inhibitors such as cycloheximide, puromycin, the use of phosphorylation inhibitors, e.g., protein kinase inhibitors such as staurosporine, 2-aminopurine, sphingosine, and DMAP, combinations thereof, as well as other methods.

Such activation methods are well known in the art and are discussed U.S. Pat. No. 5,945,577, incorporated herein by reference.

In one embodiment, a human cell in metaphase II, typically an oocyte or blastomere comprising DNA of all male or female origin, is artificially activated for effecting artificial activation of oocytes.

In a related aspect, the activated cell, e.g., oocyte, which is diploid, is allowed to develop into an embryo that comprises a trophectoderm and an inner cell mass. This can be effected using known methods and culture media that facilitate blastocyst development.

After the gynogenetic embryos have been cultured to produce a discernable trophectoderm and inner cell mass, the cells of the inner cell mass are then used to produce the desired pluripotent cell lines. This can be accomplished by transferring cells derived from the inner cell mass or the entire inner cell mass onto a culture that inhibits differentiation. This can be effected by transferring the inner cell mass cells onto a feeder layer that inhibits differentiation, e.g., fibroblasts or epithelial cells, such as fibroblasts derived from postnatal human tissues, etc., or other cells that produce LIF. Other factors/components may be employed to provide appropriate culture conditions for maintaining cells in the undifferentiated state including, but not limited to, addition of conditioned media (Amit et al., Developmental Biol (2000) 227:271-278), bFGF and TGF-β1 (with or without LIF) (Amit et al., Biol Reprod (2004) 70:837-845), factors which activate the gp130/STAT3 pathway (Hoffman and Carpenter, Nature Biotech (2005) 23(6):699-708), factors which activate the PI3K/Akt, PKB pathway (Kim et al., FEBS Lett (2005) 579:534-540), factors that are members of the bone morphogenetic protein (BMP) super family (Hoffman and Carpenter (2005), supra), and factors which activate the canonical/β-catenin Wnt signaling pathway (e.g., GSK-3-specific inhibitor; Sato et al., Nat Med (2004) 10:55-63). In a related aspect, such factors may comprise culture conditions that include feeder cells and/or ECM substrates (Hoffman and Carpenter (2005), supra).

In one aspect, the inner cell mass cells are cultured on human postnatal foreskin or dermal fibroblast cells or other cells which produce leukemia inhibitory factor, or in the presence of leukemia inhibitory factor. In a related aspect, feeder cells are inactivated prior to seeding with the ICM. For example, the feeder cells can be mitotically inactivated using an antibiotic. In a related aspect, the antibiotic can be, but is not limited to, mitomycin C.

Culturing will be effected under conditions that maintain the cells in an undifferentiated, pluripotent state, for prolonged periods, theoretically indefinitely. In one embodiment, oocytes are parthenogenically activated with calcium ionophores under high O₂ tension followed by contacting the oocytes with a serine-threonine kinase inhibitor under low O₂ tension. The resulting ICM from the parthenogenically activated oocytes is cultured under high O₂ tension, where the cells, for example, are maintained using a gas mixture comprising 20% O₂. In one aspect, culturable refers to being capable of, or fit for, being cultivated. In a related aspect, ICM isolation is carried out mechanically after four days of blastocyst cultivation, where the cultivation is carried out on feeder cells. Such cultivation, for example, eliminates the need to use materials derived from animal sources, as would be the case for immunosurgery.

In a related aspect, culture media for the ICM is supplemented with non-animal sera, including but not limited to, human umbilical cord serum, where the serum is present in defined media (e.g., IVF, available from MediCult A/S, Denmark; Vitrolife, Sweden; or Zander IVF, Inc., Vero Beach, Fla.). In another aspect, the media and processes as provided are free of animal products. In a related aspect, animal products are those products, including serum, interferons, chemokines, cytokines, hormones, and growth factors, that are from non-human sources.

The pluripotent state of the cells produced by the present invention can be confirmed by various methods. For example, the cells can be tested for the presence or absence of characteristic ES cell markers. In the case of human ES cells, examples of such markers are identified supra, and include SSEA-4, SSEA-3, TRA-1-60, TRA-1-81 and OCT 4, and are known in the art.

Also, pluripotency can be confirmed by injecting the cells into a suitable animal, e.g., a SCID mouse, and observing the production of differentiated cells and tissues. Still another method of confirming pluripotency is using the subject pluripotent cells to generate chimeric animals and observing the contribution of the introduced cells to different cell types. Methods for producing chimeric animals are well known in the art and are described in U.S. Pat. No. 6,642,433, incorporated by reference herein.

Yet another method of confirming pluripotency is to observe ES cell differentiation into embryoid bodies and other differentiated cell types when cultured under conditions that favor differentiation (e.g., removal of fibroblast feeder layers). This method has been utilized and it has been confirmed that the subject pluripotent cells give rise to embryoid bodies and different differentiated cell types in tissue culture.

The resultant pluripotent cells and cell lines, preferably human pluripotent cells and cell lines, which are derived from DNA of entirely female original, have numerous therapeutic and diagnostic applications. Such pluripotent cells may be used for cell transplantation therapies or gene therapy (if genetically modified) in the treatment of numerous disease conditions.

In this regard, it is known that mouse embryonic stem (ES) cells are capable of differentiating into almost any cell type. Therefore, human pluripotent (ES) cells produced according to the invention should possess similar differentiation capacity. The pluripotent cells according to the invention will be induced to differentiate to obtain the desired cell types according to known methods. For example, human ES cells produced according to the invention may be induced to differentiate into hematopoietic stem cells, muscle cells, cardiac muscle cells, liver cells, islet cells, retinal cells, cartilage cells, epithelial cells, urinary tract cells, etc., by culturing such cells in differentiation medium and under conditions which provide for cell differentiation. Medium and methods which result in the differentiation of ES cells are known in the art as are suitable culturing conditions.

For example, Palacios et al, Proc. Natl. Acad. Sci., USA, 92:7530-7537 (1995) teach the production of hematopoietic stem cells from an embryonic cell line by subjecting stem cells to an induction procedure comprising initially culturing aggregates of such cells in a suspension culture medium lacking retinoic acid followed by culturing in the same medium containing retinoic acid, followed by transferal of cell aggregates to a substrate which provides for cell attachment.

Moreover, Pedersen, J. Reprod. Fertil. Dev., 6:543-552 (1994) is a review article which references numerous articles disclosing methods for in vitro differentiation of embryonic stem cells to produce various differentiated cell types including hematopoietic cells, muscle, cardiac muscle, nerve cells, among others.

Further, Bain et al, Dev. Biol., 168:342-357 (1995) teach in vitro differentiation of embryonic stem cells to produce neural cells which possess neuronal properties. These references are exemplary of reported methods for obtaining differentiated cells from embryonic or stem cells. These references and in particular the disclosures therein relating to methods for differentiating embryonic stem cells are incorporated by reference in their entirety herein. Thus, using known methods and culture medium, one skilled in the art may culture the subject ES cells, including genetically engineered or transgenic ES cells, to obtain desired differentiated cell types, e.g., neural cells, muscle cells, hematopoietic cells, etc. Pluripotent cells produced by the methods described herein may be used to obtain any desired differentiated cell type. Therapeutic usages of differentiated human cells are unparalleled. For example, human hematopoietic stem cells may be used in medical treatments requiring bone marrow transplantation. Such procedures are used to treat many diseases, e.g., late stage cancers such as ovarian cancer and leukemia, as well as diseases that compromise the immune system, such as AIDS. Hematopoietic stem cells can be obtained, e.g., by incorporating male or female DNA derived from a male or female cancer or AIDS patient with an enucleated oocyte, obtaining pluripotent cells as described above, and culturing such cells under conditions which favor differentiation, until hematopoietic stem cells are obtained. Such hematopoietic cells may be used in the treatment of diseases including cancer and AIDS.

Alternatively, the subject pluripotent cells may be used to treat a patient with a neurological disorder by culturing such cells under differentiation conditions that produce neural cell lines. Specific diseases treatable by transplantation of such human neural cells include, by way of example, Parkinson's disease, Alzheimer's disease, ALS and cerebral palsy, among others. In the specific case of Parkinson's disease, it has been demonstrated that transplanted fetal brain neural cells make the proper connections with surrounding cells and produce dopamine. This can result in long-term reversal of Parkinson's disease symptoms. In a related aspect, nerve precursors can be used to reanneal severed/damaged nerve fibers to restore movement after hand, leg, and spinal cord injuries.

One object of the subject invention is that it provides an essentially limitless supply of pluripotent, human cells that can be used to produce differentiated cells suitable for autologous transplantation for the oocyte donor. Human embryonic stem cells and their differentiated progeny derived from blastocysts remaining after infertility treatments, or created using NT, will likely be rejected by a recipient's immune system when used in allogenic cell transplantation therapy. Parthenogenically derived stem cells should result in differentiated cells that could alleviate the significant problem associated with current transplantation methods, i.e., rejection of the transplanted tissue which may occur because of host-vs-graft or graft-vs-host rejection relative to the oocyte donor. Conventionally, rejection is prevented or reduced by the administration of anti-rejection drugs such as cyclosporin. However, such drugs have significant adverse side-effects, e.g., immunosuppression, carcinogenic properties, as well as being very expensive. Cells produced by the methods as disclosed should eliminate, or at least greatly reduce, the need for anti-rejection drugs relative to the oocyte donor.

Another object of the subject invention is that it provides an essentially limitless supply of pluripotent, human cells that can be used to produce differentiated cells suitable for allogenic transplantation to members of the oocyte donor's family (e.g., siblings). The cells will be immunologically and genetically similar to those of the oocytes donor's direct family members and thus less likely to be rejected by the donor's family members.

Another object of this method is that parthenogenic activation of mammalian oocytes is a relatively simple procedure when compared to SCNT and results in the creation of stem cells with less cell manipulation.

Parthenogenic activation of mammalian oocytes has shown to be more efficient in the creation of stem cells than methods requiring mechanical manipulation of the oocyte (e.g., SCNT).

One drawback of SCNT is that subjects with deficient mitochondrial respiratory chain activity present phenotypes with striking similarities to abnormalities commonly encountered in SCNT fetuses and offspring (Hiendleder et al, Repro Fertil Dev (2005) 17(1-2):69-83). Cells normally contain only one type of mitochondrial DNA (mtDNA), termed homoplasmy, however, heteroplasmy does exist, usually as a combination of mutant and wild-type mt DNA molecules or form a combination of wild-type variants (Spikings et al., Hum Repro Update (2006) 12(4):401-415). As heteroplasmy can result in mitochondrial disease, various mechanisms exist to ensure maternal-only transmission. However, with the increasing use of protocols which bypass normal mechanisms for homoplasmy maintenance (e.g., cytoplasmic transfer (CT) and SCNT), perturbed mitochondrial function may be intrinsic to stem cells derived from these sources.

In one aspect, as the parthenotes are uniparental, the possibility of heteroplasmy is minimized.

Other diseases and conditions treatable by cell therapy include, by way of example, spinal cord injuries, multiple sclerosis, muscular dystrophy, diabetes, liver diseases Including acute diseases (viral hepatitis, drug overdoses (acetaminophen) and others), chronic diseases (chronic hepatitis and others (generally leading to cirrhosis)), heritable liver defects (hemophilia B, factor IX deficiency, bulirubin metabolism defects, urea cycle defects, lysosomal storage disease, a1-antitrypsin deficiency and others), heart diseases, cartilage replacement, burns, foot ulcers, gastrointestinal diseases, vascular diseases, kidney disease, retinal disease, urinary tract disease, and aging related diseases and conditions.

This methodology can be used to replace defective genes, e.g., defective immune system genes, cystic fibrosis genes, or to introduce genes which result in the expression of therapeutically beneficial proteins such as growth factors, lymphokines, cytokines, enzymes, etc.

For example, the gene encoding brain derived growth factor may be introduced into human pluripotent cells produced according to the invention, the cells differentiated into neural cells and the cells transplanted into a Parkinson's patient to retard the loss of neural cells during such disease.

Also, the subject pluripotent human ES cells, may be used as an in vitro model of differentiation, in particular for the study of genes which are involved in the regulation of early development. Also, differentiated cell tissues and organs produced using the subject ES cells may be used in drug studies.

Further, the subject ES cells or differentiated cells derived therefrom may be used as nuclear donors for the production of other ES cells and cell colonies.

Still further, pluripotent cells obtained according to the present disclosure may be used to identify proteins and genes that are involved in embryogenesis. This can be effected, e.g., by differential expression, i.e., by comparing mRNAs that are expressed in pluripotent cells provided according to the invention to mRNAs that are expressed as these cells differentiate into different cell types, e.g., neural cells, myocardiocytes, other muscle cells, skin cells, etc. Thereby, it may be possible to determine what genes are involved in differentiation of specific cell types.

Further, ES cells and/or their differentiated progeny that have specific genetic defects, such as the genetic defect that leads to Duchene's Muscular Dystrophy, may be used as models to study the specific disease associated with the genetic defect.

Also, it is another object of the present disclosure to expose pluripotent cell lines produced according to the described methods to cocktails of different growth factors, at different concentrations and under different cell culture conditions such as cultured on different cell matrices or under different partial pressures of gases so as to identify conditions that induce the production and proliferation of desired differentiated cell types.

The following examples are intended to illustrate but not limit the invention.

EXAMPLE 1

Production of Human Parthenogenic Embryogenic Stem Cells

Materials and Methods

Donors voluntarily donated oocytes, cumulous cells, and blood (for DNA analysis) with no financial payment. Donors signed comprehensive informed consent documents and were informed that all donated materials were to be used for research and not for reproductive purposes. Before ovarian stimulation, oocyte donors underwent medical examination for suitability according to FDA eligibility determination guidelines for donors of human cells, tissues, and cellular and tissue-based products (Food and Drug Administration. (Draft) Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue Based Products (HCT/Ps) dated May 2004) and order N 67 (02.26.03) of Russian Public Health Ministry. It included X-ray, blood and urine analysis, and liver function test. Donors were also screened for syphilis, HIV, HBV, and HCV.

Oocytes were obtained using standard hormonal stimulation to produce superovulation in the subject donor. Each donor egg underwent ovarian stimulation by FSH from the 3rd to the 13th days of their menstrual cycle. A total of 1500IU of FSh was given. From the 10th to the 14th day of the donor's menstrual cycle, gonadoliberin antagonist Orgalutran (Organon, Holland) was injected at 0.25 mg/day. From the 12th to the 14th day of the donor's menstrual cycle a daily injection of 75IU FSH+75IU LH (Menopur, Ferring GmbH, Germany(was given, If an ultrasound examination displayed follicles between 18 and 20 mm in diameter, a single 8000IU dose of hGC (Choragon, Ferring GmbH, Germany) was administered on the 14th day of the donor's menstrual cycle. Trans-vaginal punction was performed 35 hours after hCG injection on approximately the 16th day. Follicular fluid was collected from the antral follicles of anesthetized donors by ultrasound-guided needle aspiration into sterile tubes.

Cumulus oocyte complexes (COCs) were picked from the follicular fluid, washed in Flushing Medium (MediCult) and then incubated in Universal IVF medium (MediCult, see Table 1) with a Liquid Paraffin (MediCult) overlay for 2 hours in a 20% O₂, 5% CO₂, at 37° C. humidified atmosphere.

TABLE 1
IVF media.
COMPOSITION
Calcium Chloride
EDTA
Glucose
Human Serum Albumin
Magnesium Sulfate
Penicillin G
Potassium Chloride
Potassium di-Hydrogen Phosphate
Sodium Bicarbonate
Sodium Chloride
Sodium Lactate
Sodium Pyruvate
Water

Before activation, cumulus-oocyte complexes (COCs) were treated with SynVitro Hyadase (MediCult, A/S, Denmark) to remove cumulus cells followed by incubation in Universal IVF medium with a paraffin overlay for 30 minutes.

From this point onward, the culture of oocytes and embryos was performed in a humidified atmosphere at 37° C. using O₂-reduced gas mixture (90% N₂+5% O₂+5% CO₂), with the exception of the ionomycin treatment. The oocytes were activated by incubation in 5 μM ionomycin for 5 minutes in a CO₂ incubator at 37° C. in a gas environment of 20% O₂, 5% CO₂, followed by culture with 1 mM 6-dimethylaminopurine (DMAP) for 4 hours in IVF medium, with paraffin overlay, in a gas environment of 90% N₂, 5% O₂, and 5% CO₂ at 37° C. The oocytes were then washed 3 times in IVF. Activation and cultivation were carried out in 4-well plates (Nunclon, A/S, Denmark) in 500 μl of medium overlaid with liquid paraffin oil (MediCult, A/S, Denmark).

Activated oocytes were cultivated in IVF medium in a gas environment comprising 5% O₂, 5% CO₂, and 90% N₂, and embryos generated from the activated oocytes were cultured in the same gas mixture.

Activated oocytes were allowed to incubate in IVF under the above conditions (i.e., low O₂ tension) until fully expanded blastocysts containing an inner cell mass (ICM) at a Blastocyst Scoring Modification of 1AA or 2AA (Shady Grove Fertility Center, Rockville, Md., and Georgia Reproductive Specialists, Atlanta, Ga.) was observed.

The zona pellucida was removed by 0.5% pronase (Sigma, St. Louis) treatment. The ICM from blastocysts was isolated by immuno-surgery where the blastocysts were incubated with horse antiserum to human spleen cells followed by exposure to guinea pig complement. Trophoectodern cells were removed from the ICM by gently pipetting the treated blastocysts.

For the derivation of ICM from whole blastocysts, the blastocysts were placed on a feeder layer in medium designed for culture of phESC (i.e., VitroHES™ media (e.g., DMEM/high glucose medium, VitroLife, Sweden) supplemented with 10% human umbilical cord blood serum, 5 ng/ml human recombinant LIF (Chemicon Int'l, Inc., Temecula, Calif.), 4 ng/ml recombinant human FGF (Chemicon Int'l, Inc., Temecula, Calif.) and penicillin-streptomycin (100 U/100 μg)). When blastocysts attached and trophoplast cells spread, the ICM became visible. Through three to four days of additional culture, the ICM was isolated through mechanical slicing of the ICM from the trophoectoderm outgrowth using a finely drawn glass pipette. Further, the IMC cells were cultured on a feeder cell layer of mitotically inactivated post natal human dermal fibroblasts, in VirtroHES™ media (as formulated above) in a 96-well plate in 5% CO₂ and 20% O₂ at 37° C. This gas mixture was used to culture stem cells. Human fibroblast cultures were made using non-animal materials. Inactivation of fibroblasts was carried out using 10 μg/ml mitomycin C (Sigma, St. Louis, Mo.) for 3 hours.

In a separate method, immuno-surgery was performed by incubating blastocysts with horse antiserum to human spleen cells followed by exposure to rabbit complement. The trophectoderm cells were removed from the ICM through gentle pipetting of the treated blastocyts. Further culturing of the isolated ICMs was performed on a feeder layer of neonatal human skin fibroblasts (HSF) obtained from a genetically unrelated individual (with parental consent) derived using medium containing human umbilical cord blood serum. The HSF feeder layer was mitotically inactivated using mitomycin C.

The medium for the culture of HSF consisted of 90% DMEM (high glucose, with L-glutamaine (Invitrogen), 10% human umbilical cord blood serum and penicillin-streptomycin (100 U/100 mg) Invitrogen).

For the culture of ICM and phESC, VitroHES™ (Vitrolife) supplemented with 4 ng/ml hrbFGF, 5 ng/ml hrLIF and 10% human umbilical cord blood serum was used. The ICM was mechanically plated on a fresh feeder layer and cultured for three to four days. The first colony was mechanically cut and replated after five days of culture. All subsequent passages were made after five to six days in culture. For early passages, colonies were mechanically divided into clumps and replated. Further passing of phESC was performed with collagenase IV treatment and mechanical dissociation. The propagation of phESC was performed at 37° C., 5% CO₂ in a humidified atmosphere.

Oocyte Activation

From the initial donor, four oocytes were activated, and the activated oocytes were cultivated in IVF medium in a gas environment comprising 5% O₂, 5% CO₂, and 90% N₂ and followed over five (5) days. Table 2 shows the progress of maturation of the activated oocytes. Each oocyte was separated in a 4-well plate.

TABLE 2
Cultured Activated Oocytes.*
	Day 1	Day 2	Day 3	Day 5
N1	1 pronucleus (pn),	2 blastomers	4 bl equal,	1 morula,
	1 polar body (pb)	(bl) equal,	fr-2%	fr-15%
		fragmentation
		(fr)-0%
N2	0 pn,	4 bl not equal,	5 bl not equal,	4 bl not equal,
	1 pb	fr-4%	fr-20%	fr-40%
N3	1 pn,	2 bl not equal,	6 bl equal,	early
	1 pb	fr-0%	fr-0%	blastocysts
N4	1 pn,	4 bl equal,	4 bl equal,	Fully expanded
	1 pb	fr-10%	fr-20%	blastocyst with
				good ICM 1AA
*Cells were incubated in M1 ™ media (MediCult) on the first day and M2 ™ media (MediCult) on days 2-5. Media was changed everyday. M1 ™ and M2 ™ contain human serum albumin, glucose and derived metabolites, physiological salts, essential amino acids, non-essential amino acids, vitamins, nucleotides, sodium bicarbonate, streptomycin (40 mg/l), penicillin (40.000 IU/l) and phenol red.

Inner cell masses were isolated from N4 and transferred to human fibroblast feeder cells as outlined above. N1 and N2 degenerated on Day 6. Further, on Day 6, N3 produced fully expanded blastocyst with ICM 2AB. N3 was then transferred to human fibroblast feeder cells on Day 6. ICM from N4 was unchanged. N3 was used to isolate stem cells.

ICM cells were cultivated in VitroHES™ medium in a gas environment comprising 5% CO₂, and 95% N₂ and followed over forty-five (45) days. Table 2a shows the progress of N3 ICM cell cultivation.

TABLE 2a
Progress of N3-ICM Cultivation.*
Day 3  ICM transplanted on fresh feeder cells.
Day 8  Colony of cells divided mechanically into 6 pieces and
       cultivated in 3 wells of a 96-well plate-1st passage.
Day 14 From five (5) colonies of 1st passage, cells were
       mechanically divided, and 20 colonies of a 2nd passage
       were cultivated in 3 wells of a 24-well plate.
Day 20 Cells were plated in 35 mm dish-3rd passage.
Day 24 Five (5) 35 mm dishes were seeded with cells-4th passage.
       One dish was divided chemically with 5% pronase (Sigma)
       at room temperature.
Day 30 Twenty-five (25) 35 mm were seeded with cells-5th**
       passage.
Day 34 6th** cell passage.
Day 35 11 ampules were frozen from the 6th passage.
Day 37 7th** cell passage.
Day 44 12 ampules were frozen from the 7th passage.
Day 45 8th cell passage.
*Cells were grown on M2 ™ media (MediaCult).
**These passages were made with pronase digestion.

Stem Cell Isolation.

From the oocytes from 5 donors, the use of MediCult media followed by a culture under reduced oxygen allowed for the production of 23 blastocysts on the fifth or sixth day of culture. Eleven of the blastocysts had visible ICMs (Table 3).

TABLE 3
Generation of Parthenotes and Parthenogenetic Embryonic Stem Cell Lines.
	Blastocysts derived
			Normally			Without
Donor	Oocytes	Oocytes	activated	Parthenotes		visible	Lines
Number	harvested	donated	oocytes	created	With ICM	ICM	generated
1	8	4	4	4	2	—	phESC-1
							immunosurgery
2	15	8	8	8	3	3	phESC-3
							phESC-4
							phESC-5
							all from whole
							blastocysts
3	27	14	121	112	3	2	phESC-6 from
							whole
							blastocysts
4	22	11	103	10	2	3	phESC-7 from
							whole
							blastocysts
5	20	94	7	7	1	4	No cell line
							generated
1two were not activated;
2one oocyte degenerated after activation;
3one oocyte was not activated;
4two oocytes were at metaphase stage I and were discarded.

These results indicate an approximate 57.5% success rate in the formation of blastocysts from parthenogenetically activated oocytes.

Immunohistochemical Staining

For immunostaining, hES cell colonies and phESC cells on feeder layers were seeded onto micro cover glass, washed twice with PBS and fixed with 100% methanol for 5 minutes at −20° C. Cells were washed twice with PBS+0.05% Tween-20 and permeabilized with PBS+0.1% Triton X-100 for 10 minutes at room temperature. After cell washing, non-specific binding was blocked by incubation with blocking solution (PBS+0.05% Tween-20+four percent goat serum plus three percent human umbilical cord blood serum) for 30 minutes at room temperature (RT). Monoclonal antibodies were diluted in blocking solution and used for one hour at RT: SSEA-1 (MAB4301) (1:30), SSEA-3 (MAB4303) (1:10), SSEA-4 (MAB4304) (1:50), OCT-4 (MAB4305) (1:30), TRA-1-60 (MAB4360) (1:50), and TRA-1-81 (MAB4381) (1:50) from Chemicon. After the cells were washed, secondary antibodies Alexa Fluor 546 (orange-fluorescent) and 488 (green-fluorescent) (Molecular Probes, Invitrogen) were diluted 1:1000 in PBS+0.05% Tween-20 and applied for one hour at RT. Cells were washed and nuclei were stained with DAPI (Sigma) 0.1 μg/ml in PBS+0.05% Tween-20 during ten minutes at RT. Cells were washed and mounted on slides with Mowiol (Calbiochem). Fluorescence images were visualized with a fluorescence microscope.

For the detection of mesodermal markers in three week old embryoid bodies or in contractile embryoid bodies, monoclonal mouse anti-desmina antibody anti-human alpha actinin antibody (Chemicon) as the muscle specific markers, and anti-human CD31/PECAM-1 antibody (R&D Systems), antihuman VE Cadherin (DC144) antibody (R&D Systems) as the endothelial markers were used.

For detection of the endodermal markers in embryoid bodies, monoclonal mouse anti-human alpha-fetoprotein antibody (R&D Systems) was used.

Alkaline Phosphatase and Telomerase Activity

Alkaline phosphatase and telomerase activity were performed according to the manufacturer's specifications with AP kit and TRAPEZE™ Kit (Chemicon).

Karyotyping

To analyse the karyotype, hES cells were treated with 10 μg/ml Demecolcine (Sigma) for two hours, harvested with 0.05% trypsin/EDTA (Invitrogen) and centrifuged at 700×rpm for three minutes. The pellet was resuspended in 5 ml of 0.56% KCl, and incubated for 15 minutes at RT. After repeated centrifugation, the supernatant was removed and cells were resuspended and fixed with 5 ml of an ice cold mixture of methanol/acetic acid (3:1) for five minutes at +4° C. The fixation of the cells was repeated twice, after that the cell suspension was placed onto microscope slides and the preparations were stained with Giemsa Modified Stain (Sigma). Metaphases from cells prepared in this manner were analyzed by a standard G-banding method. Quantity of 5/1000 metaphase spreads were revealed and 63 metaphases were analyzed.

Embryoid Body Formation

hES and phESC cell colonies were mechanically divided into clumps and placed in wells of a 24 well plate precoated with 1.5% agarose (Sigma) in medium containing 85% Knockout DMEM, 15% human umbilical cord blood serum, 1×MEM NEAA, 1 mM Glutamax, 0.055 mM β-mercaptoethanol, penicillin-streptomycin (50 U/50 mg), 4 ng/ml hrbFGF (all from Invitrogen, except serum). Human EBs were cultured for 14 days in suspension culture and placed on a culture dish to give outgrowth or cultivated in suspension for an additional week.

Neural differentiation was induced by the cultivation of two week old embryoid bodies attached to a culture dish surface over a period of a week in differentiation medium: DMEM/F12, B27, 2 mM Glutamax, penicillin-streptomycin (100 U/100 μg) and 20 ng/ml hrbFGF (all from Invitrogen). Some embryoid bodies gave rise to differentiated cells with neural morphology, others were dissected and additionally cultured to produce neurospheres.

Rhythmically beating embryoid bodies appeared spontaneously following five days of culture after plating on an adhesive surface in the same medium as was used for embryoid body generation.

HLA Typing

Genomic DNA was extracted from donor blood, hES, phESC cells, and human newborn skin fibroblasts (NSFs) with Dynabeads DNA Direct Blood from Dynal (Invitrogen). HLA typing was performed by PCR with allele-specific sequencing primers (PCR-SSP, Protrans) according to the manufacturer's specifications. HLA class I genes (HLA A*,B*,Cw*) were typed with PROTRANS HLA A*B*Cw* defining A*01-A*80, B*07-B*83, Cw*01-Cw*18 regions. HLA class II genes (HLA DRB1*, DRB3*, DRB4*, DRB5*, DQA1*, DQB1*) were analysed with PROTRANS HLA DRB1* defining DRB1*01-DRB1*16 (DR1-DR18), DRB3*, DRB4*, DRB5* regions and PROTRANS HLA DQB1* DQA1* defining DQB1*02-DQB1*06 (DQ2-DQ9), DQA1*0101-DQA1*0601 regions. PCR amplification was achieved: at 94° C. for 2 min; 10 cycles at 94° C. for 10 sec, 65° C. for 1 min; 20 cycles at 94° C. for 10 sec, 61° C. for 50 sec, 72° C. for 30 sec. Amplified products were detected in 2% agarose gel.

Affimetrix SNP Microarray Analysis

Genomic DNA was isolated from blood, cumulus cells, phESC and NSF by phenol/chloroform extraction method. These DNA samples obtained from four Caucasian subjects were genotyped with Affimetrix Mapping 50K Hind 240 Array (part of Affimetrix GeneChip Mapping 100K kit). Initially, the dataset contained 57,244 binary SNP markers. Since the number of markers is more than would be necessary to identify the equivalency of genomic samples and to study heterozygosity, 15 (chromosomes 1-15) out of 22 autosomal chromosomes were chosen. The shorter seven chromosomes were removed to reduce the chance that no marker, or only a single marker for a given chromosome, is selected during random sampling. The 1,459 markers were analyzed by Relcheck (version 0.67, Copyright ©) 2000 Karl W. Broman, Johns Hopkins University, Licensed under GNU General Public License version 2 (June 1991)).

Genomic Imprinting Analysis

Total nucleic acid was prepared as described Li et al. (J Biol Chem (2002) 277(16):13518-13527). RNA and DNA were extracted from cells using Tri-reagent (Sigma) or by using an RNA preparation kit from Qiagen (Valencia, Calif.).

Northern blots containing RNA from the various samples (see FIG. 3) were blotted onto filters by standard methods (See, e.g., Sambrook et al., Molecular Cloning: A Laboratory Manual, 1989, 2nd ed, Cold Spring Harbor Press). The Northern filter was hybridized with single stranded oligonucleotide probes that hybridized specifically to the mRNAs. The oligonucleotide probes were end-labeled with [γ³²P]ATP (Amersham Biosciences). The filters were subsequently washed three times for 10 min each with 0.2×SSC (1×SSC=0.15 M NaCl and 0.015 M sodium citrate) containing 0.1% SDS at 60° C. and analyzed by Phosphorlmager (Molecular Dynamics). The sequences of the oligonucleotide probes were obtained from sequences based on the following Accession Nos.: NP002393 (Peg1_—2 and Peg1_A; for these genes, human PEG1 is transcribed from two alternative promoters, resulting in the transcription of two isoforms, of which only one (isoform 1_—2) is imprinted. Paternal expression isoform 1 occurs in conjunction with an unmethylated CpG island in exon 1 of the paternal allele, whereas the corresponding CpG island in the maternal gene (isoform 1_A) is fully methylated. See, e.g., Li et al. (2002), supra); CAG29346 (SNRPN); AF087017 (H19); NR_—001564 (inactive X specific transcripts-XIST); and P04406 (GAPDH).

DNA Fingerprinting Analysis

Genomic DNA was isolated from blood, hES cells, and NSFs through a phenol/chloroform extraction, digested with HinfI restriction enzyme (Fermentas) and loaded in a 0.8% agarose gel. Following electrophoresis, denatured DNA was transferred to a nylon membrane (Hybond N, Amersham) by Southern blotting and hybridized with ³²P-labeled (CAC) 5 oligonucleotide probe. mData were analysed after membrane exposition on X-ray film (Kodak XAR) using Cronex intensifying screens.

Monolocus PCR Genotyping

In order to determine allelic identities for minisatellite loci between blood donor DNA and stem cell DNA, 11 polymorphic sites ((1) 3′ Apolipoprotein B hypervariable minisatellite locus (3'ApoB); (2) D1S80 (PMCT118) hypervariable minisatellite locus (D1S80); (3) D6S366; (4) D16S359; (5) D7S820; (6) Human von Willebrand factor gene hypervariable minisatellite locus II (vWFII); (7) D13S317; (8) Human von Willebrand factor gene hypervariable microsatellite locus (vWA); (9) Human c-fms proto-oncogene for CFS-1 receptor gene microsatellite locus (CSF1PO); (10) Human thyroid peroxidase gene microsatellite locus (TPOX); and (11) Human tyrosine hydroxylase gene microsatellite locus (TH01)) were analyzed by PCR genotyping. Allele frequencies for known populations (i.e., Russian and Caucasian-American populations) determined for the above polymorphic sites were compared to allele frequencies of these sites in test samples (i.e., hES, NSF, and donor blood DNA). Chromosomal location, Genbank locus and locus definition, repeat sequence data, allelic ladder range, VNTR ladder size range, other known alleles, allele sizes, PCR protocols, and allele frequency results for the 11 minisatellite loci of the disclosed populations analyzed are provided below.

(1) 3′ Apolipoprotein B hypervariable minisatellite locus (3′ApoB VNTR)

Chromosomal location: 2p23-p23

GenBank locus and locus definition: APOB, apolipoprotein B (including Ag(x) antigen) untranslated region

Repeat sequence 5′-3′: (TATAATTAAATATT TTATAATTAAAATATT)n (SEQ ID NO: 1)

Allelic ladder size range (bases): 450+10+2 primer+links

VNTR ladder size range (# of repeats, according to Ludwig et al, 1989): 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52

Other known alleles (# of repeats): 25, 27, 28, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 54, 55

Promega K562 DNA® Allele sizes (# of repeats): 36/36

PCR protocol:

Thermal cycler:               DNA Technology Ltd., Russia
Initial Incubation:           95° C., 2′
Cycling for 30 cycles:
Denaturation                  94° C., 1′
Elongation and primer linking 60° C., 2′
Extension step:               72° C., 5′
Hold step:                    4° C., unlimited time

The analysis may be done as described in Verbenko et al. (Apolipoprotein B 3′-VNTR polymorphism in Eastern European populations. Eur J Hum Gen (2003) 11(1):444-451). See Table 4.

TABLE 4
Allele Frequencies for Russian Populations
		Number of Alleles
Allele	Allele frequency	observed
25	0.001	1
30	0.079	75
32	0.071	68
33	0.001	1
34	0.238	227
35	0.004	4
36	0.393	375
37	0.001	1
38	0.036	36
39	0.001	1
40	0.014	13
42	0.001	1
44	0.042	41
45	0.006	6
46	0.033	31
48	0.067	64
50	0.011	10
52	0.001	1
Homozygotes	94
Heterozygotes	333
Total samples	427

(2) D1S80 (pMCT118) hypervariable minisatellite locus (D1S80 VNTR)

Chromosomal location: 1p35-36

GenBank locus and locus definition: Human D1S80 and MCT118 gene

Repeat sequence 5′-3′: (GAAGACAGACCACAG)n (SEQ ID NO: 2)

Allelic ladder size range (bases): 387-762

VNTR ladder size range (# of repeats): 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 34, 35, 36, 37, 40, 41

Other known alleles (# of repeats): 13, 14, 15, 38, 39,>41

Promega K562 DNA® Allele sizes (# of repeats): 18/29

PCR protocol:

Thermal cycler:     DNA Technology Ltd., Russia
Initial Incubation: 95° C., 2′
Cycling for 30 cycles:
Denaturation        94° C., 45″
Primer linking      60° C., 30″
Elongation          72° C., 45″
Extension step:     72° C., 5′
Hold step:          4° C., unlimited time

The analysis may be done as described in Verbenko et al. (Allele frequencies for D1S80 (pMCT118) locus in some Eastern European populations. J Forensic Sci (2003) 48(1):207-208). See Table 5.

TABLE 5
Allele Frequencies for Russian Populations
		Number of Alleles
Allele	Allele frequency	observed
18	0.280	33
20	0.017	2
21	0.009	1
22	0.042	5
23	0.017	2
24	0.390	46
25	0.017	2
26	0.025	3
28	0.068	8
29	0.009	1
30	0.034	4
31	0.059	7
33	0.017	2
34	0.008	1
36	0.008	1
Homozygotes	15
Heterozygotes	44
Total samples	59

(3) D6S366

Chromosomal location: 6q21-qter

GenBank locus and locus definition: NA

Allelic ladder size range (bases): 150-162

STR ladder size range (# of repeats): 12, 13, 15

Other known alleles (# of repeats): 10, 11, 14, 16, 17

Promega K562 DNA® Allele sizes (# of repeats): 13/14

PCR protocol:

Thermal cycler:               DNA Technology Ltd., Russia
Initial Incubation:           95° C., 2′
Cycling for 30 cycles:
Denaturation                  94° C., 1′
Elongation and primer linking 60° C., 2′
Extension step:               72° C., 5′
Hold step:                    4° C., unlimited time

The analysis may be done as described in Efremov et al. (An expert evaluation of molecular genetic individualizing systems based on the HUMvWFII and D6S366 tetranucleotide tandem repeats. Sud Med Ekspert (1998) 41(2):33-36). See Table 6.

TABLE 6
Allele Frequencies for Russian Populations
		Number of Alleles
Allele	Allele frequency	observed
10	0.008	3
11	0.059	21
12	0.316	112
13	0.251	89
14	0.085	30
15	0.175	62
16	0.015	7
17	0.011	4
Total samples	177

(4) D16S539

Chromosomal location: 16q24-qter

GenBank locus and locus definition: NA

Repeat sequence 5′-3′: (AGAT)n

Allelic ladder size range (bases): 264-304

STR ladder size range (# of repeats): 5, 8, 9, 10, 11, 12, 13, 14, 15

Promega K562 DNA™ Allele sizes (# of repeats): 11/12

PCR protocol:

Thermal cycler:     DNA Technology Ltd., Russia
Initial Incubation: 95° C., 2′
Cycling for 30 cycles:
Denaturation        94° C., 45″
Primer linking      64° C., 30″
Elongation          72° C., 30″
Extension step:     72° C., 5′
Hold step:          4° C., unlimited time

The analysis has been done as described in GenePrint™ STR Systems (Silver Stain Detection) Technical Manual No. D004. Promega Corporation, Madison, Wis. USA: 1993-2001. See Table 7.

TABLE 7
Allele Frequencies for Caucasian-Americans
Allele	Allele frequency	Number of Alleles observed
6	0.000	0
7	0.000	0
8	0.026	11
9	0.107	45
10	0.079	33
11	0.319	134
12	0.269	113
13	0.167	70
14	0.031	13
15	0.002	1
Homozygotes	57
Heterozygotes	153
Total samples	210

(5) D7S820

Chromosomal location: 7q11.21-22

GenBank locus and locus definition: NA

Repeat sequence 5′-3′: (AGAT)n

Allelic ladder size range (bases): 215-247

VNTR ladder size range (# of repeats): 6, 7, 8, 9, 10, 11, 12, 13, 14

Promega K562 DNA® Allele sizes (# of repeats): 9/11

PCR protocol:

Thermal cycler:     DNA Technology Ltd., Russia
Initial Incubation: 95° C., 2′
Cycling for 30 cycles:
Denaturation        94° C., 45″
Primer linking      64° C., 30″
Elongation          72° C., 30″
Extension step:     72° C., 5′
Hold step:          4° C., unlimited time

analysis has been done as described in GenePrint® STR Systems (Silver Stain Detection) Technical Manual No. D004. Promega Corporation, Madison, Wis. USA: 1993-2001. See Table 8.

TABLE 8
Allele Frequencies for D7S820 in Different Populations
	Allele frequency	Number of	Allele	Number of
	for Caucasian-	Alleles	frequency	Alleles
Allele	Americans	observed	for Russians	observed
6	0.002	1	0.0012	1
7	0.010	4	0.0087	7
8	0.155	65	0.1928	155
9	0.152	64	0.1480	119
10	0.295	124	0.2524	203
11	0.195	82	0.2040	164
12	0.121	51	0.1580	127
13	0.057	24	0.0299	24
14	0.012	5	0.0050	4
Homozygotes	43	92
Heterozygotes	167	310
Total samples	210	402

(6) Human von Willebrand factor gene hypervariable microsatellite locus II (vWFII)

Chromosomal location: 12p13.3-12p13.2

GenBank locus and locus definition: HUMvWFII, Human von Willebrand factor gene

Repeat sequence 5′-3′: (ATCT)n/(AGAT)n

Allelic ladder size range (bases): 154-178

STR ladder size range (# of repeats): 9, 11, 12, 13

Other known alleles (# of repeats): 8, 10, 14, 15

Promega K562 DNA® Allele sizes (# of repeats): 13/13

PCR protocol:

Thermal cycler:               DNA Technology Ltd., Russia
Initial Incubation:           95° C., 2′
Cycling for 30 cycles:
Denaturation                  94° C., 1′
Elongation and primer linking 60° C., 2′
Extension step:               72° C., 5′
Hold step:                    4° C., unlimited time

The analysis has been done as described in Efremov et al. (An expert evaluation of molecular genetic individualizing systems based on the HUMvWFII and D6S366 tetranucleotide tandem repeats. Sud Med Ekspert (1998) 41(2):33-36). See Table 9.

TABLE 9
Allele Frequencies for Russian Populations
		Number of Alleles
Allele	Allele frequency	observed
9	0.082	37
10	0.088	40
11	0.392	177
12	0.296	134
13	0.069	31
14	0.058	26
15	0.015	7
Total samples	226

(7) D13S317

Chromosomal location: 13q22-q31

GenBank locus and locus definition: NA

Repeat sequence 5′-3′: (AGAT)n

Allelic ladder size range (bases): 165-197

STR ladder size range (# of repeats): 8, 9, 10, 11, 12, 13, 14, 15

Other known alleles (# of repeats): 7

Promega K562 DNA® Allele sizes (# of repeats): 8/8

PCR protocol:

Thermal cycler:     DNA Technology Ltd., Russia
Initial Incubation: 95° C., 2′
Cycling for 30 cycles:
Denaturation        94° C., 45″
Primer linking      64° C., 30″
Elongation          72° C., 30″
Extension step:     72° C., 5′.
Hold step:          4° C., unlimited time

The analysis has been done as described in GenePrint® STR Systems (Silver Stain Detection) Technical Manual No. D004. Promega Corporation, Madison, Wis. USA: 1993-2001. See Table 10.

TABLE 10
Allele Frequencies for D13S317 in Different Populations
	Allele frequency for	Number of	Allele frequency for	Number of
Allele	Caucasian-Americans	Alleles observed	Russians	Alleles observed
7	0.000	0	0	0
8	0.143	60	0.1393	112
9	0.052	22	0.0883	71
10	0.052	22	0.0684	55
11	0.305	128	0.3706	298
12	0.307	129	0.2040	164
13	0.083	35	0.0871	70
14	0.057	24	0.0423	34
15	0.000	0	0	0
Homozygotes	61	90
Heterozygotes	149	312
Total samples	210	402

(8) Human von Willebrand factor gene hypervariable microsatellite locus (vWA)

Chromosomal location: 12p 12pter

GenBank locus and locus definition: HUMVWFA31, Human von Willebrand factor gene

Repeat sequence 5′-3′: (AGAT)n

Allelic ladder size range (bases): 139-167

STR ladder size range (# of repeats): 14, 16, 17, 18

Other known alleles (# of repeats): 11, 12, 13, 15, 19, 20, 21

Promega K562 DNA® Allele sizes (# of repeats): 16/16

PCR protocol:

Thermal cycler:               DNA Technology Ltd., Russia
Initial Incubation:           95° C., 2′
Cycling for 30 cycles:
Denaturation                  94° C., 1′
Elongation and primer linking 60° C., 2′
Extension step:               72° C., 5′
Hold step:                    4° C., unlimited time

The analysis has been done as described in GenePrint® STR Systems (Silver Stain Detection) Technical Manual No. D004. Promega Corporation, Madison, Wis. USA: 1993-2001. See Table 11.

TABLE 11
Allele Frequencies for HUMVWFA31 in Different Populations
	Allele frequency for	Number of Alleles	Allele frequency for	Number of Alleles
Allele	Caucasian-Americans	observed	Russians	observed
13	0.000	0	0.0025	2
14	0.131	56	0.0796	64
15	0.082	35	0.0920	74
16	0.211	90	0.2127	171
17	0.265	113	0.2836	228
18	0.202	86	0.2251	181
19	0.087	37	0.0833	67
20	0.021	9	0.0199	16
21	0.000	0	0.0012	1
Homozygotes	38	70
Heterozygotes	175	332
Total samples	213	402

(9) Human c-fms proto-oncogene for CSF-1 receptor gene microsatellite locus (CSF1PO)

Chromosomal location: 5q33.3-34

GenBank locus and locus definition: HUMCSF1PO, Human c-fms proto-oncogene

Repeat sequence 5′-3′: (AGAT)n

Allelic ladder size range (bases): 295-327

STR ladder size range (# of repeats): 7, 8, 9, 10, 11, 12, 13, 14, 15

Other known alleles (# of repeats): 6

Promega K562 DNA® Allele sizes (# of repeats): 9/10

PCR protocol:

Thermal cycler:     DNA Technology Ltd., Russia
Initial Incubation: 95° C., 2′
Cycling for 30 cycles:
Denaturation        94° C., 45″
Primer linking      64° C., 30″
Elongation          72° C., 30″
Extension step:     72° C., 5′
Hold step:          4° C., unlimited time

The analysis has been done as described in GenePrint® STR Systems (Silver Stain Detection) Technical Manual No. D004. Promega Corporation, Madison, Wis. USA: 1993-2001. See Table 12.

TABLE 12
Allele Frequencies for Caucasian-Americans
Allele	Allele frequency	Number of Alleles observed
6	0.000	0
7	0.000	0
8	0.002	1
9	0.033	14
10	0.251	108
11	0.309	133
12	0.330	142
13	0.060	26
14	0.014	6
15	0.000	0
Homozygotes	47
Heterozygotes	168
Total samples	215

(10) Human thyroid peroxidase gene microsatellite locus (TPOX)

Chromosomal location: 2p25.1-pter

GeneBank locus and locus definition: HUMTPOX, Human thyroid peroxidase gene

Repeat sequence 5′-3′: (AATG)n

Allelic ladder size range (bases): 224-252

STR ladder size range (# of repeats): 6, 7, 8, 9, 10, 11, 12, 13

Other known alleles (# of repeats): none

Promega K562 DNA® Allele sizes (# of repeats): 8/9

PCR protocol:

Thermal cycler:     DNA Technology Ltd., Russia
Initial Incubation: 95° C., 2′
Cycling for 30 cycles:
Denaturation        94° C., 45″
Primer linking      64° C., 30″
Elongation          72° C., 30″
Extension step:     72° C., 5′
Hold step:          4° C., unlimited time

The analysis has been done as described in GenePrint® STR Systems (Silver Stain Detection) Technical Manual No. D004. Promega Corporation, Madison, Wis. USA: 1993-2001. See Table 13.

TABLE 13
Allele Frequencies for Caucasian-Americans
Allele	Allele frequency	Number of Alleles observed
6	0.002	1
7	0.000	0
8	0.528	227
9	0.093	40
10	0.056	24
11	0.284	122
12	0.037	16
13	0.000	0
Homozygotes	76
Heterozygotes	139
Total samples	215

(11) Human tyrosine hydroxylase gene microsatellite locus (TH01)

Chromosomal location: 5q33.3-34

GenBank locus and locus definition: HUMTHO1, Human tyrosine hydroxylase gene

Repeat sequence 5′-3′: (AATG)n

Allelic ladder size range (bases): 179-203

STR ladder size range (# of repeats): 5, 6, 7, 8, 9, 10, 11

Other known alleles (# of repeats): 9.3

Promega K562 DNA® Allele sizes (# of repeats): 9.3/9.3

PCR protocol:

Thermal cycler:     DNA Technology Ltd., Russia
Initial Incubation: 95° C., 2′
Cycling for 30 cycles:
Denaturation        94° C., 45″
Primer linking      64° C., 30″
Elongation          72° C., 30″
Extension step:     72° C., 5′
Hold step:          4° C., unlimited time

The analysis has been done as described in GenePrint® STR Systems (Silver Stain Detection) Technical Manual No. D004. Promega Corporation, Madison, Wis. USA: 1993-2001. See Table 14.

TABLE 14
Allele Frequencies for Caucasian-Americans
Allele	Allele frequency	Number of Alleles observed
5	0.007	3
6	0.237	101
7	0.148	63
8	0.117	50
9	0.155	66
9.3	0.331	141
10	0.005	2
11	0.000	0
Homozygotes	50
Heterozygotes	163
Total samples	213

Results

The hES cells from this method display many features that are typical for embryonic stem cells: cytoplasmic lipid bodies, small cytoplasmic/nuclear ratio and clearly distinguishable nucleoli. The hES cell colonies display similar morphology to that reported previously for human embryonic stem cells derived after in vitro fertilization. The cells were immunoreactively positive for alkaline phosphatase (FIG. 1A), octamer-binding transcription factor 4 mRNA (Oct-4) (FIG. 1B), stage-specific embryonic antigen 1 (SSEA-1) (FIG. 1C),stage-specific embryonic antigen 3 (SSEA-3) (FIG. 1D), stage-specific embryonic antigen 4 (SSEA-4) (FIG. 1E), tumor rejection antigen 1-60 (TRA-1-60) (FIG. 1F), tumor rejection antigen 1-81 (TRA-1-81) (FIG. 1G), and negative for stage-specific embryonic antigen 1 (SSEA-1) (FIG. 1C), (which is positive for mouse embryonic stem cells, but not for human). Telomerase activity is often correlated with replicative immortality and is typically expressed in germ cells, cancer cells, and a variety of stem cells, including stem cells, but absent in most somatic cell types. The cells prepared by this method after three months in in vitro proliferation maintained their undifferentiated morphology and displayed high levels of telomerase activity (FIG. 2A). The pluripotency of the cells was investigated in vitro by embryoid body formation (FIGS. 2B, 2C), G-banded karyotyping shows that cells have normal human 46XX karyotype (FIG. 2D).

DNA fingerprinting analysis was performed on the blood of the oocyte donor, on the ES cells, and on the HNSF feeder cells by Southern blotting and hybridization with a ³²P-labeled (CAC)s oligonucleotide probe (FIG. 2E), and monolocus polymerase chain reaction (PCR) with different locuses.

For monolocus PCR, genotyping revealed identical alleles for all loci (but one, D7S820) between blood (donor) DNA and OL1 DNA. See Table 15.

TABLE 15
Monolocus PCR genotyping.
	Locus	Chromosomal
NN	definition	location	hES	NSF	Blood
1.	3′ApoB	2p24-p23	36/48	36/36	36/48
2.	D1S80	1p35-36	18/24	22/31	18/24
3.	D6S366	6q21-qter	13/15	17/17	13/15
4.	D16S359	16q24-qter	8/13	12/13	8/13
5.	D7S820	7q11.21-22	11/11	9/10	10/11
6.	vWFII	12p13.3-12p13.2	11/13	9/11	11/13
7.	D13S317	13q22-q31	9/12	11/12	9/12
8.	vWA	12p12pter	14/18	17/18	14/18
9.	CSF1PO	5q33.3-34	12/12	12/13	12/12
10.	TPOX	2p25.1-pter	8/11	8/11	8/11
11.	TH01	5q33.3-34	6/6	6/9.3	6/6

Heterozygosity (heterozygosis) of all heterozygous donor loci (but one, D7S820) was not changed in hES loci. Homozygosity (homozygosis) of D7S820 locus in hES DNA is a result of mutation (insertion of one AGAT monomer in microsatellite repeat) due to slipped-strand mispairing during DNA replication and DNA repair.

These results are in accordance with those obtained with multilocus DNA fingerprinting (when substantially identical fingerprint patterns for donor DNA and hES DNA were found).

FIG. 2E demonstrated heterozygosity of hES cells and their identity with the oocyte donor's blood, and there was no similarity between the hES cells and the feeder cells. The DNA profile of hES cell line was confirmed by PCR-based haplotype analysis using polymorphic genes within the MHC class I and class II. Total genomic DNA from the oocyte donor blood cells, from hES cells, and feeder HNSFs were genotyped and compared. The data demonstrated that hES cells and cells from donor blood were indistinguishable from each other and therefore should be considered autologous, and both distinguished from DNA of the feeder cells (Table 16).

TABLE 16
HLA Typing.
	MHC I	MHC II
	HLA-A	HLA-B	HLA-C	DRB1	DQB1	DQA1
pHES-1	A*01	B*15(63)	Cw*04	DRB1*12	DQB1*06	DQA1*01
	A*02	B*35	Cw*0708	DRB1*13	DQB1*03	DQA1*0505
Donor	A*01	B*15(63)	Cw*04	DRB1*12	DQB1*06	DQA1*01
	A*02	B*35	Cw*0708	DRB1*13	DQB1*03	DQA1*0505
HNSF	A*25	B*15(62)	Cw*12	DRB1*04	DQB1*06	DQA1*01
	A*32	B*18	Cw*12	DRB1*15	DQB1*03	DQA1*03

DNA fingerprinting and HLA typing analysis confirmed that the hES cells are heterozygous and contain the whole donor genetic material. These results coincide with data from parthenogenetic monkey stem cell lines (Vrana et al., Proc Natl Acad Sci USA (2003) 100(Suppl 1): 11911-11916), and do not coincide with data from parthenogenetic mouse stem cell lines (Lin et al., Stem Cells (2003) 21:153-161), which contains half of the donor genetic material.

The phESC lines display a morphology expected in hES cells, forming colonies with tightly packed cells, prominent nucleoli and a small cytoplasm to nucleus ratio (FIG. 4). These cells express traditional hES markers SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, and OCT-4, and do not express SSEA-1, a positive marker for undifferentiated mouse embryonic stem cells (FIG. 4). The cells derived from all lines demonstrate high levels of alkaline phosphatase and telomerase activity (FIG. 5 and FIG. 6). G-banded karyotyping showed that phESC lines have a normal human 46,XX karyotype, with the exception of the phESC-7 line (FIG. 7). Approximately 91% of cells from the phESC-7 line have a 47,XXX karyotype and 9% of the cells have a 48,XXX,+6 karyotype. A different degree of X chromosome heteromorphism was observed in the lines; approximately 12% of the phESC-1 and phESC-6 lines; 42% for the phESC-5 line; and 70, 80, and 86% for the cell lines phESC7, phESC-3, and phESC-4, respectively (FIG. 7).

Comparative DNA profiling of was performed on all the phESC lines, the donor somatic cells and the feeder cells. These studies used Affimetrix SNP microarrays (Mapping 50K Hind 240 Arrays) to study chromosome changes and to confirm the genetic similarity of the phESC to the donor's somatic cells. All paired genotype relationships between phESC lines and their associated donor somatic cells were identified as “full siblings”, and all other combinations of pairs were identified as “unrelated”. Internal controls identified the paired genotype relationship between split cultures derived from the same phESC line as “monozygotic twins” (Table 17, Database S1).

TABLE 17
Database S1.
Database S1 Identifying DNA samples from phESC and related donors
genotype	genotype	putative	Inferred						LOD	LOD	LOD	LOD
1	2	relationship	relationship	IBS 0	IBS 1	IBS 2	n_typed	MZtwins	par/off	fullsibs	halfsibs	unrelated
1	2	unrelated	unrelated	166	662	631	1459	−1503.03	−300.45	−23.15	−8.41	0
1	3	unrelated	unrelated	241	616	602	1459	−1560.65	−434.85	−28.04	−12.22	0
1	4	unrelated	unrelated	225	623	611	1459	−1535.94	−400.61	−31.39	−14.39	0
1	5	unrelated	unrelated	225	623	611	1459	−1535.94	−400.61	−31.39	−14.39	0
1	6	unrelated	unrelated	243	644	572	1459	−1642.35	−445.78	−31.74	−14.54	0
1	7	unrelated	unrelated	252	638	569	1459	−1641.11	−453.5	−29.25	−12.86	0
1	8	unrelated	unrelated	250	643	566	1459	−1656.02	−460.02	−32.86	−15.32	0
1	9	unrelated	unrelated	219	657	583	1459	−1605.31	−382.39	−27.37	−11.58	0
1	10	unrelated	unrelated	158	707	594	1459	−1591.43	−279.21	−26.37	−10..89	0
1	11	unrelated	unrelated	193	668	598	1459	−1584.71	−354.76	−29.65	−13..31	0
1	12	unrelated	unrelated	166	671	622	1459	−1523.1	−300.5	−30.53	−13..92	0
2	3	unrelated	full sibs	0	282	1177	1459	−440.02	−146.3	0	−167.42	−363.63
2	4	unrelated	unrelated	233	627	599	1459	−1569.66	−423.24	−28.24	−12.91	0
2	5	unrelated	unrelated	233	627	599	1459	−1569.66	−423.24	−28.24	−12.91	0
2	6	unrelated	unrelated	217	650	592	1459	−1584.75	−388.44	−22.62	−8.53	0
2	7	unrelated	unrelated	243	650	566	1459	−1645.94	−437.91	−23.23	−8.72	0
2	8	unrelated	unrelated	225	649	585	1459	−1603.18	−404.41	−27.04	−11.97	0
2	9	unrelated	unrelated	210	639	610	1459	−1532.75	−360.46	−24.72	−9.89	0
2	10	unrelated	unrelated	144	683	632	1459	−1491.18	−243.56	−16.82	−4.51	0
2	11	unrelated	unrelated	172	680	607	1459	−1556.46	−310.03	−23.5	−9.7	0
2	12	unrelated	unrelated	176	667	616	1459	−1538.57	−327.95	−27.31	−12..06	0
3	4	unrelated	unrelated	336	457	666	1459	−1391.57	−599.92	−30.6	−14.62	0
3	5	unrelated	unrelated	336	457	666	1459	−1391.57	−599.92	−30.6	−14.62	0
3	6	unrelated	unrelated	322	482	655	1459	−1415.98	−571.23	−26.08	−11.86	0
3	7	unrelated	unrelated	369	442	648	1459	−1432.05	−664.95	−27.39	−11.93	0
3	8	unrelated	unrelated	334	483	642	1459	−1449.86	−597.75	−31.68	−15.14	0
3	9	unrelated	unrelated	307	493	659	1459	−1395.19	−530.45	−24.56	−10	0
3	10	unrelated	unrelated	215	623	621	1459	−1503.92	−364.97	−17.26	−4.43	0
3	11	unrelated	unrelated	264	582	613	1459	−1531.91	−473.48	−28.41	−12..81	0
3	12	unrelated	unrelated	254	595	610	1459	−1544.73	−460.57	−29.92	−13..88	0
4	5	unrelated	MZ twins	0	0	1459	1459	0	−379.58	−45.47	−401.67	−677.74
4	6	unrelated	unrelated	334	475	650	1459	−1436.59	−599.55	−32.73	−15.19	0
4	7	unrelated	unrelated	365	439	655	1459	−1418.34	−656.01	−31.6	−14.56	0
4	8	unrelated	unrelated	329	486	644	1459	−1450.75	−586.4	−32.06	−14.88	0
4	9	unrelated	unrelated	332	466	661	1459	−1395.18	−590.12	−28.69	−12.94	0
4	10	unrelated	unrelated	245	606	608	1459	−1542.32	−438.93	−28.75	−12..74	0
4	11	unrelated	unrelated	273	569	617	1459	−1530.97	−492.84	−29.03	−12..34	0
4	12	unrelated	full sibs	0	224	1235	1459	−326.17	−162.34	0	−183.44	−393.46
5	6	unrelated	unrelated	334	475	650	1459	−1436.59	−599.55	−32.73	−15.19	0
5	7	unrelated	unrelated	365	439	655	1459	−1418.34	−656.01	−31.6	−14.56	0
5	8	unrelated	unrelated	329	486	644	1459	−1450.75	−586.4	−32.06	−14.88	0
5	9	unrelated	unrelated	332	466	661	1459	−1395.18	−590.12	−28.69	−12.94	0
5	10	unrelated	unrelated	245	606	608	1459	−1542.32	−438.93	−28.75	−12..74	0
5	11	unrelated	unrelated	273	569	617	1459	−1530.97	−492.84	−29.03	−12..34	0
5	12	unrelated	full sibs	0	224	1235	1459	−326.17	−162.34	0	−183.44	−393.46
6	7	unrelated	full sibs	45	176	1238	1459	−277.78	−217.21	0	−165.72	−390.62
6	8	unrelated	full sibs	44	187	1228	1459	−289.8	−201.32	0	−153.75	−365.51
6	9	unrelated	unrelated	333	481	645	1459	−1436.5	−595.4	−30.3	−13.77	0
6	10	unrelated	unrelated	240	601	618	1459	−1518.17	−425.03	−27.11	−11..53	0
6	11	unrelated	full sibs	0	164	1295	1459	−209.27	−191.66	0	−213.25	−440.56
6	12	unrelated	unrelated	234	615	610	1459	−1547.15	−416.14	−30.21	−13..64	0
7	8	unrelated	full sibs	38	225	1196	1459	−326.62	−150.16	0	−121.55	−334.09
7	9	unrelated	unrelated	359	473	627	1459	−1479.28	−642.41	−30.61	−14.47	0
7	10	unrelated	unrelated	252	623	584	1459	−1598.35	−443.81	−28.88	−13..09	0
7	11	unrelated	full sibs	0	230	1229	1459	−318.49	−137.93	0	−159.55	−389.58
7	12	unrelated	unrelated	265	583	611	1459	−1539.33	−472.91	−30.55	−13..87	0
8	9	unrelated	unrelated	347	480	632	1459	−1472.41	−625.68	−30.93	−14.31	0
8	10	unrelated	unrelated	244	614	601	1459	−1561.3	−434	−28.07	−12..37	0
8	11	unrelated	full sibs	0	175	1284	1459	−223.73	−178.56	0	−200.12	−428.04
8	12	unrelated	unrelated	236	610	613	1459	−1539.08	−417.14	−29.32	−13..14	0
9	10	unrelated	full sibs	0	228	1231	1459	−315.15	−152.88	0	−174.27	−392.91
9	11	unrelated	unrelated	269	567	623	1459	−1502.69	−479.57	−28.47	−12..55	0
9	12	unrelated	unrelated	245	612	602	1459	−1557.25	−438.53	−26.07	−11..15	0
10	11	unrelated	unrelated	187	635	637	1459	−1478.7	−328.06	−25.52	−10.6	0
10	12	unrelated	unrelated	181	662	616	1459	−1534.36	−329	−25.2	−10.6	0
DNA samples were numbered as follows: 1-human neonatal skin fibroblasts; 2-phESC-7 line donor; 3-phESC-7 line; 4-phESC-1 line; 5-phESC-1 line; 6-phESC-3 line; 7-phESC-4 line; 8-phESC-5 line; 9-phESC-6 line; 10-phESC-6 line donor; 11-phESC-3 to phESC-5 lines donor; and 12-phESC-1 line donor.
The result shows that only one pair (sample 4-5), has been identified as monozygotic (MZ) twins. Ten other pairs (samples 2-3, 4-12, 5-12, 6-7, 6-11, 7-8, 7-11, 8-11, 9-10) have been identified as full siblings, and all the other combination of pairs have been identified as unrelated. The IBS columns in the output display the number of markers at which
# the pair are both typed and share 0, 1, or 2 alleles identical by state (For MZ twins under ideal conditions of no genotyping errors, all markers must be placed under IBS = 2). The output does not display P (observed markers | given relationship) directly, but it displays LOD score —log10 {P(observed markers | putative relationship/P(observed markers | relationship
# for which maximum likelihood was obtained and thus the call was made)} as a measure of similarity. The smaller the LOD score is, the less likely the putative relationship between two samples it.

Comparative analysis of 1,459 SNP markers revealed phESC heterozygosity and showed that changes had occurred in the phESC cell genotype in comparison to the related donor somatic cell genotype. Some segments of the somatic cell genome that had formerly been heterozygous became homozygous in the related phESC line genome. This heterozygous to homozygous pattern occurred in 11-15% of the phESC-1, PhESC-3, phESC-4, phESC-5 and phESC-6 lines, and was 19% for the phESC7 line (Database S2). Moreover, genetic differences were observed between the phESC and phESC-5 lines that had been derived from the same oocyte donor (Table 18, Database S2).

TABLE 18

Database S2.

Database S2 Heterozygosity or phESC (Abbreviated as “pC”) Lines

Freq

chromo-

RS ID

basepair

A in

pC-1

N3-5

pC-6

pC-7

some

SNP ID

(dbSNP)

basepair

(Mb)

Caucasian

pC-1

donor

pC-3

pC-4

pC-5

donor

pC-6

donor

pC-7

donor

1

SNP_A-

rs10752719

3744122

3.744122

0.436

AB

AB

BB

AB

AB

AB

BB

BB

BB

BB

1697748

1

SNP_A-

rs806104

5977200

5.9772

0.631

AB

AB

AA

AB

AB

AB

AB

AB

AA

AA

1743594

1

SNP_A-

rs301791

8402638

8.402638

0.274

AB

AB

BB

BB

BB

BB

AB

AB

AA

AB

1687843

1

SNP_A-

rs1474868

11978430

11.97843

0.333

BB

BB

AA

AA

AA

AA

AA

AA

AA

AA

1647681

1

SNP_A-

rs1417144

14211391

14.211391

0.548

AA

AA

AB

AB

AB

AB

AA

AA

AB

AB

1673737

1

SNP_A-

rs860379

18414756

18.414756

0.25

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1747116

1

SNP_A-

rs10492997

19514677

19.514677

0.631

AA

AA

BB

BB

BB

BB

AB

AB

AA

AA

1662223

1

SNP_A-

rs559346

28077956

28.077956

0.583

BB

AB

AB

AB

AB

AB

AB

AB

AA

AB

1662225

1

SNP_A-

rs4949455

31783886

31.783886

0.382

AA

AB

AB

BB

AB

AB

AB

AB

AA

AA

1646469

1

SNP_A-

rs6661190

33872782

33.872782

0.274

BB

BB

BB

BB

BB

BB

BB

BB

BB

AB

1695076

1

SNP_A-

rs4653029

34558585

34.558585

0.274

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1679571

1

SNP_A-

rs7531479

36798680

36.79868

0.714

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1675060

1

SNP_A-

rs1010805

37858235

37.858235

0.738

AA

AA

AB

AA

BB

AB

AA

AA

BB

BB

1753902

1

SNP_A-

rs6693076

39972196

39.972196

0.441

AA

AA

AB

AA

BB

AB

AB

AB

BB

BB

1691977

1

SNP_A-

rs407752

40472948

40.472948

0.333

BB

BB

AB

AA

BB

AB

BB

BB

BB

BB

1723259

1

SNP_A-

rs7515340

41055964

41.055964

0.381

AB

AB

AA

AA

AA

AA

AA

AA

BB

BB

1692103

1

SNP_A-

rs4660575

41902429

41.902429

0.429

BB

BB

BB

BB

BB

BB

AA

AA

BB

AB

1696731

1

SNP_A-

rs1408412

42787470

42.78747

0.679

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1701070

1

SNP_A-

rs1771551

45552736

45.552736

0.738

AA

AA

AA

AA

AA

AA

AA

AA

BB

AB

1729559

1

SNP_A-

rs2245122

47358015

47.358015

0.598

AA

AA

AA

AA

AA

AA

BB

BB

BB

AB

1670587

1

SNP_A-

rs1875645

50501900

50.5019

0.524

AB

AB

BB

BB

BB

BB

BB

BB

BB

BB

1711898

1

SNP_A-

rs625643

54349188

54.349188

0.25

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1645411

1

SNP_A-

rs10493206

56531172

56.531172

0.488

AA

AA

BB

BB

BB

BB

AB

AB

AA

AB

1718210

1

SNP_A-

rs1831870

57339224

57.339224

0.524

AB

AB

AB

AA

BB

AB

BB

BB

BB

AB

1752670

1

SNP_A-

rs852766

57998529

57.998529

0.564

AA

AA

AA

AA

AA

AA

AA

AA

BB

AB

1669308

1

SNP_A-

rs1969772

58917123

58.917123

0.738

AA

AA

AA

AA

AA

AA

AB

AB

AA

AB

1681141

1

SNP_A-

rs10489908

61576784

61.576784

0.738

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1690420

1

SNP_A-

rs2765249

62441479

62.441479

0.75

AA

AA

AA

AA

AA

AA

BB

BB

AA

AB

1727043

1

SNP_A-

rs3861943

63439667

63.439667

0.405

BB

BB

BB

BB

BB

BB

AB

AB

AA

AB

1646105

1

SNP_A-

rs592298

64000081

64.000081

0.25

BB

BB

BB

BB

BB

BB

AB

AB

BB

AB

1654674

1

SNP_A-

rs746633

64503887

64.503887

0.692

AA

AA

BB

BB

BB

BB

BB

BB

AA

AB

1708628

1

SNP_A-

rs1171279

65700514

65.700514

0.345

BB

BB

BB

BB

BB

BB

BB

BB

BB

AB

1713897

1

SNP_A-

rs1280310

66928844

66.928844

0.655

AB

AB

AB

BB

AA

AB

AB

AB

AA

AB

1717648

1

SNP_A-

rs1408956

67849084

67.849084

0.536

AB

AB

AB

AA

BB

AB

AB

AB

BB

BB

1712508

1

SNP_A-

rs1413953

70834525

70.834525

0.571

AB

AB

AA

AA

AA

AA

AB

AB

AA

AB

1688631

1

SNP_A-

rs1338655

73569634

73.569634

0.429

AB

AB

AA

AA

AA

AA

AA

AA

BB

BB

1720162

1

SNP_A-

rs10493539

74427598

74.427598

0.25

AA

AA

BB

BB

BB

BB

BB

BB

AA

AB

1697494

1

SNP_A-

rs277355

75002805

75.002805

0.345

BB

BB

BB

BB

BB

BB

AB

AB

BB

AB

1649261

1

SNP_A-

rs1250876

75905253

75.905253

0.345

AB

AB

AB

BB

AA

AB

AB

AB

BB

BB

1744876

1

SNP_A-

rs3928852

76926021

76.926021

0.607

AA

AA

AA

AA

AA

AA

AB

AB

AA

AA

1739854

1

SNP_A-

rs10493596

77438262

77.438262

0.718

AA

AA

AA

AA

AA

AA

AB

AB

AA

AA

1687047

1

SNP_A-

rs1248480

79071260

79.07126

0.357

BB

BB

AA

AA

AA

AA

AB

AB

BB

BB

1732619

1

SNP_A-

rs2127436

79792017

79.792017

0.488

AB

AB

AB

BB

AA

AB

BB

BB

AA

AB

1664985

1

SNP_A-

rs2389016

80511350

80.51135

0.738

AA

AA

AB

BB

AA

AB

AB

AB

AA

AB

1644541

1

SNP_A-

rs10518660

82094088

82.094088

0.738

AB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1645927

1

SNP_A-

rs6598991

82697988

82.697988

0.524

BB

BB

AB

AA

AB

AB

AA

AA

AA

AA

1693780

1

SNP_A-

rs2268667

85505767

85.505767

0.321

BB

BB

AB

AA

AB

AB

BB

BB

BB

AB

1674234

1

SNP_A-

rs306322

88673430

88.67343

0.726

AA

AA

AA

AA

AA

AA

AB

AB

BB

AB

1752288

1

SNP_A-

rs1831298

90211840

90.21184

0.262

AB

AB

BB

BB

BB

BB

AA

AA

BB

AB

1736094

1

SNP_A-

rs4233429

90811924

90.811924

0.25

BB

BB

AB

BB

AB

AB

BB

BB

BB

BB

1711115

1

SNP_A-

rs665484

91375951

91.375951

0.512

AB

AB

AA

AA

AA

AA

AA

AA

BB

BB

1714794

1

SNP_A-

rs490800

92304926

92.304926

0.369

BB

BB

AB

BB

AB

AB

AB

AB

BB

AB

1675488

1

SNP_A-

rs6703310

93500761

93.500761

0.393

AB

AB

AB

AA

AB

AB

BB

BB

BB

BB

1656572

1

SNP_A-

rs223237

96276742

96.276742

0.476

BB

BB

BB

BB

BB

BB

AA

AA

AA

AA

1755223

1

SNP_A-

rs1911500

98291841

98.291841

0.738

AA

AA

AA

AA

AA

AA

AB

AB

AA

AB

1691383

1

SNP_A-

rs1838587

101983453

101.983453

0.525

AA

AA

AB

AA

AB

AB

AB

AB

AA

AB

1725993

1

SNP_A-

rs7521799

102944538

102.944538

0.619

BB

BB

AB

AA

AB

AB

AA

AB

BB

BB

1689489

1

SNP_A-

rs1576516

104210964

104.210964

0.452

AB

AB

AA

AA

AA

AA

BB

BB

AA

AA

1684273

1

SNP_A-

rs1919894

107240697

107.240697

0.381

BB

BB

BB

BB

BB

BB

AA

AB

BB

BB

1733369

1

SNP_A-

rs10494081

108114145

108.114145

0.667

AA

AA

AA

AA

AA

AA

AA

AB

BB

AB

1715038

1

SNP_A-

rs2026485

108978565

108.978565

0.333

BB

BB

AB

BB

AB

AB

BB

BB

BB

AB

1699288

1

SNP_A-

rs6682717

110527665

110.527665

0.441

AA

AA

AB

BB

AB

AB

AA

AB

AA

AA

1750726

1

SNP_A-

rs694180

111438255

111.438255

0.464

AB

AB

BB

BB

BB

BB

BB

BB

AA

AB

1648811

1

SNP_A-

rs1936061

112187978

112.187978

0.595

AA

AA

AA

AA

AA

AA

BB

AB

BB

BB

1753842

1

SNP_A-

rs2359417

113685242

113.685242

0.452

BB

BB

BB

BB

BB

BB

AA

AB

BB

BB

1689065

1

SNP_A-

rs3767824

118152606

118.152606

0.429

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1746401

1

SNP_A-

rs1766803

119095860

119.09586

0.366

BB

AB

BB

BB

BB

BB

BB

BB

BB

BB

1688653

1

SNP_A-

rs477992

119969618

119.969618

0.286

AA

AB

BB

BB

BB

AB

BB

BB

BB

AB

1708513

1

SNP_A-

rs10494240

143040559

143.040559

0.321

AB

AB

AA

AA

AA

AA

BB

AB

AA

AB

1701244

1

SNP_A-

rs10494267

148366991

148.366991

0.321

BB

BB

BB

BB

BB

BB

AB

AB

BB

BB

1706430

1

SNP_A-

rs2879490

149760236

149.760236

0.381

BB

BB

BB

BB

BB

AB

AA

AA

AA

AA

1680305

1

SNP_A-

rs10494303

150706096

150.706096

0.571

BB

BB

AA

AA

AA

AB

AB

AB

AA

AA

1723421

1

SNP_A-

rs884664

151516798

151.516798

0.702

AA

AA

AA

AA

AA

AB

AA

AA

AA

AA

1681003

1

SNP_A-

rs10494315

154072954

154.072954

0.655

AB

AB

AA

AA

AA

AB

BB

BB

BB

AB

1667931

1

SNP_A-

rs919477

155585918

155.585918

0.25

BB

BB

BB

BB

BB

BB

BB

BB

BB

AB

1647211

1

SNP_A-

rs1149392

157241261

157.241261

0.286

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1662451

1

SNP_A-

rs6683968

158923070

158.92307

0.571

AA

AA

BB

BB

BB

BB

AA

AA

AA

AA

1695012

1

SNP_A-

rs869513

159832184

159.832184

0.607

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1716490

1

SNP_A-

rs4656422

161688624

161.688624

0.25

AB

AB

AA

AA

AB

AB

BB

BB

BB

BB

1727494

1

SNP_A-

rs4657482

162563307

162.563307

0.405

AB

AB

BB

BB

BB

BB

AB

AB

BB

BB

1646555

1

SNP_A-

rs2093658

164086850

164.08685

0.317

AA

AA

AA

AA

AB

AB

AA

AA

AA

AA

1743854

1

SNP_A-

rs1358948

165590931

165.590931

0.31

BB

BB

BB

BB

BB

BB

AB

AB

AA

AB

1681011

1

SNP_A-

rs2205848

166407951

166.407951

0.31

BB

BB

BB

BB

BB

BB

BB

BB

BB

AB

1751990

1

SNP_A-

rs10494487

167046739

167.046739

0.298

AB

AB

BB

BB

BB

BB

BB

BB

BB

BB

1736240

1

SNP_A-

rs3753538

168481215

168.481215

0.691

AA

AA

AA

AA

AA

AA

AA

AA

BB

AB

1674510

1

SNP_A-

rs10489280

169204277

169.204277

0.488

AA

AA

BB

BB

BB

BB

AA

AA

BB

BB

1719434

1

SNP_A-

rs989423

171514180

171.51418

0.75

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1753950

1

SNP_A-

rs1359587

172487558

172.487558

0.691

AB

AB

BB

BB

AB

AB

AB

AB

AA

AB

1722081

1

SNP_A-

rs2861746

173128066

173.128066

0.452

AB

AB

AA

AA

AA

AA

AB

AB

BB

BB

1694706

1

SNP_A-

rs2493119

175995013

175.995013

0.333

BB

BB

BB

BB

BB

BB

BB

BB

AA

AB

1733825

1

SNP_A-

rs1281294

178629596

178.629596

0.714

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1671505

1

SNP_A-

rs2274984

179839103

179.839103

0.524

AB

AB

AB

BB

AB

AB

AA

AA

BB

BB

1694118

1

SNP_A-

rs1184639

180355276

180.355276

0.357

BB

BB

BB

BB

BB

BB

BB

BB

BB

AB

1644471

1

SNP_A-

rs2840274

180942462

180.942462

0.429

AA

AA

BB

BB

BB

BB

AA

AB

BB

BB

1711261

1

SNP_A-

rs170885

181673406

181.673406

0.512

AB

AB

AA

AA

AA

AA

BB

AB

BB

AB

1706912

1

SNP_A-

rs10489701

182242226

182.242226

0.595

AA

AA

AB

BB

AB

AB

AA

AA

AA

AA

1703470

1

SNP_A-

rs10489756

182835425

182.835425

0.262

BB

BB

AB

AA

AB

AB

AA

AA

BB

AB

1696277

1

SNP_A-

rs726706

183604111

183.604111

0.429

AB

AB

BB

BB

BB

BB

BB

BB

AA

AB

1744486

1

SNP_A-

rs7543266

184360480

184.36048

0.595

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1693312

1

SNP_A-

rs6665263

185050414

185.050414

0.452

BB

BB

BB

BB

BB

BB

BB

BB

AA

AA

1739170

1

SNP_A-

rs10494626

186275233

186.275233

0.464

AA

AA

BB

BB

BB

BB

BB

BB

BB

AB

1726093

1

SNP_A-

rs815160

186988747

186.988747

0.427

AB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1658415

1

SNP_A-

rs1563191

187849406

187.849406

0.333

AB

AB

AB

BB

AB

AB

BB

BB

BB

BB

1666089

1

SNP_A-

rs1338034

188358939

188.358939

0.393

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1753798

1

SNP_A-

rs4657868

190164348

190.164348

0.524

AB

AB

BB

BB

BB

BB

BB

AB

BB

BB

1688981

1

SNP_A-

rs10494707

191296870

191.29687

0.357

BB

BB

BB

BB

BB

BB

AA

AB

BB

BB

1723115

1

SNP_A-

rs822456

191826836

191.826836

0.439

BB

BB

BB

BB

BB

BB

BB

BB

AA

AB

1651749

1

SNP_A-

rs10494728

192402426

192.402426

0.25

AB

AB

BB

BB

BB

BB

AA

AB

BB

BB

1642592

1

SNP_A-

rs3762271

193802099

193.802099

0.6

AB

AB

AA

AA

AA

AA

BB

BB

AA

AB

1658925

1

SNP_A-

rs1927246

195048356

195.048356

0.702

AB

AB

AB

BB

AB

AB

AA

AA

AA

AB

1687705

1

SNP_A-

rs10494808

196821529

196.821529

0.548

AB

AB

AA

AA

AA

AA

BB

BB

BB

AB

1725025

1

SNP_A-

rs6667172

197375495

197.375495

0.5

BB

BB

AA

AA

AA

AA

AA

AB

AA

AB

1665029

1

SNP_A-

rs832174

197990176

197.990176

0.25

AA

AA

BB

BB

BB

BB

BB

BB

BB

BB

1747494

1

SNP_A-

rs7555556

199822633

199.822633

0.293

AB

AB

AB

AB

AB

AB

AA

AB

BB

AB

1651207

1

SNP_A-

rs10494844

200501548

200.501548

0.75

AA

AA

AA

AA

AA

AA

AA

AB

AA

AA

1714962

1

SNP_A-

rs10494852

201189443

201.189443

0.655

BB

BB

BB

BB

BB

BB

AA

AB

AA

AA

1724123

1

SNP_A-

rs311286

203999303

203.999303

0.286

AB

AB

BB

BB

BB

BB

BB

BB

BB

BB

1673439

1

SNP_A-

rs684431

204553812

204.553812

0.381

BB

BB

AA

AB

AA

AB

BB

BB

AB

AB

1669116

1

SNP_A-

rs2358452

208747444

208.747444

0.707

AA

AA

AA

AA

AA

AA

BB

BB

AA

AA

1650733

1

SNP_A-

rs340840

210516282

210.516282

0.393

AB

AB

BB

BB

BB

BB

BB

BB

AA

AA

1651975

1

SNP_A-

rs10494987

211525052

211.525052

0.691

AB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1683565

1

SNP_A-

rs10495003

212237742

212.237742

0.417

AB

AB

BB

AB

BB

AB

AA

AB

AA

AA

1750462

1

SNP_A-

rs6604634

213109650

213.10965

0.524

BB

BB

AA

AA

AA

AA

BB

BB

AA

AA

1683969

1

SNP_A-

rs10495045

213806233

213.806233

0.714

AA

AA

AA

AB

AA

AB

BB

BB

AB

AB

1731002

1

SNP_A-

rs618171

215537693

215.537693

0.631

AB

AB

AA

AA

AA

AA

AA

AA

AB

AB

1677675

1

SNP_A-

rs10495156

217494419

217.494419

0.298

BB

BB

BB

BB

BB

BB

AA

AA

AB

AB

1703136

1

SNP_A-

rs1338077

218118775

218.118775

0.321

BB

BB

BB

AB

BB

AB

BB

BB

BB

BB

1711849

1

SNP_A-

rs4481859

219121051

219.121051

0.512

AB

AB

AA

AA

AA

AA

BB

BB

BB

BB

1755399

1

SNP_A-

rs10495236

221802391

221.802391

0.691

AB

AB

AA

AB

AA

AB

AB

AB

AB

AB

1739524

1

SNP_A-

rs710805

225430849

225.430849

0.429

AB

AB

BB

AB

BB

AB

AB

AB

AA

AA

1710164

1

SNP_A-

rs1998067

226545242

226.545242

0.298

BB

BB

AA

AA

AA

AA

BB

BB

BB

BB

1688357

1

SNP_A-

rs9286801

229119361

229.119361

0.476

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1732138

1

SNP_A-

rs1892298

230387334

230.387334

0.714

AA

AA

AA

AA

AA

AA

AA

AB

AA

AA

1747040

1

SNP_A-

rs2463190

232711157

232.711157

0.441

AB

AB

BB

AB

BB

AB

AA

AA

AA

AA

1717898

1

SNP_A-

rs819639

233219640

233.21964

0.56

AB

AB

AA

AA

AA

AA

BB

AB

AA

AA

1710935

1

SNP_A-

rs2819774

234214896

234.214896

0.691

AA

AA

AA

AA

AA

AA

BB

AB

AB

AB

1755297

1

SNP_A-

rs6685861

235621137

235.621137

0.357

BB

BB

AA

AA

AA

AA

AA

AB

AA

AA

1677233

1

SNP_A-

rs732160

236262770

236.26277

0.298

BB

BB

BB

BB

BB

BB

BB

BB

AB

AB

1679485

1

SNP_A-

rs1039529

238918670

238.91867

0.619

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1679759

1

SNP_A-

rs879725

240732087

240.732087

0.464

BB

AB

AA

AA

AA

AA

AA

AB

AB

AB

1664943

1

SNP_A-

rs1093961

241902498

241.902498

0.415

BB

AB

AB

BB

AB

AB

AA

AB

AB

AB

1724627

1

SNP_A-

rs3844080

243632874

243.632874

0.655

BB

BB

AA

AA

AA

AA

BB

AB

AA

AA

1672603

2

SNP_A-

rs10519439

108913

0.108913

0.274

BB

BB

BB

BB

BB

BB

AB

AB

BB

BB

1753456

2

SNP_A-

rs6759198

2342478

2.342478

0.56

AA

AA

BB

BB

BB

BB

AB

AB

BB

BB

1746820

2

SNP_A-

rs2119075

4395806

4.395806

0.607

AA

AA

AA

AB

AB

AB

AB

AB

AB

AB

1697325

2

SNP_A-

rs963964

5206872

5.206872

0.321

BB

BB

BB

BB

BB

BB

BB

BB

AB

AB

1740868

2

SNP_A-

rs1429220

5881639

5.881639

0.369

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1677893

2

SNP_A-

rs6727796

7605796

7.605796

0.512

BB

BB

AA

AA

AA

AA

BB

BB

AB

AB

1650909

2

SNP_A-

rs9287698

8437894

8.437894

0.281

BB

BB

BB

BB

BB

BB

AB

AB

AA

AA

1663651

2

SNP_A-

rs2271333

9323848

9.323848

0.5

AB

AB

AA

AA

AA

AA

BB

BB

BB

BB

1647101

2

SNP_A-

rs2241113

10226344

10.226344

0.31

BB

BB

AB

AB

AB

AB

BB

AB

BB

BB

1717786

2

SNP_A-

rs1686426

10899146

10.899146

0.5

BB

BB

AB

AB

AB

AB

BB

BB

BB

BB

1706150

2

SNP_A-

rs4669806

12151350

12.15135

0.619

BB

BB

AA

AA

AA

AA

AA

AA

AB

AB

1676173

2

SNP_A-

rs625842

12779571

12.779571

0.583

BB

BB

AA

AA

AA

AA

BB

BB

AB

AB

1664687

2

SNP_A-

rs7568703

15041402

15.041402

0.571

AA

AA

AB

AB

AB

AB

BB

BB

AA

AA

1696327

2

SNP_A-

rs4668968

15835884

15.835884

0.369

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1683239

2

SNP_A-

rs9306902

16971747

16.971747

0.631

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1677981

2

SNP_A-

rs10495699

19918971

19.918971

0.56

AB

AB

AB

AB

AA

AB

AA

AB

AB

AB

1714454

2

SNP_A-

rs10495705

20662972

20.662972

0.564

AA

AA

AA

AA

AA

AA

BB

AB

AA

AA

1668860

2

SNP_A-

rs7594267

23344557

23.344557

0.571

AA

AA

BB

BB

BB

BB

BB

BB

AA

AA

1693698

2

SNP_A-

rs1275963

26804398

26.804398

0.643

AB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1751070

2

SNP_A-

rs2014701

30210694

30.210694

0.631

AA

AA

AA

AA

AA

AA

BB

AB

BB

BB

1684619

2

SNP_A-

rs10490360

32207919

32.207919

0.441

BB

BB

AA

AA

AA

AA

BB

BB

AB

AB

1648557

2

SNP_A-

rs219145

33123165

33.123165

0.634

AA

AA

AA

AA

AA

AA

AA

AA

BB

BB

1671421

2

SNP_A-

rs10495796

34029149

34.029149

0.274

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1696185

2

SNP_A-

rs2049638

34866446

34.866446

0.738

AA

AA

AA

AA

AA

AA

AA

AB

AB

AB

1642658

2

SNP_A-

rs1401242

35923474

35.923474

0.417

AB

AB

AB

AB

AA

AB

AA

AB

AB

AB

1696029

2

SNP_A-

rs2161905

36427824

36.427824

0.286

BB

BB

BB

BB

BB

BB

AA

AB

BB

BB

1748242

2

SNP_A-

rs975315

38407251

38.407251

0.631

AB

AB

AA

AA

AA

AA

AA

AB

AA

AA

1660238

2

SNP_A-

rs9309043

39939220

39.93922

0.643

BB

BB

AB

AB

BB

AB

BB

BB

BB

BB

1719460

2

SNP_A-

rs2059338

41186539

41.186539

0.714

AB

AB

AB

AB

BB

AB

AA

AB

BB

BB

1714203

2

SNP_A-

rs10495900

43528810

43.52881

0.369

AB

AB

BB

BB

BB

BB

BB

BB

BB

BB

1690204

2

SNP_A-

rs4276071

44121457

44.121457

0.417

BB

BB

AA

AA

AA

AA

AB

AB

BB

BB

1740164

2

SNP_A-

rs6708061

44721790

44.72179

0.357

BB

BB

BB

BB

BB

BB

AA

AA

AB

AB

1685265

2

SNP_A-

rs6737073

45442330

45.44233

0.286

BB

BB

BB

BB

BB

BB

AA

AA

AB

AB

1680505

2

SNP_A-

rs935661

45967008

45.967008

0.56

AB

AB

AB

AA

AB

AB

AB

AB

AB

AB

1680749

2

SNP_A-

rs7589621

46494033

46.494033

0.738

AB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1721531

2

SNP_A-

rs6544955

47235732

47.235732

0.643

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1734011

2

SNP_A-

rs10495972

49412546

49.412546

0.298

AB

AB

BB

BB

BB

BB

BB

BB

BB

BB

1699364

2

SNP_A-

rs10495987

50064931

50.064931

0.286

AB

AB

AA

AA

AA

AA

BB

BB

BB

BB

1696353

2

SNP_A-

rs10490176

50979585

50.979585

0.738

AB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1646009

2

SNP_A-

rs1160297

53148971

53.148971

0.321

AB

AB

BB

BB

BB

BB

BB

BB

AB

AB

1676509

2

SNP_A-

rs843622

54460133

54.460133

0.524

BB

BB

AA

AA

AA

AA

BB

BB

AA

AA

1742892

2

SNP_A-

rs5008666

59390639

59.390639

0.65

AA

AA

BB

BB

BB

BB

AA

AA

AA

AB

1704006

2

SNP_A-

rs1517401

63452358

63.452358

0.738

AA

AA

BB

BB

BB

BB

AB

AB

AA

AA

1673301

2

SNP_A-

rs2581047

64219699

64.219699

0.286

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1711471

2

SNP_A-

rs2971828

66466238

66.466238

0.667

BB

BB

AA

AA

AA

AA

AA

AA

AA

AA

1652253

2

SNP_A-

rs9309400

67746695

67.746695

0.738

AB

AB

AA

AA

AA

AA

BB

BB

AA

AA

1722279

2

SNP_A-

rs10496165

68531740

68.53174

0.333

BB

BB

BB

BB

BB

BB

BB

BB

AA

AB

1656216

2

SNP_A-

rs2312209

69633766

69.633766

0.524

BB

BB

AA

AA

AB

AB

BB

BB

BB

BB

1703772

2

SNP_A-

rs10489986

70719802

70.719802

0.75

AA

AA

AA

AA

AA

AA

AB

AB

AA

AA

1753748

2

SNP_A-

rs6724782

73591645

73.591645

0.286

AA

AB

BB

BB

BB

BB

AB

AB

BB

BB

1723065

2

SNP_A-

rs730148

76269470

76.26947

0.408

BB

BB

AA

AA

AB

AB

AA

AA

BB

BB

1665193

2

SNP_A-

rs1446707

77141310

77.14131

0.429

BB

BB

AA

AA

AA

AA

AA

AA

BB

BB

1718918

2

SNP_A-

rs4852483

79513076

79.513076

0.75

AA

AB

BB

BB

BB

BB

AA

AA

AA

AA

1749208

2

SNP_A-

rs216616

80715814

80.715814

0.298

BB

BB

AA

AA

AA

AA

BB

BB

BB

BB

1745171

2

SNP_A-

rs9309572

81381197

81.381197

0.321

BB

BB

BB

BB

BB

AB

AA

AA

BB

AB

1750234

2

SNP_A-

rs7577293

85846940

85.84694

0.274

AA

AB

BB

BB

BB

BB

BB

BB

AA

AB

1728812

2

SNP_A-

rs9308826

99738211

99.738211

0.738

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1676217

2

SNP_A-

rs9308849

101983905

101.983905

0.714

AA

AA

AA

AA

AA

AA

AA

AB

BB

AB

1655416

2

SNP_A-

rs956966

103046093

103.046093

0.512

AA

AA

BB

BB

BB

AB

BB

BB

BB

BB

1655538

2

SNP_A-

rs1869070

106074094

106.074094

0.714

AA

AA

AA

AA

AA

AA

AB

AB

AB

AB

1690274

2

SNP_A-

rs1398132

106705516

106.705516

0.607

AB

AB

AA

AA

AA

AA

BB

BB

AB

AB

1742362

2

SNP_A-

rs826690

108705477

108.705477

0.429

BB

BB

AA

AA

AB

AB

AB

AB

AB

AB

1654768

2

SNP_A-

rs1469529

109207139

109.207139

0.583

AB

AB

AA

AA

AB

AB

AB

AB

AA

AA

1709888

2

SNP_A-

rs3961919

112959552

112.959552

0.298

BB

BB

AA

AA

AB

AB

AB

AB

AB

AB

1671489

2

SNP_A-

rs2166965

114191141

114.191141

0.679

AA

AA

AA

AA

AB

AB

AA

AA

AA

AA

1720080

2

SNP_A-

rs1346762

114988791

114.988791

0.72

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1712138

2

SNP_A-

rs9284719

118395025

118.395025

0.595

AB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1752188

2

SNP_A-

rs1370380

120731125

120.731125

0.286

AB

AB

AA

AA

AA

AA

BB

BB

AB

AB

1685413

2

SNP_A-

rs4848174

122659698

122.659698

0.655

AA

AA

AA

AA

AB

AB

AB

AB

AA

AA

1721631

2

SNP_A-

rs1215318

125809045

125.809045

0.536

AA

AA

BB

BB

BB

BB

BB

BB

AB

AB

1707304

2

SNP_A-

rs548032

127461866

127.461866

0.631

AA

AA

AA

AA

AA

AA

AA

AA

AB

AB

1673583

2

SNP_A-

rs2124432

128900396

128.900396

0.61

AB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1671177

2

SNP_A-

rs10496731

135431360

135.43136

0.488

BB

BB

AB

BB

AB

AB

AB

AB

BB

BB

1676259

2

SNP_A-

rs10496750

137176540

137.17654

0.667

AB

AB

AB

AA

AB

AB

AA

AA

AB

AB

1689435

2

SNP_A-

rs10490739

137712397

137.712397

0.287

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1695208

2

SNP_A-

rs3884566

139082237

139.082237

0.357

AB

AB

BB

BB

BB

BB

AB

AB

AB

AB

1651715

2

SNP_A-

rs3922799

139592638

139.592638

0.476

BB

BB

BB

BB

BB

BB

BB

BB

AA

AA

1665733

2

SNP_A-

rs838042

140153918

140.153918

0.262

AA

AA

AB

AA

AB

AB

BB

BB

BB

BB

1713885

2

SNP_A-

rs1518441

140908218

140.908218

0.286

AA

AA

BB

BB

BB

BB

AB

AB

AB

AB

1663529

2

SNP_A-

rs10496859

141502410

141.50241

0.536

BB

BB

AA

AA

AA

AA

AA

AA

BB

BB

1643152

2

SNP_A-

rs355562

142245134

142.245134

0.321

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1689866

2

SNP_A-

rs7560400

143121832

143.121832

0.75

AA

AA

AB

BB

AB

AB

AB

AB

AA

AA

1688373

2

SNP_A-

rs1437717

146329325

146.329325

0.571

AB

AB

AB

BB

AB

AB

AB

AB

AA

AA

1725903

2

SNP_A-

rs1528842

148291308

148.291308

0.75

AB

AB

AB

BB

AB

AB

AA

AA

AA

AA

1729119

2

SNP_A-

rs6734792

151450390

151.45039

0.738

AA

AA

AA

AA

AA

AA

BB

BB

AA

AA

1716616

2

SNP_A-

rs9287956

151979514

151.979514

0.464

BB

BB

AA

AA

AA

AA

AB

AB

AB

AB

1645341

2

SNP_A-

rs1370502

153235438

153.235438

0.667

BB

BB

BB

BB

BB

BB

AA

AA

AB

AB

1711079

2

SNP_A-

rs10497129

153977886

153.977886

0.31

AB

AB

AA

AA

AA

AA

BB

BB

BB

BB

1751360

2

SNP_A-

rs1469155

155088509

155.088509

0.726

AA

AA

AA

AA

AA

AA

BB

BB

AB

AB

1682179

2

SNP_A-

rs6750583

159423695

159.423695

0.738

BB

BB

AB

BB

AA

AB

AB

AB

AB

AB

1729675

2

SNP_A-

rs997163

161593412

161.593412

0.366

AA

AA

BB

BB

BB

BB

AA

AA

BB

BB

1710753

2

SNP_A-

rs1227921

162517707

162.517707

0.512

BB

BB

AB

BB

AA

AB

AB

AB

BB

BB

1657420

2

SNP_A-

rs1446471

164812395

164.812395

0.345

BB

BB

AB

AA

BB

AB

AA

AA

BB

BB

1681353

2

SNP_A-

rs10497261

166152395

166.152395

0.702

AB

AB

AA

AA

AA

AA

AB

AB

BB

AB

1755647

2

SNP_A-

rs9287874

167411538

167.411538

0.738

AA

AA

AA

AA

AA

AA

AB

AB

BB

AB

1656096

2

SNP_A-

rs2278785

168822282

168.822282

0.381

BB

BB

BB

BB

BB

BB

AA

AA

BB

BB

1673653

2

SNP_A-

rs830995

169955143

169.955143

0.702

AA

AA

AA

AA

AA

AA

AB

AB

AA

AB

1702574

2

SNP_A-

rs961313

170759024

170.759024

0.274

BB

BB

BB

BB

BB

BB

AB

AB

BB

BB

1645337

2

SNP_A-

rs731693

171622741

171.622741

0.667

AA

AA

AA

AA

AA

AA

AB

AB

BB

BB

1687817

2

SNP_A-

rs4095835

172330518

172.330518

0.429

BB

BB

BB

BB

BB

BB

BB

BB

BB

AB

1749036

2

SNP_A-

rs7575189

173840675

173.840675

0.512

BB

BB

AB

BB

AA

AB

AB

AB

BB

BB

1683223

2

SNP_A-

rs2119137

174843221

174.843221

0.333

AB

AB

AB

AA

BB

AB

AB

AB

BB

BB

1743510

2

SNP_A-

rs1993385

175563974

175.563974

0.476

AA

AA

AB

BB

AA

AB

AB

AB

AA

AB

1673703

2

SNP_A-

rs9287989

176543248

176.543248

0.643

BB

BB

AA

AA

AA

AA

AA

AA

AA

AB

1730586

2

SNP_A-

rs6722762

177140660

177.14066

0.345

AB

AB

BB

BB

BB

BB

AB

AB

AA

AB

1676261

2

SNP_A-

rs10497467

177733918

177.733918

0.75

AA

AA

AB

BB

AA

AB

AB

AB

AA

AA

1668972

2

SNP_A-

rs2008999

179796838

179.796838

0.643

AA

AA

BB

BB

BB

BB

AA

AA

AA

AA

1643400

2

SNP_A-

rs259845

180560120

180.56012

0.75

AA

AA

AA

AA

AA

AA

BB

BB

BB

BB

1721647

2

SNP_A-

rs9288052

181299542

181.299542

0.488

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1643999

2

SNP_A-

rs288332

183450856

183.450856

0.262

BB

BB

AA

AA

AA

AA

AA

AA

AA

AB

1668465

2

SNP_A-

rs1454042

184407382

184.407382

0.357

BB

BB

BB

BB

BB

BB

AB

AB

AA

AB

1723211

2

SNP_A-

rs10490389

186428458

186.428458

0.702

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1668055

2

SNP_A-

rs2044683

187026818

187.026818

0.366

BB

BB

BB

BB

BB

BB

AB

AB

BB

BB

1678177

2

SNP_A-

rs840611

188023952

188.023952

0.583

BB

BB

BB

BB

BB

BB

BB

BB

AA

AA

1728072

2

SNP_A-

rs10497725

192818722

192.818722

0.667

AA

AA

BB

BB

BB

BB

AA

AA

AA

AB

1750900

2

SNP_A-

rs10497744

194316402

194.316402

0.31

BB

BB

BB

BB

BB

BB

BB

BB

BB

AB

1642958

2

SNP_A-

rs1350208

198911771

198.911771

0.571

AB

AB

AB

BB

AB

AB

AA

AA

AA

AB

1669242

2

SNP_A-

rs10497821

199463403

199.463403

0.31

BB

BB

BB

BB

BB

BB

BB

BB

AA

AB

1673517

2

SNP_A-

rs1376877

204097596

204.097596

0.607

AA

AA

BB

BB

BB

BB

BB

BB

BB

AB

1645863

2

SNP_A-

rs6707500

204941128

204.941128

0.667

AB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1650883

2

SNP_A-

rs10490293

206049378

206.049378

0.274

BB

BB

AA

AA

AA

AA

BB

BB

BB

BB

1757786

2

SNP_A-

rs10490474

207934338

207.934338

0.571

BB

BB

AB

AA

AB

AB

AB

AB

AA

AA

1752790

2

SNP_A-

rs10497888

208586741

208.586741

0.679

AA

AA

BB

BB

BB

BB

AA

AA

AA

AA

1642246

2

SNP_A-

rs1607181

209364109

209.364109

0.655

AA

AB

AA

AA

AA

AA

AB

AB

BB

AB

1644145

2

SNP_A-

rs1816532

212093746

212.093746

0.75

AA

AA

BB

BB

BB

BB

AA

AA

AA

AA

1669816

2

SNP_A-

rs1402769

212906949

212.906949

0.274

BB

BB

BB

BB

BB

BB

BB

BB

BB

AB

1661335

2

SNP_A-

rs10497986

213664725

213.664725

0.702

AA

AA

BB

BB

BB

BB

AB

AB

AA

AA

1720206

2

SNP_A-

rs9283527

214674151

214.674151

0.417

AA

AA

AB

BB

AB

AB

AA

AA

AA

AA

1701518

2

SNP_A-

rs2166459

215505298

215.505298

0.31

AA

AB

BB

BB

BB

BB

AA

AA

BB

AB

1692929

2

SNP_A-

rs1250225

216151895

216.151895

0.744

BB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1755667

2

SNP_A-

rs1110998

217169458

217.169458

0.429

BB

BB

AB

AA

AB

AB

BB

BB

BB

BB

1705890

2

SNP_A-

rs6719545

218277340

218.27734

0.286

BB

AB

BB

BB

BB

BB

BB

BB

AA

AB

1743410

2

SNP_A-

rs1344645

219363524

219.363524

0.405

AA

AB

BB

BB

BB

BB

AA

AA

BB

BB

1728154

2

SNP_A-

rs715345

220649461

220.649461

0.274

AA

AA

AB

AB

AB

AB

BB

BB

BB

BB

1726837

2

SNP_A-

rs1356399

221348562

221.348562

0.702

AA

AA

AB

AB

AB

AB

BB

AB

AA

AA

1721280

2

SNP_A-

rs1430234

222049201

222.049201

0.274

BB

BB

BB

BB

BB

BB

BB

BB

BB

AB

1655920

2

SNP_A-

rs4673013

222802583

222.802583

0.619

BB

AB

AB

AB

AB

AB

AA

AA

AA

AB

1711521

2

SNP_A-

rs1961637

223730613

223.730613

0.452

AA

AB

AB

AB

AB

AB

BB

BB

BB

BB

1695224

2

SNP_A-

rs10498158

224777152

224.777152

0.417

AA

AB

BB

BB

BB

BB

BB

BB

BB

BB

1713318

2

SNP_A-

rs10498171

225622115

225.622115

0.524

BB

AB

AA

AA

AA

AA

BB

AB

BB

AB

1702406

2

SNP_A-

rs1835533

226193946

226.193946

0.738

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1643000

2

SNP_A-

rs1522804

226814661

226.814661

0.548

AA

AB

AB

AB

AB

AB

BB

BB

BB

AB

1739924

2

SNP_A-

rs1950134

227888457

227.888457

0.714

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1683533

2

SNP_A-

rs1524023

228615089

228.615089

0.75

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1663421

2

SNP_A-

rs6759815

229797926

229.797926

0.571

BB

BB

AA

AA

AA

AA

BB

BB

BB

AB

1707748

2

SNP_A-

rs4973304

230936568

230.936568

0.298

BB

BB

BB

BB

BB

BB

AA

AA

AA

AB

1661533

2

SNP_A-

rs10498257

231818543

231.818543

0.702

BB

AB

AB

AB

AB

AB

BB

AB

AA

AA

1727506

2

SNP_A-

rs3791711

233258388

233.258388

0.524

BB

AB

BB

BB

BB

BB

BB

AB

AA

AB

1728658

2

SNP_A-

rs1880747

235240125

235.240125

0.512

BB

AB

AA

AA

AA

AA

BB

AB

AA

AA

1747120

2

SNP_A-

rs103718

239180488

239.180488

0.441

AA

AA

AA

AA

AA

AA

AB

AB

AA

AA

1738177

3

SNP_A-

rs1516342

147906

0.147906

0.262

AB

AB

BB

BB

BB

BB

AA

AB

BB

BB

1675236

3

SNP_A-

rs10510204

981912

0.981912

0.405

AA

AA

AA

AA

AA

AA

AA

AB

AA

AA

1754907

3

SNP_A-

rs1720194

2366613

2.366613

0.631

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1726483

3

SNP_A-

rs1508734

3538991

3.538991

0.607

AB

AB

AB

BB

BB

AB

BB

AB

AB

AB

1717220

3

SNP_A-

rs4684484

5437541

5.437541

0.441

BB

BB

AA

AA

AA

AA

AA

AA

AA

AA

1668475

3

SNP_A-

rs9311817

6172932

6.172932

0.72

AB

AB

AA

AA

AA

AA

AA

AA

AB

AB

1646075

3

SNP_A-

rs1450097

7520521

7.520521

0.293

BB

BB

BB

BB

BB

BB

AB

AB

AB

AB

1658187

3

SNP_A-

rs486012

9016299

9.016299

0.56

AA

AA

AA

AA

AA

AA

AB

AB

AA

AB

1718736

3

SNP_A-

rs2160871

10421826

10.421826

0.75

AB

AB

AB

BB

BB

AB

AA

AA

AA

AB

1679373

3

SNP_A-

rs6792718

11409380

11.40938

0.429

AB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1649097

3

SNP_A-

rs172429

14880517

14.880517

0.25

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1713577

3

SNP_A-

rs1983085

15504547

15.504547

0.56

AA

AA

BB

BB

BB

BB

AB

AB

AA

AA

1719120

3

SNP_A-

rs2733528

17211259

17.211259

0.571

AB

AB

AA

AA

AA

AA

AB

AB

BB

BB

1701284

3

SNP_A-

rs336615

18605807

18.605807

0.619

AA

AA

AB

BB

BB

AB

AB

AB

BB

AB

1653347

3

SNP_A-

rs2053506

19350795

19.350795

0.595

AA

AA

AA

AA

AA

AA

AA

AA

BB

BB

1753110

3

SNP_A-

rs6770717

20406548

20.406548

0.726

AB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1649119

3

SNP_A-

rs365392

21465872

21.465872

0.583

BB

BB

AB

BB

BB

AB

AB

AB

BB

AB

1685927

3

SNP_A-

rs3732395

23209622

23.209622

0.378

AA

AB

BB

BB

BB

BB

BB

BB

BB

AB

1738848

3

SNP_A-

rs10510568

25577736

25.577736

0.679

BB

AB

AA

AA

AA

AA

AB

AB

AA

AB

1730534

3

SNP_A-

rs9284859

26883268

26.883268

0.655

BB

BB

AB

AB

BB

AB

AB

AB

BB

AB

1725077

3

SNP_A-

rs7639905

27951868

27.951868

0.429

BB

AB

BB

BB

BB

BB

BB

BB

AA

AA

1647333

3

SNP_A-

rs9310901

29477393

29.477393

0.274

BB

AB

AA

AA

AA

AA

AB

AB

BB

AB

1744932

3

SNP_A-

rs795347

30720945

30.720945

0.369

AA

AB

AB

AB

AB

AB

BB

BB

BB

BB

1741570

3

SNP_A-

rs347163

32435579

32.435579

0.393

BB

BB

BB

BB

BB

BB

BB

BB

AB

AB

1747050

3

SNP_A-

rs1376015

35274750

35.27475

0.595

BB

AB

AB

AB

AB

AB

AB

AB

BB

BB

1735191

3

SNP_A-

rs10510667

35834447

35.834447

0.476

BB

BB

AA

AA

AA

AA

BB

BB

AB

AB

1717686

3

SNP_A-

rs10510695

37621200

37.6212

0.738

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1643995

3

SNP_A-

rs2220345

41411812

41.411812

0.429

AA

AB

AA

AA

AA

AA

AB

AB

AB

AB

1649705

3

SNP_A-

rs531888

43047989

43.047989

0.476

BB

AB

AB

AB

AB

AB

AB

AB

AA

AA

1699750

3

SNP_A-

rs2742393

45732421

45.732421

0.417

AA

AA

AB

AB

AB

AB

BB

BB

AA

AA

1722715

3

SNP_A-

rs7620394

55206368

55.206368

0.345

BB

BB

AA

AA

AA

AA

BB

BB

AB

AB

1694360

3

SNP_A-

rs6445844

57028961

57.028961

0.726

BB

BB

AB

AB

AB

AB

AB

AB

AA

AA

1643909

3

SNP_A-

rs10510803

59329572

59.329572

0.488

BB

BB

AB

AB

AB

AB

AB

AB

AB

AB

1652229

3

SNP_A-

rs3843360

60016727

60.016727

0.393

BB

BB

AB

AB

AB

AB

AB

AB

AA

AA

1669748

3

SNP_A-

rs1996520

61592725

61.592725

0.488

BB

BB

BB

BB

BB

BB

AB

AB

AB

AB

1678019

3

SNP_A-

rs7650561

62466087

62.466087

0.643

AA

AA

AB

AB

AB

AB

AA

AA

AB

AB

1665709

3

SNP_A-

rs10510929

64709076

64.709076

0.583

BB

BB

BB

BB

BB

BB

AA

AA

BB

AB

1684953

3

SNP_A-

rs725160

66943022

66.943022

0.464

AA

AA

BB

BB

BB

BB

AB

AB

BB

BB

1688393

3

SNP_A-

rs4145917

68099517

68.099517

0.679

AB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1678015

3

SNP_A-

rs2872939

69802192

69.802192

0.405

AB

AB

AA

AA

AA

AA

AB

AB

BB

BB

1707438

3

SNP_A-

rs10510996

70545357

70.545357

0.75

AA

AA

AA

AB

AB

AB

AA

AA

AA

AB

1663707

3

SNP_A-

rs830644

71748249

71.748249

0.5

AB

AB

BB

BB

BB

BB

BB

BB

AA

AB

1650625

3

SNP_A-

rs4677226

73154304

73.154304

0.613

BB

BB

BB

BB

BB

BB

AB

AB

AA

AA

1713028

3

SNP_A-

rs1107768

73959415

73.959415

0.726

AB

AB

AA

AA

AA

AA

BB

AB

AA

AA

1685633

3

SNP_A-

rs10511039

76184447

76.184447

0.583

AA

AA

BB

BB

BB

BB

AA

AA

BB

BB

1722733

3

SNP_A-

rs251552

76852596

76.852596

0.539

AB

AB

AA

AA

AA

AA

AA

AB

BB

AB

1648479

3

SNP_A-

rs9309840

80029943

80.029943

0.588

BB

BB

BB

BB

BB

BB

BB

AB

BB

BB

1642486

3

SNP_A-

rs2639611

81623522

81.623522

0.274

BB

BB

BB

BB

BB

BB

BB

BB

AA

AA

1685115

3

SNP_A-

rs9309888

82418655

82.418655

0.262

BB

AB

BB

BB

BB

BB

BB

BB

AA

AB

1642250

3

SNP_A-

rs10511085

85614577

85.614577

0.619

BB

AB

BB

AB

BB

AB

AA

AA

AA

AB

1732971

3

SNP_A-

rs1509783

87634505

87.634505

0.476

BB

BB

BB

BB

BB

BB

AA

AB

BB

BB

1731608

3

SNP_A-

rs9310061

88146455

88.146455

0.631

AA

AA

BB

BB

BB

AB

AA

AA

AA

AB

1721601

3

SNP_A-

rs724972

89664098

89.664098

0.607

AA

AB

AA

AA

AA

AA

AA

AA

AA

AA

1715294

3

SNP_A-

rs10511152

96638708

96.638708

0.381

BB

BB

AA

AA

AA

AB

AA

AB

BB

AB

1648583

3

SNP_A-

rs3856571

99031739

99.031739

0.298

BB

AB

BB

BB

BB

BB

BB

BB

BB

BB

1701406

3

SNP_A-

rs10511169

100116062

100.116062

0.691

AA

AA

AA

AA

AA

AA

AA

AB

BB

AB

1643841

3

SNP_A-

rs2700633

100643241

100.643241

0.643

AA

AB

AA

AA

AA

AA

AA

AA

BB

AB

1697988

3

SNP_A-

rs10511183

102046105

102.046105

0.738

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1740468

3

SNP_A-

rs974059

103277828

103.277828

0.25

BB

BB

BB

BB

BB

BB

AA

AB

BB

AB

1746982

3

SNP_A-

rs1391423

103923668

103.923668

0.732

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1687227

3

SNP_A-

rs10511221

105099054

105.099054

0.726

BB

AB

AA

AA

AB

AB

AA

AA

AA

AB

1677819

3

SNP_A-

rs6783422

106031580

106.03158

0.393

AA

AA

AA

AA

AA

AA

BB

BB

AA

AA

1663937

3

SNP_A-

rs10511243

106653352

106.653352

0.667

AA

AA

AA

AA

AA

AA

BB

AB

AA

AB

1674588

3

SNP_A-

rs2222039

108202685

108.202685

0.691

BB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1652015

3

SNP_A-

rs1525873

111232702

111.232702

0.702

BB

AB

BB

BB

BB

BB

AA

AA

AA

AB

1722407

3

SNP_A-

rs1512514

111766406

111.766406

0.488

BB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1674512

3

SNP_A-

rs1797626

114308943

114.308943

0.702

AA

AA

BB

BB

AB

AB

AA

AA

AA

AA

1747616

3

SNP_A-

rs1553209

116705663

116.705663

0.476

BB

AB

AA

AA

AA

AA

BB

BB

BB

BB

1668954

3

SNP_A-

rs7621196

117804184

117.804184

0.321

BB

BB

AA

AA

AA

AA

BB

AB

AA

AB

1674292

3

SNP_A-

rs1218621

118459636

118.459636

0.31

AA

AA

BB

BB

BB

BB

BB

BB

BB

BB

1643903

3

SNP_A-

rs950649

121567065

121.567065

0.691

BB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1728638

3

SNP_A-

rs2126140

122627958

122.627958

0.5

BB

AB

AB

AA

AB

AB

AB

AB

AA

AA

1730195

3

SNP_A-

rs10511409

123610479

123.610479

0.738

BB

AB

AA

AA

AA

AA

AB

AB

BB

AB

1741126

3

SNP_A-

rs1373606

125496637

125.496637

0.342

AA

AA

BB

BB

BB

BB

AA

AA

AA

AA

1739520

3

SNP_A-

rs1374804

127391196

127.391196

0.524

AA

AB

AB

AA

AB

AB

BB

BB

AA

AA

1727336

3

SNP_A-

rs2718880

132343455

132.343455

0.75

AA

AA

AA

AA

AA

AA

AB

AB

AA

AA

1683659

3

SNP_A-

rs1553975

132999274

132.999274

0.369

BB

BB

AB

AA

AB

AB

AB

AB

BB

BB

1747192

3

SNP_A-

rs2310229

133541978

133.541978

0.691

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1744702

3

SNP_A-

rs711923

136539253

136.539253

0.744

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1730051

3

SNP_A-

rs838623

144671624

144.671624

0.619

AA

AA

AA

AA

AA

AA

AA

AA

BB

AB

1654278

3

SNP_A-

rs4610179

146387799

146.387799

0.726

AB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1730514

3

SNP_A-

rs4592991

147111601

147.111601

0.393

BB

BB

BB

BB

BB

BB

AA

AA

AB

AB

1700733

3

SNP_A-

rs7645488

149410366

149.410366

0.31

AB

AB

BB

BB

BB

BB

BB

BB

AB

AB

1744174

3

SNP_A-

rs2130319

150976344

150.976344

0.333

AB

AB

BB

BB

BB

BB

AA

AA

AB

AB

1718574

3

SNP_A-

rs7648424

151906089

151.906089

0.488

AB

AB

BB

BB

BB

BB

AA

AB

AB

AB

1718772

3

SNP_A-

rs10513399

152600180

152.60018

0.488

BB

BB

BB

BB

BB

BB

BB

BB

AB

AB

1663723

3

SNP_A-

rs2418925

155234610

155.23461

0.524

AA

AA

AB

AB

AA

AB

BB

BB

BB

BB

1746211

3

SNP_A-

rs6772323

157710345

157.710345

0.667

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1658251

3

SNP_A-

rs4679851

160261035

160.261035

0.274

AB

AB

BB

BB

BB

BB

BB

AB

AB

AB

1736960

3

SNP_A-

rs10513549

161237209

161.237209

0.25

BB

BB

AB

AB

AA

AB

BB

AB

AB

AB

1716368

3

SNP_A-

rs336583

162564683

162.564683

0.417

AA

AA

BB

BB

BB

BB

BB

BB

BB

BB

1726685

3

SNP_A-

rs7635791

163720371

163.720371

0.655

AA

AA

AB

AB

AA

AB

BB

AB

AB

AB

1721879

3

SNP_A-

rs9290201

164397051

164.397051

0.31

AB

AB

AB

AB

AA

AB

BB

AB

AB

AB

1745785

3

SNP_A-

rs4352381

165179142

165.179142

0.369

BB

BB

AA

AA

AA

AA

AA

AB

AB

AB

1697475

3

SNP_A-

rs2643191

165861395

165.861395

0.524

AA

AA

AA

AA

AA

AA

BB

BB

BB

BB

1748578

3

SNP_A-

rs1371900

167443656

167.443656

0.286

AB

AB

AB

AB

AA

AB

BB

BB

AB

AB

1687865

3

SNP_A-

rs1877269

170109722

170.109722

0.548

AB

AB

AB

AB

AA

AB

AB

AB

AB

AB

1680949

3

SNP_A-

rs8192675

172207585

172.207585

0.732

AB

AB

AB

AB

BB

AB

AA

AA

AA

AA

1731022

3

SNP_A-

rs7627220

173288405

173.288405

0.441

AB

AB

AA

AA

AA

AA

BB

BB

AB

AB

1656780

3

SNP_A-

rs792354

174456847

174.456847

0.357

BB

BB

AA

AA

AA

AA

BB

BB

BB

BB

1720350

3

SNP_A-

rs1377828

177727744

177.727744

0.286

AA

AA

BB

BB

BB

BB

BB

BB

BB

BB

1662989

3

SNP_A-

rs2160836

179192927

179.192927

0.662

AB

AB

BB

BB

BB

BB

AA

AA

AA

AA

1651103

3

SNP_A-

rs6762743

180494702

180.494702

0.667

AA

AA

AA

AA

AA

AA

AA

AA

AB

AB

1699226

3

SNP_A-

rs262958

184975690

184.97569

0.583

AB

AB

AA

AA

AA

AA

BB

BB

AB

AB

1655724

3

SNP_A-

rs10513799

186032241

186.032241

0.75

AB

AB

AA

AA

AA

AA

AB

AB

AB

AB

1726281

3

SNP_A-

rs1962838

189742951

189.742951

0.405

AB

AB

AB

AB

AB

AB

AA

AA

AB

AB

1649485

3

SNP_A-

rs2378464

190305279

190.305279

0.262

AB

AB

BB

BB

BB

BB

AB

AB

BB

BB

1756920

3

SNP_A-

rs3773928

191066407

191.066407

0.405

BB

BB

AB

AB

AB

AB

BB

BB

AB

AB

1734403

3

SNP_A-

rs1405036

192749559

192.749559

0.262

AB

AB

AB

AB

AB

AB

BB

BB

BB

BB

1720858

3

SNP_A-

rs1403033

193538911

193.538911

0.441

AB

AB

AA

AA

AA

AA

AB

AB

AB

AB

1706600

3

SNP_A-

rs587612

195020261

195.020261

0.369

AA

AA

BB

BB

BB

BB

AA

AA

BB

BB

1643612

4

SNP_A-

rs1059159

5647306

5.647306

0.683

AB

AB

AA

AA

AA

AA

AA

AA

BB

BB

1669560

4

SNP_A-

rs10489076

9947117

9.947117

0.691

AB

AB

AA

AA

AA

AA

AB

AB

AA

AB

1743690

4

SNP_A-

rs959233

10578428

10.578428

0.452

AA

AA

AA

AA

AA

AA

AB

AB

BB

BB

1736300

4

SNP_A-

rs10516254

12310930

12.31093

0.714

AA

AA

AB

AB

AB

AB

BB

BB

BB

AB

1750658

4

SNP_A-

rs10489092

13327021

13.327021

0.286

AB

AB

AA

AA

AA

AA

AB

AB

AA

AB

1712820

4

SNP_A-

rs10488982

14088975

14.088975

0.5

AB

AB

AB

AA

AB

AB

BB

BB

BB

BB

1709160

4

SNP_A-

rs1496747

16275503

16.275503

0.476

BB

BB

AB

BB

AB

AB

AB

AB

BB

BB

1748456

4

SNP_A-

rs10516339

19549340

19.54934

0.725

AA

AB

AA

AA

AA

AA

AA

AA

AA

AA

1674656

4

SNP_A-

rs6834573

20123113

20.123113

0.298

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1659171

4

SNP_A-

rs10516397

21369936

21.369936

0.405

BB

BB

AB

BB

AB

AB

BB

BB

AA

AA

1687559

4

SNP_A-

rs2036713

22984189

22.984189

0.357

BB

AB

AB

BB

AB

AB

BB

BB

BB

AB

1695570

4

SNP_A-

rs1527354

24561836

24.561836

0.655

BB

AB

BB

BB

BB

BB

AA

AA

BB

BB

1649429

4

SNP_A-

rs7697266

25453418

25.453418

0.393

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1710973

4

SNP_A-

rs9291495

27032051

27.032051

0.75

AA

AA

AA

AA

AA

AA

AA

AA

AA

AB

1748352

4

SNP_A-

rs1397438

28093488

28.093488

0.463

BB

BB

BB

BB

BB

BB

BB

BB

AA

AA

1737486

4

SNP_A-

rs939573

28670407

28.670407

0.75

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1660740

4

SNP_A-

rs1441691

29221732

29.221732

0.274

BB

BB

AB

BB

AB

AB

BB

BB

BB

AB

1659069

4

SNP_A-

rs2571468

29891942

29.891942

0.667

AA

AA

AB

AA

AB

AB

AB

AB

AA

AA

1731582

4

SNP_A-

rs412253

31119019

31.119019

0.72

AA

AA

AB

BB

AB

AB

AB

AB

AA

AA

1666099

4

SNP_A-

rs10517232

31725815

31.725815

0.321

BB

BB

AA

AA

AA

AA

BB

BB

AA

AA

1659419

4

SNP_A-

rs2588544

36822899

36.822899

0.281

AA

AB

BB

BB

BB

BB

BB

BB

BB

BB

1743944

4

SNP_A-

rs7693744

42094241

42.094241

0.488

AA

AA

AB

AA

AA

AB

AA

AB

AA

AA

1650541

4

SNP_A-

rs10517054

42743857

42.743857

0.726

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1651577

4

SNP_A-

rs10517094

44153139

44.153139

0.31

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1708293

4

SNP_A-

rs10517121

44712712

44.712712

0.583

AA

AA

AB

AA

AA

AB

AA

AB

BB

AB

1672145

4

SNP_A-

rs1552419

45366813

45.366813

0.583

AA

AB

AA

AA

AA

AA

BB

AB

AA

AA

1742914

4

SNP_A-

rs279842

46181884

46.181884

0.439

BB

BB

BB

BB

BB

BB

BB

AB

AA

AB

1741538

4

SNP_A-

rs3934674

46854066

46.854066

0.305

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1726797

4

SNP_A-

rs6447614

47908885

47.908885

0.549

AA

AB

AA

AA

AA

AB

AA

AA

BB

AB

1734487

4

SNP_A-

rs6850277

54268853

54.268853

0.667

AB

AB

AA

AA

AA

AA

AA

AB

AA

AA

1659623

4

SNP_A-

rs2726610

55528245

55.528245

0.548

BB

BB

BB

BB

BB

BB

BB

AB

AA

AB

1724073

4

SNP_A-

rs4580704

56167635

56.167635

0.643

AB

AB

AA

AA

AA

AA

AA

AA

AA

AB

1643184

4

SNP_A-

rs10517400

58338522

58.338522

0.679

AB

AB

BB

BB

AB

AB

AB

AB

BB

BB

1647321

4

SNP_A-

rs10517453

60065841

60.065841

0.679

AA

AA

BB

BB

BB

BB

AB

AB

BB

BB

1685901

4

SNP_A-

rs2129274

61712878

61.712878

0.613

BB

BB

BB

BB

BB

BB

BB

BB

AA

AA

1660836

4

SNP_A-

rs2345043

62476674

62.476674

0.619

AA

AA

AA

AA

AA

AA

BB

BB

BB

BB

1712860

4

SNP_A-

rs2199219

63012534

63.012534

0.321

AB

AB

AA

AA

AA

AA

BB

BB

AA

AB

1706808

4

SNP_A-

rs7674285

65578799

65.578799

0.536

BB

BB

BB

BB

BB

BB

AA

AA

AA

AA

1657186

4

SNP_A-

rs1450036

67486005

67.486005

0.619

AA

AA

AA

AA

AB

AB

AA

AA

AA

AB

1701798

4

SNP_A-

rs2736466

70507268

70.507268

0.679

AB

AB

AA

AA

AA

AA

AA

AA

AB

AB

1734479

4

SNP_A-

rs3775745

71293834

71.293834

0.536

BB

BB

AA

AA

AA

AA

AA

AA

AB

AB

1645045

4

SNP_A-

rs7678694

75663264

75.663264

0.476

BB

BB

AA

AA

AA

AA

BB

BB

AA

AA

1741102

4

SNP_A-

rs925454

77604654

77.604654

0.595

AA

AA

AA

AA

AB

AB

AA

AA

AB

AB

1670999

4

SNP_A-

rs2703134

78171011

78.171011

0.691

AB

AB

AA

AA

AA

AA

AA

AB

AA

AA

1738063

4

SNP_A-

rs10518188

79483184

79.483184

0.405

AB

AB

BB

BB

BB

BB

BB

AB

BB

BB

1654306

4

SNP_A-

rs2119421

80807501

80.807501

0.714

AA

AA

AA

AA

AA

AA

AA

AA

BB

BB

1661108

4

SNP_A-

rs9307787

83047673

83.047673

0.75

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1703940

4

SNP_A-

rs6813014

84235884

84.235884

0.548

AB

AB

AA

AA

BB

AB

BB

BB

AA

AA

1650367

4

SNP_A-

rs10516708

85194717

85.194717

0.643

AA

AA

AA

AA

AA

AA

AA

AA

AB

AB

1752998

4

SNP_A-

rs10516739

86522131

86.522131

0.655

AB

AB

BB

BB

AA

AB

AA

AA

AB

AB

1669642

4

SNP_A-

rs10516760

87083328

87.083328

0.25

BB

BB

BB

BB

BB

BB

AA

AA

AA

AA

1725569

4

SNP_A-

rs4693803

88425710

88.42571

0.5

AA

AA

AA

AA

BB

AB

AA

AA

AB

AB

1732366

4

SNP_A-

rs10516796

89213912

89.213912

0.634

AA

AA

AA

AA

AA

AA

BB

AB

BB

BB

1657663

4

SNP_A-

rs1903002

90098072

90.098072

0.464

BB

BB

AA

AA

BB

AB

AA

AA

AB

AB

1718322

4

SNP_A-

rs7693500

90643667

90.643667

0.691

AA

AA

AA

AA

AA

AA

AA

AB

BB

BB

1659867

4

SNP_A-

rs4694023

91613152

91.613152

0.393

AB

AB

BB

BB

BB

BB

AA

AA

AB

AB

1705800

4

SNP_A-

rs7696847

92155216

92.155216

0.714

AA

AA

BB

BB

AA

AB

AA

AB

AB

AB

1757446

4

SNP_A-

rs6827937

94157783

94.157783

0.452

BB

BB

BB

BB

BB

BB

AA

AB

AB

AB

1749382

4

SNP_A-

rs10516919

94713877

94.713877

0.667

AB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1727842

4

SNP_A-

rs1048627

95944765

95.944765

0.595

AA

AA

AA

AA

BB

AB

AA

AA

AA

AA

1745861

4

SNP_A-

rs1384869

96613355

96.613355

0.274

BB

BB

AA

AA

AA

AA

BB

AB

BB

BB

1683945

4

SNP_A-

rs6853079

99800789

99.800789

0.286

BB

BB

BB

BB

BB

BB

BB

BB

AA

AA

1756011

4

SNP_A-

rs1230164

100343201

100.343201

0.274

AB

AB

BB

BB

AA

AB

BB

AB

BB

BB

1703546

4

SNP_A-

rs238486

103377982

103.377982

0.595

AA

AA

AA

AA

BB

AB

AA

AA

BB

BB

1740940

4

SNP_A-

rs227284

103964838

103.964838

0.655

AA

AA

AA

AA

BB

AB

BB

BB

AB

AB

1684917

4

SNP_A-

rs445761

104804695

104.804695

0.679

AB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1753948

4

SNP_A-

rs2866685

105649408

105.649408

0.5

BB

BB

AA

AA

BB

AB

AB

AB

AB

AB

1747884

4

SNP_A-

rs1873361

106282703

106.282703

0.345

BB

BB

AA

AA

AA

AA

BB

BB

BB

BB

1720092

4

SNP_A-

rs715706

106873632

106.873632

0.286

BB

BB

BB

BB

BB

BB

BB

BB

AA

AA

1721929

4

SNP_A-

rs1468221

108745388

108.745388

0.31

AA

AA

BB

BB

BB

BB

AB

AB

BB

BB

1662125

4

SNP_A-

rs7654940

110143969

110.143969

0.524

AB

AB

BB

BB

AA

AB

AB

AB

AB

AB

1642856

4

SNP_A-

rs6841595

113711446

113.711446

0.317

BB

BB

BB

BB

BB

BB

BB

BB

AB

AB

1686749

4

SNP_A-

rs10516593

114436416

114.436416

0.524

BB

BB

BB

BB

AB

AB

AA

AA

AA

AA

1736814

4

SNP_A-

rs998359

116228635

116.228635

0.441

BB

BB

BB

BB

BB

BB

BB

BB

AB

AB

1732667

4

SNP_A-

rs292910

117406405

117.406405

0.607

AA

AA

AA

AA

AA

AA

AA

AA

AB

AB

1671469

4

SNP_A-

rs2125710

118964366

118.964366

0.25

BB

BB

BB

BB

BB

BB

BB

BB

AB

AB

1696003

4

SNP_A-

rs10518293

119688966

119.688966

0.691

AA

AA

BB

BB

BB

BB

AA

AA

AB

AB

1695754

4

SNP_A-

rs10518336

120880537

120.880537

0.536

AA

AA

BB

BB

AB

AB

BB

BB

AB

AB

1745189

4

SNP_A-

rs2036696

121573324

121.573324

0.667

AA

AA

BB

BB

BB

BB

BB

BB

AB

AB

1648947

4

SNP_A-

rs998327

122441717

122.441717

0.726

AA

AA

AA

AA

AB

AB

AA

AA

AA

AA

1702984

4

SNP_A-

rs4833836

123858274

123.858274

0.381

BB

BB

BB

BB

BB

BB

AB

AB

BB

BB

1733111

4

SNP_A-

rs444646

124370464

124.370464

0.548

AB

AB

AA

AA

AB

AB

BB

BB

AA

AA

1643743

4

SNP_A-

rs10518307

125084153

125.084153

0.262

AB

AB

BB

BB

BB

BB

BB

BB

BB

BB

1746251

4

SNP_A-

rs7682791

125875709

125.875709

0.631

AA

AA

AA

AA

AA

AA

AA

AA

BB

BB

1648121

4

SNP_A-

rs953211

126708654

126.708654

0.488

AB

AB

AA

AA

AA

AA

AB

AB

AA

AA

1699868

4

SNP_A-

rs4834083

127331109

127.331109

0.726

AA

AA

BB

BB

AB

AB

AA

AA

AB

AB

1706772

4

SNP_A-

rs318510

130173248

130.173248

0.571

AA

AA

BB

BB

BB

BB

AA

AA

AA

AA

1653649

4

SNP_A-

rs2969001

131140397

131.140397

0.643

AA

AA

AA

AA

AA

AA

AB

AB

AA

AA

1655974

4

SNP_A-

rs6846560

131988611

131.988611

0.357

BB

BB

BB

BB

BB

BB

AB

AB

BB

AB

1694056

4

SNP_A-

rs10518609

133609659

133.609659

0.658

AA

AA

BB

BB

BB

BB

AA

AA

AA

AA

1719820

4

SNP_A-

rs9307688

134441091

134.441091

0.726

BB

BB

AA

AA

AA

AA

AA

AA

BB

AB

1721507

4

SNP_A-

rs9307703

135374277

135.374277

0.321

BB

BB

BB

BB

BB

BB

AB

AB

BB

BB

1716218

4

SNP_A-

rs6535037

135968531

135.968531

0.691

AB

AB

AA

AA

AA

AA

AB

AB

AA

AB

1719154

4

SNP_A-

rs10519369

137048788

137.048788

0.619

AB

AB

AA

AB

AB

AB

AB

AB

AA

AB

1718316

4

SNP_A-

rs7692053

138020209

138.020209

0.631

AB

AB

BB

BB

BB

BB

AA

AA

AA

AA

1643751

4

SNP_A-

rs1376088

139852726

139.852726

0.357

BB

BB

BB

BB

BB

BB

AB

AB

BB

BB

1712218

4

SNP_A-

rs10519540

141950175

141.950175

0.429

AB

AB

BB

BB

BB

BB

AA

AB

AA

AB

1688437

4

SNP_A-

rs2062597

143153292

143.153292

0.61

AA

AA

AA

AA

AA

AA

BB

BB

AA

AA

1669152

4

SNP_A-

rs331963

144031456

144.031456

0.369

AA

AA

AB

AB

AB

AB

AA

AA

BB

AB

1651007

4

SNP_A-

rs789351

146225975

146.225975

0.679

BB

BB

AA

AA

AA

AA

AA

AA

AA

AA

1705078

4

SNP_A-

rs10519824

148107681

148.107681

0.658

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1700284

4

SNP_A-

rs6810951

149441717

149.441717

0.333

BB

BB

AB

AB

AB

AB

BB

AB

BB

BB

1655082

4

SNP_A-

rs10489053

150276232

150.276232

0.643

AB

AB

AA

AA

AA

AA

AA

AA

AA

AB

1650743

4

SNP_A-

rs991529

151852936

151.852936

0.488

BB

BB

BB

BB

BB

BB

AA

AA

AA

AA

1695870

4

SNP_A-

rs361101

153131731

153.131731

0.631

BB

BB

AB

AB

AA

AB

AA

AA

BB

AB

1750768

4

SNP_A-

rs7662116

154375569

154.375569

0.691

AA

AA

AA

AA

AA

AA

BB

AB

AA

AA

1694614

4

SNP_A-

rs1125228

155126657

155.126657

0.738

AA

AA

BB

BB

BB

BB

BB

BB

BB

BB

1651497

4

SNP_A-

rs6536240

158751762

158.751762

0.381

AB

AB

BB

BB

BB

BB

AB

AB

BB

AB

1732214

4

SNP_A-

rs7678486

159498426

159.498426

0.25

BB

BB

BB

BB

BB

BB

BB

BB

AA

AB

1721547

4

SNP_A-

rs7665879

160305968

160.305968

0.31

AB

AB

BB

BB

BB

BB

AB

AB

BB

AB

1695472

4

SNP_A-

rs6856295

160845965

160.845965

0.595

BB

BB

AB

AB

AA

AB

AB

AB

AA

AA

1653797

4

SNP_A-

rs9308000

161359479

161.359479

0.655

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1705238

4

SNP_A-

rs195894

163885040

163.88504

0.366

BB

BB

AB

AB

BB

AB

BB

BB

BB

BB

1679349

4

SNP_A-

rs4057797

164602658

164.602658

0.381

BB

BB

AA

AA

AA

AA

BB

BB

BB

AB

1719176

4

SNP_A-

rs4404502

165513434

165.513434

0.738

AA

AA

AA

AA

AA

AA

AB

AB

AA

AB

1657975

4

SNP_A-

rs4691246

167437606

167.437606

0.402

BB

BB

AB

AB

AA

AB

AB

AB

BB

BB

1669824

4

SNP_A-

rs7435411

169800826

169.800826

0.524

BB

BB

AB

AB

BB

AB

AB

AB

AA

AB

1701924

4

SNP_A-

rs13212

170689681

170.689681

0.274

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1673825

4

SNP_A-

rs449424

171884933

171.884933

0.631

AA

AA

AB

AB

AA

AB

AA

AA

AA

AA

1736222

4

SNP_A-

rs1485870

173125585

173.125585

0.744

BB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1745583

4

SNP_A-

rs10520252

174445689

174.445689

0.619

AA

AA

AB

AB

AA

AB

AB

AB

AA

AA

1717120

4

SNP_A-

rs10520282

175752491

175.752491

0.738

AA

AA

AB

AB

AA

AB

AA

AA

AA

AA

1714548

4

SNP_A-

rs393279

177816548

177.816548

0.488

AA

AA

BB

BB

BB

BB

BB

BB

BB

AB

1662283

4

SNP_A-

rs10520383

178915654

178.915654

0.357

BB

BB

BB

BB

BB

BB

AB

AB

BB

AB

1675843

4

SNP_A-

rs2706012

179727204

179.727204

0.718

AA

AA

AA

AA

AA

AA

AA

AA

BB

AB

1737632

4

SNP_A-

rs10520430

180911694

180.911694

0.679

AA

AA

AB

AB

AA

AB

AA

AA

BB

BB

1720252

4

SNP_A-

rs7667245

181665445

181.665445

0.695

AA

AB

AB

AB

BB

AB

AA

AA

AA

AA

1644751

4

SNP_A-

rs10520479

182667862

182.667862

0.702

AA

AA

AA

AA

AA

AA

BB

BB

AA

AA

1649573

4

SNP_A-

rs10520518

183365702

183.365702

0.369

BB

AB

AB

AB

BB

AB

AA

AA

BB

BB

1689263

4

SNP_A-

rs830838

187288258

187.288258

0.333

BB

AB

BB

AB

AB

AB

BB

BB

AB

AB

1738928

4

SNP_A-

rs1280100

187913282

187.913282

0.345

AA

AB

AA

AA

AA

AA

AB

AB

BB

BB

1713082

4

SNP_A-

rs1505509

188945352

188.945352

0.345

AA

AB

BB

BB

BB

BB

AA

AA

BB

BB

1654608

4

SNP_A-

rs2376743

189829781

189.829781

0.679

AA

AA

AA

AA

AA

AA

AB

AB

AB

AB

1680395

5

SNP_A-

rs10512651

1816661

1.816661

0.405

BB

BB

AB

AB

BB

AB

AA

AA

AB

AB

1689409

5

SNP_A-

rs1445862

3675257

3.675257

0.25

BB

BB

AB

AB

BB

AB

BB

AB

BB

BB

1642488

5

SNP_A-

rs272190

5103830

5.10383

0.25

AB

AB

AA

AA

AA

AA

AB

AB

BB

BB

1651781

5

SNP_A-

rs2560294

5619114

5.619114

0.726

AA

AA

AA

AA

AA

AA

AB

AB

AB

AB

1663379

5

SNP_A-

rs10512858

6486915

6.486915

0.613

BB

BB

AB

AB

AB

AB

AA

AA

AB

AB

1643560

5

SNP_A-

rs4629562

7847326

7.847326

0.619

AB

AB

AB

AB

AB

AB

AA

AA

AB

AB

1651637

5

SNP_A-

rs9313236

8348429

8.348429

0.25

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1693207

5

SNP_A-

rs12515692

9883408

9.883408

0.357

AB

AB

BB

BB

BB

BB

BB

BB

AB

AB

1744546

5

SNP_A-

rs2937513

11007551

11.007551

0.619

AB

AB

BB

BB

BB

BB

AB

AB

BB

BB

1721268

5

SNP_A-

rs173671

12217918

12.217918

0.476

AB

AB

AB

BB

AB

AB

AB

AB

AA

AA

1702624

5

SNP_A-

rs1476154

13000353

13.000353

0.691

BB

BB

AA

AA

AA

AA

AA

AA

AA

AA

1695478

5

SNP_A-

rs3734108

13806984

13.806984

0.56

AA

AA

AB

BB

AB

AB

AB

AB

AB

AB

1757294

5

SNP_A-

rs2938832

15817866

15.817866

0.25

AB

AB

BB

BB

BB

BB

AB

AB

AB

AB

1696687

5

SNP_A-

rs585991

17246633

17.246633

0.274

BB

BB

AA

AA

AA

AA

BB

BB

BB

BB

1713461

5

SNP_A-

rs1394215

18359538

18.359538

0.548

BB

BB

AA

AA

AA

AA

BB

BB

AA

AA

1661473

5

SNP_A-

rs2942296

19421031

19.421031

0.429

BB

BB

AB

AA

AB

AB

AB

AB

AA

AA

1646961

5

SNP_A-

rs248202

21159137

21.159137

0.274

BB

BB

BB

BB

BB

BB

AB

AB

AB

AB

1698916

5

SNP_A-

rs7705523

23659025

23.659025

0.714

AA

AA

AB

BB

AB

AB

AA

AA

AB

AB

1757332

5

SNP_A-

rs1995599

24552793

24.552793

0.548

AB

AB

AB

BB

AB

AB

BB

BB

AB

AB

1672683

5

SNP_A-

rs9293241

26606178

26.606178

0.56

AB

AB

AA

AA

AA

AA

AB

AB

AB

AB

1660984

5

SNP_A-

rs921469

29989233

29.989233

0.583

AB

AB

AA

AA

AA

AA

AA

AA

AB

AB

1704664

5

SNP_A-

rs1921111

30906615

30.906615

0.405

BB

BB

BB

BB

BB

BB

AA

AA

AB

AB

1644843

5

SNP_A-

rs893551

33493407

33.493407

0.607

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1678791

5

SNP_A-

rs716302

35846025

35.846025

0.357

AB

AB

AA

AA

AA

AA

AA

AB

BB

BB

1724049

5

SNP_A-

rs159751

37035755

37.035755

0.464

AA

AA

BB

BB

BB

BB

BB

BB

AA

AA

1703432

5

SNP_A-

rs4072686

38003109

38.003109

0.405

AB

AB

BB

BB

BB

BB

BB

BB

BB

AB

1645375

5

SNP_A-

rs675502

39878266

39.878266

0.679

AB

AB

BB

BB

AA

AB

AA

AA

AA

AA

1719252

5

SNP_A-

rs1697938

40890439

40.890439

0.441

AA

AA

AA

AA

AA

AA

BB

BB

AA

AA

1685613

5

SNP_A-

rs276278

42016012

42.016012

0.298

BB

BB

BB

BB

BB

BB

BB

BB

BB

AB

1731232

5

SNP_A-

rs1072746

43646445

43.646445

0.441

AA

AB

BB

BB

BB

BB

BB

AB

AA

AB

1694450

5

SNP_A-

rs2404958

50098792

50.098792

0.619

AA

AB

AA

AA

BB

AB

AA

AA

AA

AA

1675759

5

SNP_A-

rs9283709

51510492

51.510492

0.595

BB

AB

BB

BB

AB

AB

AA

AA

BB

BB

1723309

5

SNP_A-

rs10512988

52085030

52.08503

0.357

BB

AB

AA

AA

AA

AA

BB

AB

AA

AA

1728968

5

SNP_A-

rs9292039

53454075

53.454075

0.268

BB

BB

BB

BB

BB

BB

AA

AB

BB

AB

1746984

5

SNP_A-

rs6450270

54287290

54.28729

0.714

AA

AA

AA

AA

AA

AA

BB

AB

AA

AA

1697874

5

SNP_A-

rs889310

56000924

56.000924

0.476

BB

BB

AB

AA

AB

AB

BB

AB

AA

AB

1684501

5

SNP_A-

rs2539731

57109292

57.109292

0.475

BB

BB

BB

BB

BB

BB

AB

AB

BB

BB

1673657

5

SNP_A-

rs9292159

57677129

57.677129

0.31

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1716782

5

SNP_A-

rs9292180

58192447

58.192447

0.25

BB

BB

AB

AA

AB

AB

BB

BB

AA

AB

1724117

5

SNP_A-

rs10514860

58859777

58.859777

0.726

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1755537

5

SNP_A-

rs6859376

59471964

59.471964

0.56

AA

AB

BB

BB

BB

BB

AB

AB

BB

BB

1653871

5

SNP_A-

rs159375

60469024

60.469024

0.691

AA

AA

AA

AA

AA

AA

BB

BB

BB

AB

1653455

5

SNP_A-

rs356598

63380121

63.380121

0.631

BB

BB

AA

AA

AA

AA

BB

BB

BB

AB

1682537

5

SNP_A-

rs7704890

66151331

66.151331

0.357

AA

AB

BB

BB

BB

BB

BB

BB

AA

AB

1755307

5

SNP_A-

rs6858907

67817289

67.817289

0.417

BB

BB

AB

BB

AB

AB

BB

BB

BB

BB

1671457

5

SNP_A-

rs1600073

74472493

74.472493

0.61

BB

BB

AB

BB

AB

AB

AB

AB

AA

AA

1654744

5

SNP_A-

rs10514059

75460983

75.460983

0.658

AA

AA

AA

AA

AA

AA

AA

AA

BB

BB

1653531

5

SNP_A-

rs2972341

76504599

76.504599

0.536

AB

AB

AA

AA

AA

AA

AB

AB

AA

AB

1720510

5

SNP_A-

rs949645

78478278

78.478278

0.564

AA

AA

AB

BB

AB

AB

BB

BB

AA

AB

1682839

5

SNP_A-

rs264986

79206180

79.20618

0.31

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1747624

5

SNP_A-

rs964102

80843469

80.843469

0.679

AB

AB

AA

AA

AA

AA

AB

AB

BB

BB

1730614

5

SNP_A-

rs10514249

82540612

82.540612

0.56

AA

AA

AA

AA

AA

AA

BB

AB

BB

BB

1732246

5

SNP_A-

rs4639197

83381853

83.381853

0.25

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1729977

5

SNP_A-

rs323744

86861304

86.861304

0.5

BB

BB

AA

AA

AA

AA

BB

AB

AA

AB

1742238

5

SNP_A-

rs819344

89093506

89.093506

0.463

AA

AA

AB

BB

AA

AB

BB

AB

BB

BB

1751644

5

SNP_A-

rs2935499

89626568

89.626568

0.548

AA

AA

BB

BB

BB

BB

AA

AB

AB

AB

1690642

5

SNP_A-

rs52308

90817903

90.817903

0.512

BB

BB

AA

AA

AA

AA

BB

BB

AA

AA

1744488

5

SNP_A-

rs248339

95229134

95.229134

0.643

AA

AA

BB

BB

BB

BB

BB

AB

AB

AB

1670907

5

SNP_A-

rs31248

96040439

96.040439

0.275

BB

BB

AB

BB

AA

AB

AA

AB

BB

BB

1729028

5

SNP_A-

rs10515273

97821155

97.821155

0.75

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1657092

5

SNP_A-

rs2887526

98552712

98.552712

0.667

AB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1643346

5

SNP_A-

rs2369754

99184261

99.184261

0.488

AA

AA

AB

BB

AA

AB

AA

AB

BB

BB

1722905

5

SNP_A-

rs1477625

101358141

101.358141

0.271

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1664073

5

SNP_A-

rs9327861

101895776

101.895776

0.655

BB

BB

AA

AA

AA

AA

BB

AB

AA

AA

1742802

5

SNP_A-

rs39984

102625191

102.625191

0.31

AA

AA

BB

BB

BB

BB

AA

AA

BB

BB

1745283

5

SNP_A-

rs10515355

103975436

103.975436

0.738

AB

AB

AA

AA

AA

AA

BB

BB

AA

AA

1734843

5

SNP_A-

rs4957531

106511277

106.511277

0.463

AA

AA

AA

AA

AA

AA

AA

AB

AB

AB

1730932

5

SNP_A-

rs245243

109258634

109.258634

0.714

AB

AB

AB

AA

BB

AB

AA

AB

AA

AA

1757418

5

SNP_A-

rs10491424

110481705

110.481705

0.56

BB

BB

AB

AB

BB

AB

AA

AA

AA

AA

1646761

5

SNP_A-

rs1213404

111130917

111.130917

0.35

BB

BB

BB

BB

BB

BB

BB

AB

BB

BB

1691719

5

SNP_A-

rs971517

112050154

112.050154

0.476

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1747768

5

SNP_A-

rs10519378

113555966

113.555966

0.738

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1726679

5

SNP_A-

rs2546480

114841054

114.841054

0.452

AB

AB

BB

BB

BB

BB

BB

BB

AB

AB

1738592

5

SNP_A-

rs2662458

115402242

115.402242

0.655

AB

AB

AB

AB

BB

AB

AA

AA

AB

AB

1708792

5

SNP_A-

rs1027292

116078486

116.078486

0.548

BB

BB

AA

AA

AA

AA

AA

AA

AB

AB

1720512

5

SNP_A-

rs1504978

118638459

118.638459

0.655

AB

AB

AB

AB

AA

AB

AA

AA

AA

AA

1701708

5

SNP_A-

rs10519615

119189176

119.189176

0.643

BB

BB

BB

BB

BB

BB

AB

AB

AB

AB

1689317

5

SNP_A-

rs6897147

119692229

119.692229

0.691

AA

AA

AA

AA

AA

AA

BB

BB

AA

AA

1751260

5

SNP_A-

rs161011

123703275

123.703275

0.286

AA

AA

AB

AB

AB

AB

BB

BB

BB

BB

1654688

5

SNP_A-

rs7716491

124265772

124.265772

0.738

AB

AB

AA

AA

AA

AA

AB

AB

AB

AB

1699578

5

SNP_A-

rs1826263

124839517

124.839517

0.571

BB

BB

AA

AA

AA

AA

AB

AB

AB

AB

1703238

5

SNP_A-

rs964185

125631547

125.631547

0.345

AA

AA

AB

AB

AB

AB

BB

BB

AB

AB

1715428

5

SNP_A-

rs1345663

126678081

126.678081

0.31

BB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1751090

5

SNP_A-

rs9327460

127338947

127.338947

0.524

AA

AA

AA

AA

AA

AA

AB

AB

BB

BB

1694738

5

SNP_A-

rs1181962

128414700

128.4147

0.333

BB

BB

AA

AA

AA

AA

AB

AB

BB

BB

1658519

5

SNP_A-

rs25810

129015788

129.015788

0.595

AA

AA

AA

AA

AA

AA

AA

AA

AB

AB

1677377

5

SNP_A-

rs10520083

129967905

129.967905

0.345

AA

AA

AB

AB

AB

AB

AB

AB

AB

AB

1673843

5

SNP_A-

rs9327673

133230970

133.23097

0.286

BB

BB

BB

BB

BB

BB

AB

AB

AB

AB

1705560

5

SNP_A-

rs10515473

134961986

134.961986

0.714

BB

AB

AA

AA

AA

AA

AA

AA

AB

AB

1662391

5

SNP_A-

rs10515481

136007946

136.007946

0.536

BB

AB

AA

AA

AA

AA

AA

AA

BB

BB

1707797

5

SNP_A-

rs1560930

136590879

136.590879

0.537

BB

BB

AA

AA

AA

AA

AA

AA

AB

AB

1720076

5

SNP_A-

rs288019

138219292

138.219292

0.39

BB

BB

AB

AB

AB

AB

BB

AB

BB

BB

1697724

5

SNP_A-

rs2336977

139130436

139.130436

0.61

AA

AB

AB

AB

AB

AB

BB

AB

AA

AA

1707038

5

SNP_A-

rs6860077

139725338

139.725338

0.31

BB

AB

BB

BB

BB

BB

BB

BB

AB

AB

1703312

5

SNP_A-

rs246002

140321288

140.321288

0.5

BB

BB

AB

AB

AB

AB

AA

AB

AA

AA

1742086

5

SNP_A-

rs32927

141102251

141.102251

0.298

AA

AB

BB

BB

BB

BB

BB

AB

AB

AB

1730974

5

SNP_A-

rs997833

141815738

141.815738

0.286

AA

AB

AB

AB

AB

AB

BB

BB

BB

BB

1736416

5

SNP_A-

rs325227

143131067

143.131067

0.31

AA

AB

AA

AA

AA

AA

AA

AA

BB

BB

1722681

5

SNP_A-

rs10515600

147316068

147.316068

0.548

AB

AB

AB

AB

AB

AB

AA

AA

BB

BB

1749482

5

SNP_A-

rs185021

148147283

148.147283

0.524

AB

AB

AB

AB

AB

AB

BB

BB

AA

AA

1716760

5

SNP_A-

rs10515632

149082624

149.082624

0.333

BB

BB

AB

AB

AB

AB

BB

AB

AA

AA

1642124

5

SNP_A-

rs1277464

150234035

150.234035

0.354

BB

BB

AB

AB

AB

AB

AB

AB

BB

BB

1737743

5

SNP_A-

rs2304054

150923278

150.923278

0.548

AB

AB

AA

AA

AA

AA

BB

BB

AB

AB

1678329

5

SNP_A-

rs10515686

152529312

152.529312

0.619

AA

AA

AB

AB

AB

AB

BB

AB

AB

AB

1649583

5

SNP_A-

rs4129128

153102070

153.10207

0.321

AB

AB

AA

AA

AA

AA

BB

AB

BB

BB

1652471

5

SNP_A-

rs991314

154438135

154.438135

0.744

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1700286

5

SNP_A-

rs2569031

155177249

155.177249

0.488

AB

AB

AB

AB

AB

AB

AA

AA

AB

AB

1752802

5

SNP_A-

rs873343

157106698

157.106698

0.25

AB

AB

AB

AB

AB

AB

AA

AA

BB

BB

1706578

5

SNP_A-

rs9313777

157878177

157.878177

0.75

AA

AA

AA

AA

AA

AA

AA

AA

AB

AB

1757398

5

SNP_A-

rs10515781

158633942

158.633942

0.321

AB

AB

AB

AB

AB

AB

BB

BB

BB

BB

1736540

5

SNP_A-

rs411005

160517741

160.517741

0.476

AB

AB

AA

AA

AA

AA

BB

BB

AA

AA

1647073

5

SNP_A-

rs2170901

161840216

161.840216

0.429

BB

BB

AB

AB

AB

AB

BB

BB

AA

AA

1724235

5

SNP_A-

rs300238

162682948

162.682948

0.452

AB

AB

AB

AB

AB

AB

AA

AA

AB

AB

1754048

5

SNP_A-

rs158295

163217790

163.21779

0.25

BB

BB

BB

BB

BB

BB

AA

AB

BB

BB

1745987

5

SNP_A-

rs6869856

166017651

166.017651

0.412

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1720394

5

SNP_A-

rs1911557

169681232

169.681232

0.25

BB

BB

BB

BB

BB

BB

AB

AB

AB

AB

1687531

5

SNP_A-

rs10516089

171083836

171.083836

0.726

AB

AB

AA

AA

AA

AA

AB

AB

AA

AA

1749300

5

SNP_A-

rs1909706

173644330

173.64433

0.707

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1665975

5

SNP_A-

rs965017

174509108

174.509108

0.548

AB

AB

AB

AB

BB

AA

AA

AA

AA

AA

1724885

5

SNP_A-

rs1071882

178068646

178.068646

0.702

AA

AA

AB

AB

AA

AB

AA

AA

AA

AA

1644515

5

SNP_A-

rs2892344

180297919

180.297919

0.536

AB

AB

BB

BB

BB

BB

BB

BB

AB

AB

1748220

6

SNP_A-

rs3765437

508013

0.508013

0.536

AA

AA

BB

BB

BB

BB

BB

BB

AA

AA

1732501

6

SNP_A-

rs238073

1192930

1.19293

0.381

AA

AA

BB

BB

BB

BB

AA

AA

AB

AB

1728682

6

SNP_A-

rs6919059

1729095

1.729095

0.691

AA

AB

AA

AA

AA

AA

AB

AB

AA

AA

1747718

6

SNP_A-

rs2326366

3923256

3.923256

0.417

BB

AB

AA

AB

AA

AB

BB

BB

AB

AB

1723553

6

SNP_A-

rs10484314

5593086

5.593086

0.333

BB

BB

BB

BB

BB

BB

BB

BB

AB

AB

1747058

6

SNP_A-

rs3851514

6219569

6.219569

0.75

BB

BB

BB

AB

BB

AB

AB

AB

AA

AA

1673883

6

SNP_A-

rs267202

7799235

7.799235

0.619

AB

AB

AA

AB

AA

AB

AA

AA

AA

AA

1737825

6

SNP_A-

rs1543731

8355978

8.355978

0.346

AA

AA

AA

AB

AA

AB

BB

BB

BB

BB

1680945

6

SNP_A-

rs9296701

9687981

9.687981

0.536

AB

AB

BB

BB

BB

BB

BB

BB

AB

AB

1702006

6

SNP_A-

rs4512212

10379387

10.379387

0.464

BB

BB

AA

AB

AA

AB

BB

BB

BB

BB

1715186

6

SNP_A-

rs2182335

11324963

11.324963

0.714

AA

AA

AA

AB

AA

AB

BB

BB

AA

AA

1680453

6

SNP_A-

rs2841555

13574809

13.574809

0.655

AA

AA

AA

AA

AA

AA

AB

AB

AB

AB

1690060

6

SNP_A-

rs2237166

16755137

16.755137

0.536

AB

AB

AB

AB

BB

AB

BB

BB

AA

AA

1646375

6

SNP_A-

rs2147211

17898170

17.89817

0.714

AA

AA

AA

AA

AA

AA

AB

AB

AB

AB

1744270

6

SNP_A-

rs9297090

18873893

18.873893

0.571

AB

AB

AA

AA

AA

AA

AA

AA

AB

AB

1679405

6

SNP_A-

rs971623

20437442

20.437442

0.405

AB

AB

BB

BB

BB

BB

AB

AB

BB

BB

1717924

6

SNP_A-

rs10485012

22715005

22.715005

0.595

AB

AB

AB

AB

AB

AB

BB

BB

AA

AA

1749068

6

SNP_A-

rs2022330

23554534

23.554534

0.667

AB

AB

AB

AB

AB

AB

AB

AB

AB

AB

1754953

6

SNP_A-

rs499466

24069410

24.06941

0.5

AB

AB

BB

BB

BB

BB

AB

AB

AA

AA

1698352

6

SNP_A-

rs9295755

28141153

28.141153

0.25

BB

BB

BB

BB

BB

BB

AB

AB

BB

BB

1682833

6

SNP_A-

rs2747430

29756485

29.756485

0.702

AB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1656688

6

SNP_A-

rs2395173

32512837

32.512837

0.691

AB

AB

AA

AA

AA

AA

AB

AB

AA

AA

1715492

6

SNP_A-

rs9296266

38990614

38.990614

0.573

AA

AA

AB

AB

AB

AB

AA

AA

AA

AB

1722893

6

SNP_A-

rs2395743

40400147

40.400147

0.488

BB

AB

BB

BB

BB

BB

BB

BB

BB

AB

1724965

6

SNP_A-

rs3804281

41853967

41.853967

0.429

BB

BB

AB

AB

AB

AB

AA

AB

BB

BB

1757782

6

SNP_A-

rs3763234

42725939

42.725939

0.298

AA

AB

BB

BB

BB

BB

BB

BB

BB

AB

1700088

6

SNP_A-

rs525043

44511878

44.511878

0.25

BB

BB

BB

BB

BB

BB

BB

BB

BB

AB

1748380

6

SNP_A-

rs9296453

45335410

45.33541

0.429

AA

AB

BB

BB

BB

BB

AA

AA

AA

AA

1685295

6

SNP_A-

rs9296468

45876662

45.876662

0.726

AA

AA

AB

AB

AB

AB

AA

AA

AA

AA

1708722

6

SNP_A-

rs10498767

46471516

46.471516

0.441

BB

AB

BB

BB

BB

BB

BB

BB

BB

AB

1736458

6

SNP_A-

rs9296547

47474339

47.474339

0.643

AA

AA

BB

BB

BB

BB

BB

AB

AA

AA

1642956

6

SNP_A-

rs2089505

48229201

48.229201

0.643

AA

AA

BB

BB

BB

BB

BB

BB

AA

AA

1742558

6

SNP_A-

rs504213

49411897

49.411897

0.607

AA

AA

AA

AA

AA

AA

AA

AA

BB

AB

1738582

6

SNP_A-

rs10484664

51124482

51.124482

0.256

BB

BB

BB

BB

BB

BB

BB

BB

BB

AB

1658085

6

SNP_A-

rs913098

51750772

51.750772

0.667

AA

AB

AA

AA

AA

AA

AA

AA

AA

AA

1723157

6

SNP_A-

rs509946

52411949

52.411949

0.369

BB

BB

AA

BB

AA

AB

BB

AB

BB

BB

1726221

6

SNP_A-

rs10484785

53457958

53.457958

0.476

BB

AB

BB

BB

BB

BB

AA

AB

BB

BB

1717116

6

SNP_A-

rs1393779

54808762

54.808762

0.464

AA

AB

AA

AA

AA

AA

BB

BB

BB

BB

1717814

6

SNP_A-

rs1925179

56129171

56.129171

0.655

AA

AA

AA

AA

AA

AA

AA

AA

AA

AB

1693069

6

SNP_A-

rs6934928

58422082

58.422082

0.714

BB

AB

AA

AA

AA

AA

BB

AB

AA

AA

1664153

6

SNP_A-

rs565795

62597708

62.597708

0.61

AA

AA

AA

AA

AA

AA

BB

BB

AA

AB

1682123

6

SNP_A-

rs9293849

63255396

63.255396

0.333

BB

BB

BB

AA

BB

AB

AA

AB

BB

AB

1692597

6

SNP_A-

rs9294630

65677619

65.677619

0.702

AA

AB

AA

AA

AA

AA

AA

AA

AA

AB

1729072

6

SNP_A-

rs2502270

67886666

67.886666

0.488

AA

AA

AA

AA

AA

AA

AB

AB

AA

AA

1685655

6

SNP_A-

rs4707479

68787830

68.78783

0.286

AA

AA

BB

BB

BB

BB

BB

BB

BB

AB

1744006

6

SNP_A-

rs579588

69639537

69.639537

0.714

AA

AA

BB

AA

BB

AB

AB

AB

BB

AA

1683273

6

SNP_A-

rs591809

72270133

72.270133

0.524

BB

BB

BB

BB

BB

BB

BB

BB

AA

AB

1659091

6

SNP_A-

rs959369

74620278

74.620278

0.607

AA

AA

AA

AA

AA

AA

AA

AA

AA

AB

1660794

6

SNP_A-

rs1575856

76774483

76.774483

0.262

BB

BB

BB

BB

BB

BB

BB

BB

BB

AB

1656648

6

SNP_A-

rs1457947

77533004

77.533004

0.619

AA

AA

AA

AA

AA

AA

AB

AB

AA

AA

1675424

6

SNP_A-

rs236225

79172654

79.172654

0.744

AA

AA

AA

AA

AA

AA

AB

AB

AA

AA

1657250

6

SNP_A-

rs239500

80761863

80.761863

0.595

AB

AB

AA

AA

AA

AA

AB

AB

BB

BB

1646741

6

SNP_A-

rs310387

81832380

81.83238

0.56

AA

AA

AA

AA

AA

AA

AA

AA

BB

AB

1733643

6

SNP_A-

rs2323435

82365338

82.365338

0.417

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1684117

6

SNP_A-

rs958568

83211843

83.211843

0.417

BB

BB

BB

BB

BB

BB

AB

AB

BB

AB

1749278

6

SNP_A-

rs6938512

85412591

85.412591

0.476

AB

AB

BB

BB

BB

BB

AA

AA

BB

BB

1737476

6

SNP_A-

rs3966882

85938190

85.93819

0.46

BB

BB

BB

AA

AB

AB

AB

AB

BB

BB

1658179

6

SNP_A-

rs3857488

88057783

88.057783

0.548

AB

AB

BB

BB

BB

BB

AA

AA

AA

AB

1704672

6

SNP_A-

rs942115

90274825

90.274825

0.691

AA

AA

BB

BB

BB

BB

AA

AA

AA

AA

1750678

6

SNP_A-

rs1753826

91283465

91.283465

0.274

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1641794

6

SNP_A-

rs427118

92400922

92.400922

0.622

AB

AB

AA

AA

AA

AA

AA

AA

AB

AB

1747902

6

SNP_A-

rs609590

93182864

93.182864

0.595

AB

AB

AA

AA

AA

AA

AB

AB

AB

AB

1699604

6

SNP_A-

rs1906966

94362973

94.362973

0.571

AA

AA

AA

AA

AA

AA

AB

AB

AB

AB

1671865

6

SNP_A-

rs2380218

95947837

95.947837

0.643

AB

AB

BB

AB

AB

AB

AB

AB

AA

AA

1672477

6

SNP_A-

rs6925466

96483564

96.483564

0.476

AB

AB

AA

AB

AB

AB

BB

BB

AB

AB

1727169

6

SNP_A-

rs2206094

97681917

97.681917

0.595

AB

AB

AA

AA

AA

AA

AB

AB

AB

AB

1669372

6

SNP_A-

rs10484477

103889951

103.889951

0.738

AA

AA

AA

AA

AA

AA

BB

BB

AB

AB

1754567

6

SNP_A-

rs1341123

104971433

104.971433

0.274

BB

BB

BB

BB

BB

BB

BB

BB

AB

AB

1687147

6

SNP_A-

rs1325421

105998201

105.998201

0.643

AB

AB

AA

AB

AB

AB

AA

AA

AA

AA

1696467

6

SNP_A-

rs1462145

107068713

107.068713

0.357

AB

AB

BB

BB

BB

BB

BB

BB

BB

BB

1733167

6

SNP_A-

rs7740028

110825873

110.825873

0.393

AA

AA

BB

BB

BB

BB

AA

AA

BB

BB

1650105

6

SNP_A-

rs2010315

112529340

112.52934

0.679

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1680493

6

SNP_A-

rs1378682

113188320

113.18832

0.405

AA

AA

BB

BB

BB

BB

AA

AA

AB

AB

1735595

6

SNP_A-

rs2810160

114329403

114.329403

0.548

AA

AB

BB

BB

BB

BB

AB

AB

AB

AB

1712634

6

SNP_A-

rs1748168

114955404

114.955404

0.56

BB

AB

AA

AA

AA

AA

AB

AB

BB

BB

1687581

6

SNP_A-

rs2250263

116940700

116.9407

0.679

AA

AB

AA

AA

AA

AA

AA

AA

BB

BB

1738139

6

SNP_A-

rs929122

117712442

117.712442

0.726

AA

AA

AA

AA

AA

AA

AA

AA

AB

AB

1729937

6

SNP_A-

rs9285429

118811259

118.811259

0.619

AA

AA

AB

AB

AB

AB

AA

AA

BB

BB

1661803

6

SNP_A-

rs1873553

120164641

120.164641

0.429

BB

BB

BB

BB

BB

BB

AB

AB

AA

AA

1665123

6

SNP_A-

rs6906196

122713901

122.713901

0.369

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1679087

6

SNP_A-

rs6924068

124232587

124.232587

0.345

BB

BB

AB

AB

AB

AB

BB

BB

BB

BB

1707510

6

SNP_A-

rs484510

125528599

125.528599

0.691

AA

AA

AA

AA

AA

AA

AA

AA

AB

AB

1745119

6

SNP_A-

rs9321057

126198636

126.198636

0.405

AA

AB

BB

BB

BB

BB

AB

AB

AB

AB

1685381

6

SNP_A-

rs270044

128228176

128.228176

0.405

AA

AB

BB

BB

BB

BB

BB

BB

AB

AB

1751986

6

SNP_A-

rs1508439

129073191

129.073191

0.655

AA

AB

AA

AA

AA

AA

AB

AB

AA

AA

1721422

6

SNP_A-

rs10484282

130107771

130.107771

0.321

BB

AB

BB

BB

BB

BB

AB

AB

BB

BB

1707720

6

SNP_A-

rs766967

130912718

130.912718

0.488

AA

AA

AB

AB

AB

AB

AB

AB

BB

BB

1652817

6

SNP_A-

rs170881

132358254

132.358254

0.655

AA

AA

BB

BB

BB

BB

AB

AB

BB

BB

1653251

6

SNP_A-

rs2745426

133045037

133.045037

0.287

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1723663

6

SNP_A-

rs509904

133558775

133.558775

0.713

AA

AB

AA

AA

AA

AA

AA

AA

BB

BB

1751418

6

SNP_A-

rs6570091

137092589

137.092589

0.464

BB

BB

AA

AA

AA

AA

BB

BB

AB

AB

1735812

6

SNP_A-

rs662100

137931606

137.931606

0.512

AA

AA

AA

AA

AA

AA

BB

AB

AA

AA

1669540

6

SNP_A-

rs2473522

139472945

139.472945

0.274

BB

BB

AB

AB

AB

AB

AA

AA

BB

BB

1692831

6

SNP_A-

rs9321743

140005650

140.00565

0.655

AA

AA

AA

AA

AA

AA

AA

AA

AB

AB

1729139

6

SNP_A-

rs225710

142582952

142.582952

0.548

AB

AB

BB

BB

BB

BB

BB

AB

AA

AA

1668519

6

SNP_A-

rs10484804

143972461

143.972461

0.262

AB

AB

BB

BB

BB

BB

BB

BB

BB

BB

1741850

6

SNP_A-

rs4243477

145767511

145.767511

0.655

AA

AA

AA

AA

AA

AA

AA

AB

AB

AB

1699598

6

SNP_A-

rs6923545

146286436

146.286436

0.417

AB

AB

BB

BB

BB

BB

BB

AB

AB

AB

1714061

6

SNP_A-

rs2025157

146851348

146.851348

0.607

AA

AA

AA

AA

AA

AA

AA

AB

BB

BB

1643757

6

SNP_A-

rs10484677

148334072

148.334072

0.702

AA

AA

AA

AA

AA

AA

AA

AA

AB

AB

1746680

6

SNP_A-

rs997682

149708313

149.708313

0.293

BB

BB

AB

AB

AB

AB

BB

AB

BB

BB

1674099

6

SNP_A-

rs1933079

151696424

151.696424

0.464

AA

AA

BB

BB

BB

BB

AA

AB

BB

BB

1742378

6

SNP_A-

rs872371

153469676

153.469676

0.732

AA

AA

BB

BB

BB

BB

AA

AB

AA

AA

1664463

6

SNP_A-

rs612450

154306471

154.306471

0.56

AB

AB

AA

AB

AB

AB

AA

AA

AA

AA

1706738

6

SNP_A-

rs1980602

155248334

155.248334

0.429

AB

AB

AA

AA

AA

AA

BB

AB

AB

AB

1661002

6

SNP_A-

rs1391655

156092837

156.092837

0.298

BB

AB

BB

BB

BB

BB

BB

AB

BB

BB

1700465

6

SNP_A-

rs7770496

156806897

156.806897

0.372

AA

AB

AA

AB

AB

AB

AA

AB

AB

AB

1660620

6

SNP_A-

rs4709298

157885415

157.885415

0.262

BB

AB

BB

AB

AB

AB

AA

AB

AA

AA

1712976

6

SNP_A-

rs7753885

158892133

158.892133

0.488

BB

AB

AA

AB

AB

AB

BB

BB

BB

BB

1676117

6

SNP_A-

rs923459

159532261

159.532261

0.513

BB

AB

AA

AA

AA

AA

BB

BB

AB

AB

1669774

6

SNP_A-

rs927450

160152507

160.152507

0.583

AA

AA

AA

AA

AA

AA

BB

AB

AB

AB

1659978

6

SNP_A-

rs598969

160664317

160.664317

0.425

BB

AB

AA

AA

AA

AA

BB

BB

BB

BB

1670969

6

SNP_A-

rs6910079

164339862

164.339862

0.441

AA

AB

BB

AB

AB

AB

BB

BB

AB

AB

1697554

6

SNP_A-

rs907223

165179009

165.179009

0.702

AA

AA

AA

AA

AA

AA

AA

AA

AB

AB

1641972

6

SNP_A-

rs162293

167420582

167.420582

0.75

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1698488

7

SNP_A-

rs1637750

2001052

2.001052

0.655

AA

AA

AA

AA

AA

AA

AB

AB

AA

AA

1647507

7

SNP_A-

rs10257982

3107838

3.107838

0.452

AA

AB

AA

AA

AA

AA

BB

BB

AB

AB

1710599

7

SNP_A-

rs10488360

4184450

4.18445

0.317

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1675597

7

SNP_A-

rs719423

7128355

7.128355

0.667

AA

AA

BB

BB

BB

BB

BB

BB

AB

AB

1712104

7

SNP_A-

rs38012

7815795

7.815795

0.464

AB

AB

AB

AB

BB

AB

AB

AB

AB

AB

1649251

7

SNP_A-

rs10253058

10364900

10.3649

0.738

AA

AA

AA

AA

AA

AA

AA

AA

AB

AB

1714013

7

SNP_A-

rs7785008

10921568

10.921568

0.452

AB

AB

BB

BB

BB

BB

AA

AA

AB

AB

1656052

7

SNP_A-

rs10270630

11629477

11.629477

0.738

BB

BB

AB

AB

BB

AB

AA

AA

AB

AB

1678735

7

SNP_A-

rs1036667

12197823

12.197823

0.488

BB

BB

AB

AB

AA

AB

AA

AA

AA

AA

1672885

7

SNP_A-

rs2214867

13507965

13.507965

0.417

AA

AA

AA

AA

AA

AA

BB

BB

AB

AB

1707354

7

SNP_A-

rs7793372

14320689

14.320689

0.619

BB

BB

BB

BB

BB

BB

AA

AA

AB

AB

1724539

7

SNP_A-

rs1527203

15931001

15.931001

0.643

AA

AA

AB

AB

AB

AB

AA

AA

AA

AA

1756798

7

SNP_A-

rs706057

16577230

16.57723

0.56

AB

AB

AB

AB

AB

AB

AB

AB

AB

AB

1755023

7

SNP_A-

rs4721619

17291814

17.291814

0.667

AB

AB

AA

AA

AA

AA

AB

AB

AA

AA

1647845

7

SNP_A-

rs2731551

18050825

18.050825

0.25

BB

BB

AB

AB

AB

AB

BB

BB

BB

BB

1693824

7

SNP_A-

rs10486334

18974842

18.974842

0.726

BB

BB

AB

AB

AB

AB

BB

BB

AA

AA

1724213

7

SNP_A-

rs2248634

21065118

21.065118

0.262

BB

BB

BB

BB

BB

BB

AB

AB

BB

BB

1716746

7

SNP_A-

rs7781044

21636203

21.636203

0.61

AA

AA

AA

AA

AA

AA

AB

AB

AB

AB

1706218

7

SNP_A-

rs2286497

22701238

22.701238

0.305

BB

BB

AB

AB

AB

AB

AB

AB

AB

AB

1718088

7

SNP_A-

rs2521642

24200036

24.200036

0.31

BB

BB

BB

BB

BB

BB

AB

AB

BB

BB

1755947

7

SNP_A-

rs4275130

26366016

26.366016

0.75

AB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1751950

7

SNP_A-

rs6953785

27237607

27.237607

0.536

AB

AB

AB

BB

AB

AB

AB

AB

AA

AA

1725907

7

SNP_A-

rs4498447

28177012

28.177012

0.524

BB

BB

AB

BB

AB

AB

BB

BB

AB

AB

1729503

7

SNP_A-

rs1859681

28699408

28.699408

0.275

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1663287

7

SNP_A-

rs1476991

29293282

29.293282

0.571

AA

AA

AA

AA

AA

AA

AA

AA

AB

AB

1728544

7

SNP_A-

rs997349

29955684

29.955684

0.357

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1718026

7

SNP_A-

rs10487729

31345524

31.345524

0.726

AA

AA

AA

AA

AA

AA

AB

AB

BB

BB

1695134

7

SNP_A-

rs215675

32156237

32.156237

0.286

AA

AB

BB

BB

BB

BB

BB

BB

AB

AB

1694740

7

SNP_A-

rs10254116

33010729

33.010729

0.631

BB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1717858

7

SNP_A-

rs10486619

33600838

33.600838

0.262

BB

BB

BB

BB

BB

BB

BB

BB

AB

AB

1678175

7

SNP_A-

rs741202

35093154

35.093154

0.262

BB

BB

BB

BB

AB

AB

BB

BB

AA

AA

1749566

7

SNP_A-

rs4720228

36725169

36.725169

0.476

BB

AB

BB

BB

BB

BB

BB

BB

BB

BB

1731924

7

SNP_A-

rs2893552

37928803

37.928803

0.679

AA

AA

AA

AA

AA

AA

BB

BB

AA

AA

1671783

7

SNP_A-

rs4723791

38613746

38.613746

0.56

BB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1730217

7

SNP_A-

rs10486802

39497008

39.497008

0.571

AA

AA

BB

BB

BB

BB

AA

AA

AA

AA

1669882

7

SNP_A-

rs7807596

40599281

40.599281

0.417

AA

AA

BB

BB

AB

AB

AB

AB

AA

AA

1721388

7

SNP_A-

rs384469

41099793

41.099793

0.702

AA

AB

AA

AA

AA

AA

AB

AB

AA

AA

1750290

7

SNP_A-

rs721273

42867596

42.867596

0.702

AA

AA

BB

BB

AB

AB

AA

AA

AA

AA

1695614

7

SNP_A-

rs2330918

43444472

43.444472

0.75

AA

AB

AA

AA

AA

AA

AA

AA

AA

AA

1736506

7

SNP_A-

rs10253161

46769632

46.769632

0.714

AA

AA

AA

AA

AA

AA

AA

AA

BB

AB

1732094

7

SNP_A-

rs7357251

47841498

47.841498

0.417

AA

AA

AA

AA

AA

AB

BB

BB

BB

BB

1710294

7

SNP_A-

rs3923511

48463293

48.463293

0.688

AA

AA

AA

AA

AA

AA

AB

AB

BB

AB

1669906

7

SNP_A-

rs716719

50102978

50.102978

0.262

AA

AA

BB

BB

BB

BB

BB

BB

BB

BB

1748806

7

SNP_A-

rs2159809

52287324

52.287324

0.39

AA

AB

BB

BB

BB

BB

BB

BB

BB

BB

1646085

7

SNP_A-

rs6955211

63316490

63.31649

0.464

BB

AB

AA

AA

AA

AA

AA

AB

BB

BB

1655668

7

SNP_A-

rs9638255

67214110

67.21411

0.655

AA

AA

AA

AA

AA

AA

AA

AB

AA

AA

1695272

7

SNP_A-

rs1699443

68224124

68.224124

0.583

AA

AB

AA

AA

AA

AA

AA

AA

BB

AB

1673105

7

SNP_A-

rs10499812

69098641

69.098641

0.333

AA

AB

BB

BB

BB

BB

BB

BB

BB

BB

1667673

7

SNP_A-

rs6976144

77019455

77.019455

0.5

AA

AB

BB

BB

BB

BB

AB

AB

AA

AB

1757146

7

SNP_A-

rs10485887

77712706

77.712706

0.548

AA

AA

AA

AB

AA

AB

BB

BB

AA

AB

1741890

7

SNP_A-

rs984312

78285441

78.285441

0.631

AA

AA

BB

AB

AB

AB

AA

AA

BB

AB

1663217

7

SNP_A-

rs3211816

79922641

79.922641

0.39

BB

BB

BB

BB

BB

BB

AB

AB

BB

BB

1676663

7

SNP_A-

rs3801720

81447606

81.447606

0.595

AA

AB

BB

AB

AB

AB

AB

AB

BB

AB

1724625

7

SNP_A-

rs1693380

82818863

82.818863

0.738

AA

AA

AA

AA

AA

AA

AB

AB

AA

AA

1701440

7

SNP_A-

rs10499889

84765715

84.765715

0.369

BB

BB

BB

BB

BB

BB

AB

AB

AA

AA

1690947

7

SNP_A-

rs1063964

87480120

87.48012

0.607

AA

AA

AA

AA

AA

AA

AA

AA

BB

AB

1722683

7

SNP_A-

rs7799830

88761617

88.761617

0.429

BB

BB

AA

AA

AA

AA

AB

AB

AA

AA

1697794

7

SNP_A-

rs3802029

90126750

90.12675

0.595

AB

AB

AA

AB

AB

AB

BB

BB

BB

AB

1692549

7

SNP_A-

rs1468180

92759526

92.759526

0.441

BB

BB

AA

AA

AA

AA

AA

AA

AA

AB

1721485

7

SNP_A-

rs6465448

94217939

94.217939

0.548

AB

AB

BB

BB

BB

BB

AA

AA

BB

AB

1705566

7

SNP_A-

rs1403179

96113755

96.113755

0.75

AB

AB

AA

AA

AA

AA

AB

AB

AA

AA

1644895

7

SNP_A-

rs7779090

96790254

96.790254

0.345

BB

BB

BB

BB

BB

BB

AB

AB

BB

AB

1698924

7

SNP_A-

rs2572009

99133656

99.133656

0.524

AA

AA

BB

AB

AB

AB

AA

AA

AA

AA

1755481

7

SNP_A-

rs10487284

102064226

102.064226

0.667

AA

AA

AA

AA

AA

AA

AA

AA

AA

AB

1669180

7

SNP_A-

rs10487162

102860400

102.8604

0.256

AB

AB

BB

AB

AB

AB

BB

BB

BB

AB

1730488

7

SNP_A-

rs2519681

105578447

105.578447

0.369

AB

AB

AA

AB

AB

AB

AB

AB

AA

AB

1715320

7

SNP_A-

rs997381

106280867

106.280867

0.524

AB

AB

BB

BB

BB

BB

AA

AA

BB

BB

1657867

7

SNP_A-

rs3801948

106832398

106.832398

0.643

AA

AA

BB

AB

AB

AB

AA

AA

BB

AB

1703262

7

SNP_A-

rs1015422

107930809

107.930809

0.298

BB

AB

AA

AB

AB

AB

AB

AB

BB

AB

1687475

7

SNP_A-

rs2106442

108493824

108.493824

0.476

AA

AA

BB

BB

BB

BB

AB

AB

AA

AA

1643849

7

SNP_A-

rs10487320

109537858

109.537858

0.619

BB

AB

BB

BB

BB

BB

AA

AB

AA

AA

1688527

7

SNP_A-

rs10500003

110076704

110.076704

0.702

AA

AB

AA

AA

AA

AA

AA

AA

AA

AA

1641802

7

SNP_A-

rs10487331

110945463

110.945463

0.726

AA

AA

AA

AB

AB

AB

BB

AB

AA

AB

1740412

7

SNP_A-

rs2529588

111697006

111.697006

0.726

AA

AA

AA

AA

AA

AA

AA

AB

AA

AB

1745955

7

SNP_A-

rs1548395

112947523

112.947523

0.298

BB

BB

BB

BB

BB

BB

BB

AB

AA

AB

1724315

7

SNP_A-

rs6973150

114297804

114.297804

0.45

BB

BB

AB

AB

AB

AB

BB

BB

BB

BB

1719538

7

SNP_A-

rs10500054

115247129

115.247129

0.5

BB

BB

BB

BB

BB

BB

AA

AB

BB

BB

1736164

7

SNP_A-

rs7783832

116468422

116.468422

0.298

BB

BB

AB

AB

AB

AB

BB

AB

BB

AB

1733815

7

SNP_A-

rs10487392

117466579

117.466579

0.488

BB

BB

AB

AB

AB

AB

AA

AA

AA

AB

1676935

7

SNP_A-

rs10488301

119761267

119.761267

0.262

AA

AB

BB

BB

BB

BB

AA

AB

BB

BB

1647647

7

SNP_A-

rs1206486

121146345

121.146345

0.441

BB

BB

BB

BB

BB

BB

AA

AB

BB

BB

1655036

7

SNP_A-

rs10487974

122442567

122.442567

0.381

AA

AB

AB

AB

AB

AB

BB

BB

BB

BB

1643783

7

SNP_A-

rs6948425

123386447

123.386447

0.476

AA

AA

AB

AB

AB

AB

AA

AB

BB

AB

1690238

7

SNP_A-

rs723444

124253175

124.253175

0.417

BB

BB

AB

AB

AB

AB

BB

BB

BB

BB

1745008

7

SNP_A-

rs2107098

124969695

124.969695

0.488

BB

AB

AA

AA

AA

AA

BB

AB

BB

AB

1675675

7

SNP_A-

rs2299447

125743520

125.74352

0.738

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1678693

7

SNP_A-

rs6467115

126530478

126.530478

0.643

AA

AA

AA

AA

AA

AA

AA

AA

BB

BB

1670675

7

SNP_A-

rs10487505

127454114

127.454114

0.464

BB

BB

AB

AB

AB

AB

BB

BB

BB

AB

1708033

7

SNP_A-

rs10488628

127961843

127.961843

0.405

AA

AB

AB

AB

AB

AB

AA

AA

AA

AB

1656498

7

SNP_A-

rs7803075

130199321

130.199321

0.726

AA

AA

BB

BB

BB

BB

BB

AB

AA

AA

1742598

7

SNP_A-

rs1790998

133595635

133.595635

0.476

AA

AA

AB

AB

AB

AB

BB

BB

BB

BB

1695048

7

SNP_A-

rs2551778

134556904

134.556904

0.548

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1721434

7

SNP_A-

rs10253975

135674764

135.674764

0.662

BB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1669022

7

SNP_A-

rs2253729

139396073

139.396073

0.583

AA

AB

BB

BB

BB

BB

AA

AA

BB

BB

1715624

7

SNP_A-

rs1527304

141162389

141.162389

0.571

AA

AA

BB

BB

BB

BB

AA

AA

AA

AB

1652925

7

SNP_A-

rs6949653

143162918

143.162918

0.691

AA

AB

AB

AB

AB

AB

AA

AA

AA

AA

1715016

7

SNP_A-

rs4725680

144870787

144.870787

0.369

AA

AB

BB

BB

BB

BB

AA

AA

AA

AA

1666637

7

SNP_A-

rs10487936

145527849

145.527849

0.732

AA

AA

AA

AA

AA

AA

AA

AA

BB

AB

1681703

7

SNP_A-

rs10278315

146403556

146.403556

0.726

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1680321

7

SNP_A-

rs1177946

147495250

147.49525

0.643

AA

AA

AA

AA

AA

AA

AA

AA

BB

BB

1720798

7

SNP_A-

rs1403222

149691561

149.691561

0.536

AB

AB

AA

AA

AA

AA

BB

BB

AA

AB

1713513

7

SNP_A-

rs306293

154243700

154.2437

0.643

AA

AA

BB

BB

BB

BB

AA

AA

AB

AB

1736364

7

SNP_A-

rs2301916

156473603

156.473603

0.369

AB

AB

AB

AB

BB

AB

BB

BB

AB

AB

1691199

8

SNP_A-

rs747351

228574

0.228574

0.369

AB

AB

AB

AB

AA

AB

AB

AB

AA

AB

1659972

8

SNP_A-

rs4876153

2291741

2.291741

0.691

BB

BB

AA

AA

AA

AA

AA

AA

AA

AB

1725579

8

SNP_A-

rs9314492

3332437

3.332437

0.476

AA

AA

BB

BB

BB

BB

BB

BB

BB

AB

1651465

8

SNP_A-

rs10503246

4117771

4.117771

0.714

AB

AB

AA

AA

AA

AA

BB

AB

BB

AB

1695486

8

SNP_A-

rs4146469

5253259

5.253259

0.441

AB

AB

AB

AB

AB

AB

BB

AB

BB

BB

1650643

8

SNP_A-

rs6559072

5839489

5.839489

0.679

AB

AB

AA

AA

AA

AA

BB

BB

AA

AA

1714359

8

SNP_A-

rs3020252

6450411

6.450411

0.634

AB

AB

BB

BB

BB

BB

AA

AA

BB

AB

1660050

8

SNP_A-

rs2409113

8849712

8.849712

0.72

AB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1757262

8

SNP_A-

rs1588198

9929939

9.929939

0.655

AB

AB

AB

AB

AB

AB

AA

AB

AA

AA

1680667

8

SNP_A-

rs2278335

10740863

10.740863

0.702

AB

AB

AA

AA

AA

AA

AA

AA

AA

AB

1679891

8

SNP_A-

rs10503478

13876453

13.876453

0.607

AA

AA

AB

AB

AB

AB

AA

AB

BB

BB

1715348

8

SNP_A-

rs2410193

14445035

14.445035

0.738

AA

AA

AA

AA

AA

AA

BB

RB

AA

AB

1659353

8

SNP_A-

rs351572

16065839

16.065839

0.595

AA

AA

AA

AA

AA

AA

AA

AA

BB

AB

1756484

8

SNP_A-

rs7003503

17226143

17.226143

0.25

BB

BB

AB

AA

AB

AB

BB

BB

BB

AB

1750990

8

SNP_A-

rs7006702

19316813

19.316813

0.333

AA

AB

AB

BB

AB

AB

BB

BB

BB

AB

1688509

8

SNP_A-

rs2083637

19909455

19.909455

0.738

AA

AB

AB

BB

AB

AB

AB

AB

AA

AA

1747706

8

SNP_A-

rs2306518

22526253

22.526253

0.357

BB

AB

BB

BB

BB

BB

BB

BB

AA

AA

1646595

8

SNP_A-

rs10503733

23589963

23.589963

0.714

AA

AB

AA

AA

AA

AA

AB

AB

AA

AA

1699334

8

SNP_A-

rs2976457

24923988

24.923988

0.548

BB

AB

AA

AA

AA

AA

AB

AB

BB

BB

1752532

8

SNP_A-

rs10503776

25765786

25.765786

0.671

BB

BB

AA

AA

AA

AA

AB

AB

AA

AA

1746191

8

SNP_A-

rs10503872

30556573

30.556573

0.476

AA

AB

BB

AA

AA

AB

AA

AA

BB

BB

1742962

8

SNP_A-

rs10503907

32291552

32.291552

0.607

AA

AA

AA

BB

BB

AB

AB

AB

AA

AB

1710298

8

SNP_A-

rs1551652

34443033

34.443033

0.662

AA

AA

BB

AA

AA

AB

BB

BB

AA

AA

1646333

8

SNP_A-

rs10503970

34985910

34.98591

0.262

BB

BB

BB

AA

AA

AB

AB

AB

BB

BB

1679337

8

SNP_A-

rs581187

37119893

37.119893

0.286

BB

BB

AA

AA

AA

AA

BB

BB

BB

AB

1701068

8

SNP_A-

rs3935233

39307991

39.307991

0.31

AA

AB

BB

BB

BB

BB

BB

BB

BB

BB

1747018

8

SNP_A-

rs9298596

40431722

40.431722

0.333

AA

AA

BB

AA

AA

AB

BB

BB

BB

BB

1730295

8

SNP_A-

rs341817

50186153

50.186153

0.56

AA

AA

AA

BB

BB

AB

AA

AB

BB

AB

1664173

8

SNP_A-

rs318913

51075845

51.075845

0.262

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1712754

8

SNP_A-

rs10504120

52554998

52.554998

0.726

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1716236

8

SNP_A-

rs2249236

53110767

53.110767

0.286

AA

AB

AA

BB

AB

AB

AA

AB

BB

BB

1645251

8

SNP_A-

rs360956

54063839

54.063839

0.61

BB

BB

BB

AA

AB

AB

AA

AA

BB

BB

1674928

8

SNP_A-

rs7824078

55966296

55.966296

0.631

AA

AA

BB

AA

AB

AB

AA

AA

AA

AB

1661925

8

SNP_A-

rs2670052

57666163

57.666163

0.583

AA

AB

AA

BB

AB

AB

AA

AA

AA

AA

1734483

8

SNP_A-

rs9297980

58641477

58.641477

0.476

AA

AA

AB

BB

AB

AB

AA

AB

AB

AB

1649879

8

SNP_A-

rs7012230

62449232

62.449232

0.31

BB

BB

BB

BB

BB

BB

BB

BB

AB

AB

1689109

8

SNP_A-

rs874777

65147501

65.147501

0.583

BB

BB

BB

BB

BB

BB

AA

AA

AA

AA

1729837

8

SNP_A-

rs977467

67469418

67.469418

0.56

BB

AB

AA

AA

AA

AA

AA

AB

AB

AB

1688563

8

SNP_A-

rs900896

68690751

68.690751

0.702

AA

AA

AB

AA

AB

AB

AA

AA

AA

AA

1656454

8

SNP_A-

rs1404605

69369253

69.369253

0.585

BB

AB

AA

AA

AA

AA

BB

BB

AA

AA

1673083

8

SNP_A-

rs10504451

70626182

70.626182

0.524

AA

AB

BB

BB

BB

BB

AA

AA

AB

AB

1673921

8

SNP_A-

rs10504477

71500739

71.500739

0.487

BB

AB

AB

AA

AB

AB

BB

AB

AB

AB

1660240

8

SNP_A-

rs2732090

72080811

72.080811

0.5

AA

AB

AA

AA

AA

AA

AA

AB

AB

AB

1698932

8

SNP_A-

rs10504526

73129106

73.129106

0.548

AA

AA

AA

AA

AA

AA

BB

AB

AA

AA

1710462

8

SNP_A-

rs10504552

75038119

75.038119

0.286

BB

BB

AA

AA

AA

AA

AA

AA

AA

AA

1684163

8

SNP_A-

rs1375646

76679672

76.679672

0.321

BB

BB

BB

BB

BB

BB

BB

BB

AB

AB

1673775

8

SNP_A-

rs1993196

78213269

78.213269

0.583

BB

BB

AA

AA

AA

AA

AB

AB

AA

AA

1753574

8

SNP_A-

rs2461063

80781668

80.781668

0.631

AA

AA

AB

BB

AB

AB

AB

AB

AB

AB

1713893

8

SNP_A-

rs1199030

81917969

81.917969

0.357

BB

BB

AA

AA

AA

AA

BB

BB

BB

BB

1650035

8

SNP_A-

rs1525339

83916405

83.916405

0.738

AA

AA

AA

AA

AA

AA

BB

BB

AA

AA

1709456

8

SNP_A-

rs1465809

85243012

85.243012

0.25

BB

BB

BB

BB

BB

BB

BB

BB

AB

AB

1747972

8

SNP_A-

rs3808538

86308563

86.308563

0.738

AA

AA

BB

BB

BB

BB

AA

AA

AB

AB

1690861

8

SNP_A-

rs10504819

87183400

87.1834

0.369

BB

BB

AA

AA

AA

AA

AA

AA

BB

BB

1642120

8

SNP_A-

rs997597

88259667

88.259667

0.274

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1704458

8

SNP_A-

rs10504855

88844371

88.844371

0.345

BB

BB

BB

BB

BB

BB

AB

AB

AB

AB

1731702

8

SNP_A-

rs160410

90717844

90.717844

0.658

AA

AA

BB

BB

BB

BB

AA

AA

AA

AA

1669078

8

SNP_A-

rs1818193

91886818

91.886818

0.631

AA

AA

AA

AA

AA

AA

AA

AA

AB

AB

1713264

8

SNP_A-

rs2245797

95329376

95.329376

0.31

BB

BB

BB

BB

BB

BB

AB

AB

AB

AB

1679699

8

SNP_A-

rs962451

101400186

101.400186

0.583

AA

AA

AA

AA

AA

AA

AA

AA

BB

BB

1738642

8

SNP_A-

rs4495397

103476369

103.476369

0.268

BB

BB

AA

AA

AA

AA

BB

BB

BB

BB

1677965

8

SNP_A-

rs543736

104082125

104.082125

0.619

AB

AB

BB

BB

BB

BB

AA

AB

AA

AA

1718730

8

SNP_A-

rs10505064

105831730

105.83173

0.345

AB

AB

BB

BB

BB

BB

BB

AB

BB

BB

1724051

8

SNP_A-

rs2930485

107881851

107.881851

0.607

AB

AB

AB

BB

AB

AB

AA

AB

BB

BB

1691919

8

SNP_A-

rs10505107

108392560

108.39256

0.619

AA

AA

AB

AA

AB

AB

AA

AA

AA

AA

1652191

8

SNP_A-

rs1353298

108959098

108.959098

0.321

BB

BB

BB

BB

BB

BB

BB

BB

AB

AB

1756952

8

SNP_A-

rs5772

110167808

110.167808

0.571

AB

AB

AB

BB

AB

AB

AA

AB

AB

AB

1695466

8

SNP_A-

rs10505135

111120579

111.120579

0.345

AA

AA

BB

BB

BB

BB

AA

AB

AB

AB

1747370

8

SNP_A-

rs10505156

112369457

112.369457

0.25

AB

AB

BB

BB

BB

BB

BB

BB

BB

BB

1745327

8

SNP_A-

rs10505180

113392265

113.392265

0.726

AB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1681911

8

SNP_A-

rs2125552

113984509

113.984509

0.274

BB

BB

AB

BB

AB

AB

BB

AB

BB

BB

1694542

8

SNP_A-

rs9297496

114629527

114.629527

0.321

BB

BB

BB

BB

BB

BB

BB

BB

AB

AB

1713409

8

SNP_A-

rs7828185

116438576

116.438576

0.286

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1725803

8

SNP_A-

rs10505328

119219639

119.219639

0.441

AB

AB

BB

BB

BB

BB

BB

BB

BB

BB

1698988

8

SNP_A-

rs3924784

121618858

121.618858

0.667

AA

AA

AA

AA

AA

AA

BB

AB

AB

AB

1753414

8

SNP_A-

rs17478

122793072

122.793072

0.595

AA

AA

AB

AA

AB

AB

BB

AB

AB

AB

1735413

8

SNP_A-

rs6470143

124219594

124.219594

0.345

BB

BB

BB

BB

BB

BB

BB

AB

AA

AA

1655430

8

SNP_A-

rs3909562

124803864

124.803864

0.405

AA

AB

AA

AA

AA

AA

BB

BB

AB

AB

1754805

8

SNP_A-

rs2382993

125770106

125.770106

0.345

BB

AB

BB

BB

BB

BB

BB

AB

BB

BB

1696789

8

SNP_A-

rs897153

126747483

126.747483

0.643

BB

AB

AB

BB

AB

AB

AA

AB

AB

AB

1686811

8

SNP_A-

rs2091933

127485749

127.485749

0.679

AA

AB

BB

BB

BB

BB

AA

AA

AB

AB

1753008

8

SNP_A-

rs10505486

128074016

128.074016

0.441

BB

BB

BB

BB

BB

BB

BB

AB

AB

AB

1651085

8

SNP_A-

rs4123791

129288419

129.288419

0.417

BB

BB

AA

AA

AA

AA

AA

AA

AA

AA

1682761

8

SNP_A-

rs9297775

129805894

129.805894

0.333

BB

AB

BB

BB

BB

BB

BB

BB

BB

BB

1692841

8

SNP_A-

rs10505545

130646449

130.646449

0.538

AA

AA

AB

AB

AB

AB

BB

BB

BB

BB

1653731

8

SNP_A-

rs7460225

131408555

131.408555

0.464

AA

AB

AB

AB

AB

AB

AA

AB

AA

AA

1655374

8

SNP_A-

rs7008202

132143592

132.143592

0.357

BB

AB

AA

AA

AA

AA

BB

BB

AB

AB

1672735

8

SNP_A-

rs4736424

133782292

133.782292

0.31

BB

BB

BB

BB

BB

BB

AA

AB

BB

BB

1725115

8

SNP_A-

rs10505607

134527931

134.527931

0.441

AA

AB

BB

BB

BB

BB

BB

BB

AB

AB

1647079

8

SNP_A-

rs4909801

135948341

135.948341

0.702

AA

AB

BB

BB

BB

BB

AA

AB

AA

AA

1700220

8

SNP_A-

rs4909582

137288153

137.288153

0.488

AA

AA

BB

AB

AB

AB

BB

BB

AA

AA

1675316

8

SNP_A-

rs9324439

138086052

138.086052

0.452

BB

AB

BB

BB

BB

BB

BB

BB

AB

AB

1661056

8

SNP_A-

rs1325053

139156386

139.156386

0.732

AA

AA

AA

AB

AB

AB

BB

BB

AA

AA

1689603

8

SNP_A-

rs2468705

140618265

140.618265

0.75

AB

AB

BB

AB

AB

AB

AA

AA

AA

AA

1710354

9

SNP_A-

rs10491691

336963

0.336963

0.655

AB

AB

AA

AA

AA

AA

AB

AB

BB

BB

1643050

9

SNP_A-

rs2370220

907667

0.907667

0.726

AA

AA

AB

AB

AB

AB

AA

AA

AA

AA

1704718

9

SNP_A-

rs7040916

2645520

2.64552

0.726

BB

BB

AA

AA

AA

AA

AA

AA

AA

AA

1681445

9

SNP_A-

rs1358908

3162093

3.162093

0.524

AA

AA

BB

BB

BB

BB

BB

BB

AA

AA

1734535

9

SNP_A-

rs1455177

3782613

3.782613

0.488

BB

BB

BB

BB

BB

BB

AB

AB

AB

AB

1685961

9

SNP_A-

rs10491650

5193054

5.193054

0.354

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1642494

9

SNP_A-

rs1407473

7989681

7.989681

0.31

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1696419

9

SNP_A-

rs1433548

8927116

8.927116

0.31

AB

AB

AB

AB

AB

AB

BB

BB

BB

BB

1709516

9

SNP_A-

rs1613507

9791755

9.791755

0.563

AB

AB

AA

AA

AA

AA

BB

BB

AA

AA

1682679

9

SNP_A-

rs10511545

10341048

10.341048

0.726

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1673445

9

SNP_A-

rs4740473

11080005

11.080005

0.369

AB

AB

AA

AA

AA

AA

BB

BB

BB

BB

1679185

9

SNP_A-

rs1825739

11777410

11.77741

0.429

BB

BB

BB

BB

BB

BB

AB

AB

AA

AB

1744452

9

SNP_A-

rs1086377

12824688

12.824688

0.702

AA

AA

BB

BB

BB

BB

AB

AB

AA

AA

1714556

9

SNP_A-

rs7038474

13355816

13.355816

0.702

AB

AB

AA

AA

AA

AA

BB

BB

BB

AB

1672461

9

SNP_A-

rs10511587

13970584

13.970584

0.738

AB

AB

AA

AA

AA

AA

AB

AB

AA

AA

1704214

9

SNP_A-

rs4615688

14495861

14.495861

0.714

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1714243

9

SNP_A-

rs10511603

15006475

15.006475

0.536

BB

BB

BB

BB

BB

BB

AB

AB

AA

AA

1741448

9

SNP_A-

rs1001265

17618726

17.618726

0.726

BB

BB

AA

AA

AA

AA

AA

AA

AA

AA

1742240

9

SNP_A-

rs7862683

18257947

18.257947

0.427

BB

BB

AA

AA

AB

AB

AB

AB

BB

BB

1675206

9

SNP_A-

rs7859334

20660966

20.660966

0.56

AA

AA

BB

BB

AB

AB

AB

AB

BB

AB

1706426

9

SNP_A-

rs871024

21793880

21.79388

0.441

AA

AA

AA

AA

AA

AA

AB

AB

BB

AB

1669996

9

SNP_A-

rs10511705

22537789

22.537789

0.512

BB

BB

BB

BB

AB

AB

AB

AB

BB

AB

1662201

9

SNP_A-

rs9298846

23216243

23.216243

0.655

AB

AB

AA

AA

AA

AA

AA

AA

AA

AB

1673761

9

SNP_A-

rs10511761

25602704

25.602704

0.441

BB

BB

BB

BB

BB

BB

AA

AA

AA

AA

1752066

9

SNP_A-

rs4978049

26131011

26.131011

0.381

AB

AB

BB

BB

BB

BB

BB

BB

BB

BB

1690106

9

SNP_A-

rs983863

26681668

26.681668

0.345

BB

BB

BB

BB

AB

AB

AA

AA

AA

AA

1700687

9

SNP_A-

rs1452357

28090846

28.090846

0.707

BB

BB

BB

BB

AB

AB

AA

AA

AA

AA

1690672

9

SNP_A-

rs824257

28765262

28.765262

0.655

AA

AA

AA

AA

AA

AA

AA

AA

BB

BB

1693514

9

SNP_A-

rs10511842

30009704

30.009704

0.25

AA

AB

BB

BB

AB

AB

BB

BB

AA

AB

1665553

9

SNP_A-

rs10511886

31826555

31.826555

0.607

BB

AB

BB

BB

AB

AB

AB

AB

BB

BB

1724125

9

SNP_A-

rs20583

33016572

33.016572

0.452

AA

AB

BB

BB

BB

BB

AA

AA

AA

AB

1648177

9

SNP_A-

rs6476493

35884737

35.884737

0.691

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1717742

9

SNP_A-

rs4880042

36940301

36.940301

0.393

AA

AA

BB

BB

BB

BB

BB

BB

BB

BB

1671263

9

SNP_A-

rs2181139

38364977

38.364977

0.25

BB

AB

AA

AA

AA

AA

AB

AB

BB

AB

1681599

9

SNP_A-

rs4111409

40345280

40.34528

0.262

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1666811

9

SNP_A-

rs7864775

69030853

69.030853

0.548

BB

BB

BB

BB

BB

BB

BB

BB

AA

AB

1727790

9

SNP_A-

rs10511972

69672094

69.672094

0.619

BB

BB

AA

AA

AA

AB

BB

AB

BB

BB

1699350

9

SNP_A-

rs10511984

70399849

70.399849

0.75

AA

AA

AA

AA

AA

AA

AA

AB

AA

AA

1753754

9

SNP_A-

rs10511999

71526051

71.526051

0.595

AA

AA

AA

AA

AA

AA

AA

AA

BB

AB

1748876

9

SNP_A-

rs1998372

72123726

72.123726

0.369

BB

BB

BB

BB

BB

AB

BB

BB

BB

BB

1750024

9

SNP_A-

rs2377524

76002013

76.002013

0.321

BB

BB

BB

BB

BB

BB

BB

BB

BB

AB

1733975

9

SNP_A-

rs10512079

78602073

78.602073

0.25

AA

AA

AA

AA

AB

AB

AA

AB

BB

BB

1707951

9

SNP_A-

rs1316823

79531349

79.531349

0.643

AB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1655498

9

SNP_A-

rs1572147

80160841

80.160841

0.634

AA

AA

AB

AA

AB

AB

AA

AA

BB

AB

1721234

9

SNP_A-

rs7873639

80780459

80.780459

0.286

BB

BB

BB

BB

BB

BB

AA

AA

AA

AB

1757764

9

SNP_A-

rs2774635

82184146

82.184146

0.286

BB

BB

BB

BB

BB

BB

BB

BB

AA

AB

1685995

9

SNP_A-

rs1436932

83903397

83.903397

0.476

AB

AB

AA

AA

AA

AA

AA

AA

AA

AB

1698246

9

SNP_A-

rs7030902

85064645

85.064645

0.548

AA

AA

AB

BB

AB

AB

BB

BB

AA

AB

1743644

9

SNP_A-

rs1475524

87362117

87.362117

0.357

BB

BB

AB

AA

AB

AB

AA

AB

AA

AA

1642838

9

SNP_A-

rs4744114

91732136

91.732136

0.452

BB

BB

AB

AA

AB

AB

BB

BB

AA

AA

1683979

9

SNP_A-

rs1547201

95896039

95.896039

0.548

AA

AA

BB

BB

BB

BB

AB

AB

AB

AB

1645449

9

SNP_A-

rs1924001

102134812

102.134812

0.643

BB

BB

AA

AA

AA

AA

AB

AB

AA

AA

1751508

9

SNP_A-

rs1463983

105506339

105.506339

0.429

BB

BB

AB

AA

AB

AB

BB

BB

AB

AB

1724479

9

SNP_A-

rs2418076

110092906

110.092906

0.298

BB

BB

AA

AA

AA

AA

BB

BB

BB

BB

1653563

9

SNP_A-

rs1813202

111767658

111.767658

0.286

AB

AB

BB

BB

BB

BB

AB

AB

BB

BB

1744924

9

SNP_A-

rs10513222

113757379

113.757379

0.321

BB

BB

AB

BB

AB

AB

AA

AA

BB

BB

1731818

9

SNP_A-

rs10513267

115067920

115.06792

0.75

AA

AB

AA

AA

AA

AA

AA

AA

AA

AA

1733479

9

SNP_A-

rs4112759

117313823

117.313823

0.75

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1643236

9

SNP_A-

rs7849366

118191918

118.191918

0.286

AA

AA

AB

BB

AB

AB

AB

AB

BB

BB

1750306

9

SNP_A-

rs10514837

118919482

118.919482

0.321

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1686447

9

SNP_A-

rs10491529

120012279

120.012279

0.25

BB

AB

AB

AB

AB

AB

BB

BB

BB

BB

1656426

9

SNP_A-

rs306796

121206889

121.206889

0.631

AA

AA

AA

AA

AA

AA

AA

AA

AB

AB

1677789

9

SNP_A-

rs7043602

126285054

126.285054

0.738

AA

AA

AA

AA

AA

AA

AB

AB

AA

AA

1705544

9

SNP_A-

rs883335

129165519

129.165519

0.595

BB

BB

AB

AB

AB

AB

AA

AA

AB

AB

1653355

9

SNP_A-

rs2269337

130602238

130.602238

0.742

BB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1699424

9

SNP_A-

rs2809243

132799854

132.799854

0.298

BB

BB

AA

AA

AA

AA

AB

AB

AA

AA

1747024

10

SNP_A-

rs1392827

1234414

1.234414

0.667

AA

AA

AB

AB

AB

AB

AB

AB

AA

AA

1659685

10

SNP_A-

rs4880915

1747289

1.747289

0.293

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1753764

10

SNP_A-

rs9329289

2532389

2.532389

0.405

AA

AA

AB

AB

AB

AB

AB

AB

AB

AB

1727231

10

SNP_A-

rs2388557

3181527

3.181527

0.321

BB

BB

BB

BB

BB

BB

AB

AB

BB

BB

1732637

10

SNP_A-

rs1679440

4468715

4.468715

0.286

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1679829

10

SNP_A-

rs946785

7041660

7.04166

0.595

AA

AA

AB

AB

AB

AB

BB

BB

AB

AB

1713889

10

SNP_A-

rs4385796

8539643

8.539643

0.286

BB

BB

BB

BB

BB

BB

BB

BB

AA

AB

1717612

10

SNP_A-

rs1762757

9449776

9.449776

0.726

AA

AA

AA

AA

AA

AA

BB

BB

AA

AA

1740604

10

SNP_A-

rs10508380

10003736

10.003736

0.738

AA

AA

AB

AB

AA

AB

BB

BB

AA

AA

1686911

10

SNP_A-

rs1041044

10644387

10.644387

0.5

BB

BB

AB

AB

BB

AB

AB

AB

BB

BB

1739848

10

SNP_A-

rs4750093

11829643

11.829643

0.429

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1721418

10

SNP_A-

rs1108131

12537753

12.537753

0.75

AB

AB

AB

AB

AA

AB

BB

BB

AA

AA

1739768

10

SNP_A-

rs564166

13110955

13.110955

0.738

AB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1737160

10

SNP_A-

rs10508465

13725194

13.725194

0.429

AA

AA

AB

AB

BB

AB

AB

AB

AA

AA

1678303

10

SNP_A-

rs10508473

14241057

14.241057

0.417

BB

BB

BB

BB

BB

BB

AB

AB

AA

AA

1669628

10

SNP_A-

rs1361588

16119457

16.119457

0.298

BB

BB

BB

BB

BB

BB

BB

BB

BB

AB

1714770

10

SNP_A-

rs10490962

17240369

17.240369

0.56

AB

AB

BB

BB

BB

BB

AB

AB

BB

BB

1700268

10

SNP_A-

rs10508555

18316688

18.316688

0.441

AB

AB

AB

AB

BB

AB

BB

BB

BB

BB

1744374

10

SNP_A-

rs984292

19028813

19.028813

0.393

BB

BB

AB

AB

AA

AB

BB

BB

AA

AB

1748644

10

SNP_A-

rs2358348

19533421

19.533421

0.643

AA

AA

BB

BB

BB

BB

AA

AA

AA

AA

1686549

10

SNP_A-

rs788977

21229153

21.229153

0.262

BB

BB

AB

AB

BB

AB

BB

BB

BB

BB

1678189

10

SNP_A-

rs1417374

23168481

23.168481

0.298

BB

BB

AA

AA

AA

AA

AA

AA

AA

AB

1672001

10

SNP_A-

rs2150651

24829491

24.829491

0.321

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1726471

10

SNP_A-

rs10508686

25367068

25.367068

0.714

AA

AA

AB

AB

AA

AB

AA

AA

AA

AA

1751938

10

SNP_A-

rs4747530

25876455

25.876455

0.56

AB

AB

AB

AB

BB

AB

AB

AB

AA

AA

1713661

10

SNP_A-

rs10508717

26712334

26.712334

0.524

AA

AA

AB

AB

AA

AB

BB

BB

BB

BB

1706402

10

SNP_A-

rs1970631

28271741

28.271741

0.452

AA

AA

BB

BB

BB

BB

AA

AA

AA

AB

1713649

10

SNP_A-

rs703041

29265782

29.265782

0.25

BB

BB

AB

AB

BB

AB

BB

BB

BB

AB

1707064

10

SNP_A-

rs2776644

30294654

30.294654

0.488

AB

AB

AB

AB

BB

AB

BB

AB

BB

BB

1755663

10

SNP_A-

rs2490527

32711123

32.711123

0.631

BB

AB

AB

BB

BB

AB

AA

AB

AA

AA

1679427

10

SNP_A-

rs2269101

33546185

33.546185

0.286

AA

AB

AB

AA

AA

AB

BB

AB

BB

AB

1678169

10

SNP_A-

rs224750

34271036

34.271036

0.619

AA

AA

AA

AA

AA

AA

BB

AB

AA

AA

1674978

10

SNP_A-

rs1032408

43808849

43.808849

0.738

AA

AA

BB

BB

BB

BB

AA

AA

AA

AA

1722205

10

SNP_A-

rs1583421

45099157

45.099157

0.583

BB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1700828

10

SNP_A-

rs10508908

49643864

49.643864

0.5

BB

BB

AA

BB

BB

AB

AA

AB

AB

AB

1718604

10

SNP_A-

rs10508929

51841987

51.841987

0.423

AA

AB

AA

BB

BB

AB

BB

BB

AA

AA

1741518

10

SNP_A-

rs2339628

52548976

52.548976

0.679

AA

AB

BB

BB

BB

BB

BB

BB

AB

AB

1674358

10

SNP_A-

rs1937666

53326630

53.32663

0.464

AB

AB

AA

BB

BB

AB

AA

AB

BB

BB

1665161

10

SNP_A-

rs10508976

54302305

54.302305

0.56

BB

BB

BB

AA

AB

AB

AB

AB

BB

BB

1648887

10

SNP_A-

rs422296

54965065

54.965065

0.714

AA

AA

BB

AA

AB

AB

AA

AA

AB

AB

1660432

10

SNP_A-

rs6481257

58608558

58.608558

0.274

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1642640

10

SNP_A-

rs10509093

60193775

60.193775

0.452

AA

AA

BB

BB

BB

BB

AA

AA

AA

AA

1697033

10

SNP_A-

rs4245585

61596196

61.596196

0.286

BB

BB

BB

AA

AB

AB

BB

BB

BB

BB

1723683

10

SNP_A-

rs10509139

62150158

62.150158

0.691

AB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1653973

10

SNP_A-

rs2787720

63018471

63.018471

0.488

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1713014

10

SNP_A-

rs1255484

65108003

65.108003

0.488

BB

BB

BB

BB

BB

BB

AB

AB

AA

AA

1667099

10

SNP_A-

rs7073489

67452445

67.452445

0.274

AB

AB

BB

BB

BB

BB

BB

BB

BB

BB

1658163

10

SNP_A-

rs4746654

68476694

68.476694

0.441

AB

AB

BB

BB

BB

BB

BB

BB

AB

AB

1642112

10

SNP_A-

rs7918860

70340702

70.340702

0.583

BB

BB

AA

BB

AB

AB

AA

AA

AB

AB

1720304

10

SNP_A-

rs10509321

71655739

71.655739

0.298

AB

AB

AA

AA

AA

AA

BB

BB

AB

AB

1729287

10

SNP_A-

rs10509334

73110058

73.110058

0.427

BB

BB

BB

BB

BB

BB

AB

AB

AA

AA

1707688

10

SNP_A-

rs1865636

77473753

77.473753

0.5

AA

AA

BB

AA

AB

AB

BB

BB

BB

BB

1654508

10

SNP_A-

rs10509384

78693188

78.693188

0.726

AB

AB

AA

AA

AA

AA

AB

AB

AB

AB

1697249

10

SNP_A-

rs1344967

79197624

79.197624

0.262

AA

AA

BB

BB

BB

BB

BB

BB

AB

AB

1679101

10

SNP_A-

rs10509397

79905374

79.905374

0.476

BB

BB

AA

BB

AB

AB

AB

AB

AA

AA

1748530

10

SNP_A-

rs7914988

80540330

80.54033

0.441

AB

AB

AA

BB

AB

AB

AA

AA

AB

AB

1736610

10

SNP_A-

rs342372

84579316

84.579316

0.536

AB

AB

BB

AA

AB

AB

AA

AA

AB

AB

1665139

10

SNP_A-

rs2067731

86973180

86.97318

0.381

BB

BB

AB

AA

AB

AB

BB

BB

AA

AA

1715818

10

SNP_A-

rs2949392

87497414

87.497414

0.5

AA

AA

AB

AA

AB

AB

BB

BB

AB

AB

1689101

10

SNP_A-

rs391683

90510663

90.510663

0.679

BB

BB

AB

AA

AB

AB

AB

AB

AA

AA

1657815

10

SNP_A-

rs303212

91151335

91.151335

0.298

AB

AB

BB

BB

BB

BB

BB

BB

BB

BB

1706118

10

SNP_A-

rs747334

92734724

92.734724

0.476

AA

AA

AB

AB

AB

AB

AB

AB

AA

AA

1703070

10

SNP_A-

rs716361

93308518

93.308518

0.321

AB

AB

BB

BB

BB

BB

BB

BB

AB

AB

1717632

10

SNP_A-

rs2490739

94587885

94.587885

0.631

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1713435

10

SNP_A-

rs3781270

95520148

95.520148

0.607

AA

AA

AA

AA

AA

AA

BB

BB

AB

AB

1642080

10

SNP_A-

rs10509692

97226588

97.226588

0.583

AB

AB

AB

AB

AB

AB

AA

AA

AB

AB

1680183

10

SNP_A-

rs10509700

97884521

97.884521

0.5

AA

AA

AB

AB

AB

AB

AA

AA

BB

BB

1705694

10

SNP_A-

rs793515

98978459

98.978459

0.345

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1753314

10

SNP_A-

rs10509754

103711687

103.711687

0.262

AB

AB

BB

BB

BB

BB

BB

BB

AB

AB

1742188

10

SNP_A-

rs2451500

106622867

106.622867

0.707

AA

AA

AA

AA

AA

AA

AB

AB

BB

BB

1716744

10

SNP_A-

rs10509832

109070424

109.070424

0.667

AA

AA

BB

BB

BB

BB

BB

BB

AB

AB

1684935

10

SNP_A-

rs4113

111223756

111.223756

0.369

AA

AA

AB

AB

AB

AB

BB

BB

BB

BB

1676403

10

SNP_A-

rs7099088

114343455

114.343455

0.631

AB

AB

AB

AB

AB

AB

AB

AB

AA

AA

1726183

10

SNP_A-

rs10509976

115170888

115.170888

0.286

BB

BB

BB

BB

BB

BB

BB

BB

AB

AB

1732939

10

SNP_A-

rs2420070

116671318

116.671318

0.548

AB

AB

BB

BB

BB

BB

BB

BB

BB

BB

1675599

10

SNP_A-

rs4447088

117536799

117.536799

0.274

BB

BB

BB

BB

BB

BB

AB

AB

AB

AB

1700278

10

SNP_A-

rs880977

118409221

118.409221

0.452

AB

AB

AA

AA

AA

AA

AB

AB

AB

AB

1660760

10

SNP_A-

rs2619111

118956986

118.956986

0.702

AA

AA

AB

AB

AB

AB

AA

AA

AA

AA

1747698

10

SNP_A-

rs10490913

120144426

120.144426

0.537

AB

AB

BB

BB

BB

BB

AB

AB

AB

AB

1682085

10

SNP_A-

rs1980030

120960017

120.960017

0.393

AB

AB

BB

BB

BB

BB

AB

AB

BB

BB

1731688

10

SNP_A-

rs1326654

122305416

122.305416

0.405

AB

AB

BB

BB

BB

BB

BB

BB

BB

BB

1641760

10

SNP_A-

rs2420995

123842994

123.842994

0.393

BB

BB

BB

BB

BB

BB

AB

AB

AB

AB

1741090

10

SNP_A-

rs845101

125180422

125.180422

0.631

AB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1751948

10

SNP_A-

rs1278305

127801415

127.801415

0.524

BB

BB

BB

BB

BB

BB

AB

AB

BB

BB

1711689

10

SNP_A-

rs10510154

128412532

128.412532

0.738

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1715610

10

SNP_A-

rs2251104

130003906

130.003906

0.333

AA

AA

BB

BB

BB

BB

AB

AB

AB

AB

1706112

10

SNP_A-

rs1886380

130596834

130.596834

0.702

AA

AA

AB

BB

AA

AB

AA

AA

AB

AB

1712012

10

SNP_A-

rs4077516

133237947

133.237947

0.369

AA

AB

BB

BB

BB

BB

BB

BB

AB

AB

1652639

11

SNP_A-

rs2499935

5066470

5.06647

0.417

BB

BB

AA

AB

BB

AB

BB

BB

BB

BB

1727870

11

SNP_A-

rs2001778

5575584

5.575584

0.452

BB

BB

BB

BB

BB

BB

BB

BB

AB

AB

1656094

11

SNP_A-

rs10500667

6284499

6.284499

0.274

BB

BB

AA

AB

BB

AB

BB

BB

BB

BB

1680969

11

SNP_A-

rs2595456

6841339

6.841339

0.524

BB

BB

BB

BB

BB

BB

BB

AB

AB

AB

1656388

11

SNP_A-

rs3884596

7488751

7.488751

0.571

AB

AB

BB

BB

BB

BB

AA

AB

AB

AB

1649885

11

SNP_A-

rs3993279

10627568

10.627568

0.321

BB

BB

AB

AB

AA

AB

BB

BB

BB

BB

1663461

11

SNP_A-

rs10500740

11167698

11.167698

0.274

AB

AB

BB

BB

BB

BB

AB

AB

AB

AB

1723239

11

SNP_A-

rs1344613

12408280

12.40828

0.31

AB

AB

BB

BB

BB

BB

AB

AB

BB

BB

1712474

11

SNP_A-

rs1894131

15104916

15.104916

0.441

AA

AB

AA

AA

AA

AA

AB

AB

BB

BB

1705810

11

SNP_A-

rs2190454

17490211

17.490211

0.333

AA

AB

BB

BB

BB

BB

BB

BB

AB

AB

1674594

11

SNP_A-

rs211102

18003069

18.003069

0.25

BB

BB

AB

AB

AA

AB

BB

BB

AB

AB

1701156

11

SNP_A-

rs894556

19822510

19.82251

0.56

BB

BB

AB

AB

AB

AB

AA

AA

AB

AB

1685951

11

SNP_A-

rs10500886

20976742

20.976742

0.607

BB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1685201

11

SNP_A-

rs6483807

21873219

21.873219

0.5

BB

BB

AA

AB

AB

AB

BB

BB

AA

AA

1668135

11

SNP_A-

rs10500927

22398998

22.398998

0.262

BB

AB

BB

BB

BB

BB

AB

AB

AB

AB

1713403

11

SNP_A-

rs1600958

23180524

23.180524

0.388

BB

BB

BB

AB

AB

AB

AA

AA

AA

AA

1697826

11

SNP_A-

rs975980

24515539

24.515539

0.441

AA

AB

BB

BB

BB

BB

AA

AA

AB

AB

1753516

11

SNP_A-

rs10501011

25497059

25.497059

0.417

AA

AB

BB

BB

BB

BB

AA

AA

AB

AB

1652525

11

SNP_A-

rs980562

30413393

30.413393

0.726

AA

AB

AA

AB

AB

AB

AB

AB

AA

AA

1665219

11

SNP_A-

rs1848394

30965654

30.965654

0.619

BB

BB

BB

AB

AB

AB

BB

BB

BB

BB

1720570

11

SNP_A-

rs10488689

31659092

31.659092

0.286

BB

BB

AA

AA

AA

AA

BB

BB

AB

AB

1749112

11

SNP_A-

rs1033717

33023147

33.023147

0.342

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1701102

11

SNP_A-

rs2136509

34753380

34.75338

0.537

BB

BB

BB

AB

AB

AB

AA

AA

AB

AB

1752850

11

SNP_A-

rs10501163

36830990

36.83099

0.286

AA

AA

AA

AA

AA

AA

AA

AA

BB

BB

1691121

11

SNP_A-

rs992118

40016469

40.016469

0.286

BB

AB

AA

AB

AB

AB

AA

AB

BB

BB

1725595

11

SNP_A-

rs7102885

40922404

40.922404

0.655

AA

AA

AA

AB

AB

AB

BB

AB

BB

AB

1667717

11

SNP_A-

rs1531932

41781058

41.781058

0.643

AA

AA

BB

AB

AA

AB

AA

AA

AA

AA

1717738

11

SNP_A-

rs692726

50396846

50.396846

0.321

AA

AA

BB

BB

BB

BB

BB

AB

BB

BB

1709380

11

SNP_A-

rs629948

55113024

55.113024

0.643

AA

AA

AA

BB

BB

AB

AA

AA

AA

AA

1752494

11

SNP_A-

rs1080800

56067666

56.067666

0.381

AA

AB

BB

AA

AA

AB

BB

AB

BB

BB

1697650

11

SNP_A-

rs540505

56621831

56.621831

0.536

AA

AB

BB

BB

BB

BB

BB

AB

BB

AB

1658985

11

SNP_A-

rs612688

57333672

57.333672

0.25

BB

BB

BB

BB

BB

BB

AA

AA

BB

BB

1749414

11

SNP_A-

rs10501369

57870148

57.870148

0.512

AA

AA

AA

AA

AA

AA

BB

BB

AA

AA

1698180

11

SNP_A-

rs1941030

59982334

59.982334

0.56

BB

BB

AA

BB

BB

AB

AB

AB

AA

AA

1729269

11

SNP_A-

rs528736

65461684

65.461684

0.393

BB

AB

AB

BB

BB

AB

AA

AA

BB

BB

1656934

11

SNP_A-

rs624765

69826722

69.826722

0.714

AA

AB

AA

AA

AA

AA

AA

AA

AA

AA

1738462

11

SNP_A-

rs527529

74298448

74.298448

0.573

AA

AA

BB

BB

BB

BB

AB

AB

AA

AA

1645461

11

SNP_A-

rs1793483

76653115

76.653115

0.583

AA

AA

AA

AA

AA

AA

AA

AA

AA

AB

1711405

11

SNP_A-

rs3819256

77379509

77.379509

0.571

BB

BB

AB

BB

AB

AB

BB

BB

AA

AB

1739334

11

SNP_A-

rs7128417

77883622

77.883622

0.25

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1712184

11

SNP_A-

rs483089

78543310

78.54331

0.655

AA

AA

AB

BB

AB

AB

AA

AA

AA

AB

1734963

11

SNP_A-

rs1569168

79525377

79.525377

0.441

AB

AB

AB

AA

AB

AB

AA

AA

BB

AB

1695384

11

SNP_A-

rs10501496

80598450

80.59845

0.298

AB

AB

AA

AA

AA

AA

AB

AB

AA

AB

1695760

11

SNP_A-

rs666649

81460553

81.460553

0.56

AB

AB

AB

BB

AB

AB

AB

AB

BB

AB

1679629

11

SNP_A-

rs2000922

82720260

82.72026

0.619

AA

AA

AA

AA

AA

AA

AB

AB

AA

AA

1674894

11

SNP_A-

rs7924334

83853909

83.853909

0.714

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1645839

11

SNP_A-

rs10501586

84433725

84.433725

0.726

AA

AA

AA

AA

AA

AA

AB

AB

AA

AB

1654894

11

SNP_A-

rs10501612

85594787

85.594787

0.342

BB

BB

BB

BB

BB

BB

AB

AB

BB

BB

1756404

11

SNP_A-

rs503952

86520236

86.520236

0.268

AB

AB

BB

BB

BB

BB

BB

BB

AA

AB

1722491

11

SNP_A-

rs10501723

89922680

89.92268

0.5

AB

AB

AB

AA

AB

AB

AA

AA

AA

AB

1740548

11

SNP_A-

rs1528760

90459676

90.459676

0.738

AA

AA

AA

AA

AA

AA

AA

AA

AA

AB

1741388

11

SNP_A-

rs10501759

91082163

91.082163

0.537

BB

BB

BB

BB

BB

BB

AA

AA

AA

AA

1755135

11

SNP_A-

rs554735

91994827

91.994827

0.524

AB

AB

AA

AA

AA

AA

BB

BB

AA

AB

1656446

11

SNP_A-

rs2605592

92842667

92.842667

0.702

AA

AA

AA

AA

AA

AA

AB

AB

BB

AB

1720756

11

SNP_A-

rs609493

93708735

93.708735

0.286

BB

BB

BB

BB

BB

BB

AA

AB

BB

AB

1672903

11

SNP_A-

rs12627

94442268

94.442268

0.607

AA

AA

AB

AA

AB

AB

BB

BB

AA

AB

1659851

11

SNP_A-

rs1940201

95387950

95.38795

0.31

AB

AB

AB

AA

AB

AB

BB

BB

AB

AB

1649021

11

SNP_A-

rs10501859

95973889

95.973889

0.298

AB

AB

BB

BB

BB

BB

BB

AB

AB

AB

1706350

11

SNP_A-

rs1939713

99567868

99.567868

0.631

AA

AA

AB

AA

AB

AB

BB

AB

AA

AA

1670058

11

SNP_A-

rs667504

100221671

100.221671

0.738

AA

AA

AA

AA

AA

AA

AA

AA

AB

AB

1712712

11

SNP_A-

rs313403

102697742

102.697742

0.524

AA

AA

BB

BB

BB

BB

AA

AB

AA

AA

1729283

11

SNP_A-

rs260818

103425315

103.425315

0.417

BB

BB

BB

BB

BB

BB

BB

BB

AB

AB

1643334

11

SNP_A-

rs10502051

104808805

104.808805

0.286

BB

BB

BB

BB

BB

BB

BB

AB

BB

BB

1690312

11

SNP_A-

rs10502080

106341710

106.34171

0.346

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1746850

11

SNP_A-

rs2640757

107936868

107.936868

0.31

AA

AA

BB

BB

BB

BB

BB

BB

BB

BB

1718590

11

SNP_A-

rs2298501

109571744

109.571744

0.56

AA

AA

BB

BB

BB

BB

BB

BB

BB

BB

1739572

11

SNP_A-

rs170486

110202174

110.202174

0.452

AB

AB

AA

AA

AA

AA

AA

AA

AA

AA

1742110

11

SNP_A-

rs10502152

111296905

111.296905

0.321

BB

BB

BB

BB

BB

BB

AA

AB

BB

BB

1720008

11

SNP_A-

rs7118530

113395335

113.395335

0.357

AA

AB

BB

BB

BB

BB

AA

AA

AA

AA

1658493

11

SNP_A-

rs2247060

114257194

114.257194

0.536

BB

AB

BB

BB

BB

BB

BB

AB

BB

BB

1689389

11

SNP_A-

rs572619

115738853

115.738853

0.619

AA

AA

BB

BB

BB

BB

AA

AB

AA

AA

1652091

11

SNP_A-

rs660443

116265903

116.265903

0.362

AA

AA

AB

AB

AB

AB

AA

AA

AA

AA

1737192

11

SNP_A-

rs1219410

121294459

121.294459

0.691

BB

AB

AA

AA

AA

AA

AA

AA

BB

BB

1643985

11

SNP_A-

rs872414

122170647

122.170647

0.452

AA

AA

AA

AB

AB

AB

BB

AB

BB

BB

1728568

11

SNP_A-

rs2078158

122950070

122.95007

0.333

BB

BB

AA

AB

AB

AB

BB

BB

BB

BB

1696469

11

SNP_A-

rs1940751

127447038

127.447038

0.683

AA

AA

AA

AA

AA

AA

AA

AA

BB

BB

1748196

11

SNP_A-

rs1368850

130433518

130.433518

0.598

AA

AB

AA

AB

AB

AB

BB

BB

AA

AA

1741458

11

SNP_A-

rs748807

131232636

131.232636

0.452

AA

AB

BB

BB

BB

BB

BB

BB

AB

AB

1732434

12

SNP_A-

rs7973282

1095178

1.095178

0.738

AA

AA

AA

AA

AA

AA

AA

AB

AA

AA

1644365

12

SNP_A-

rs215994

2587421

2.587421

0.274

BB

BB

BB

BB

BB

BB

AA

AB

BB

BB

1716332

12

SNP_A-

rs4625554

4286565

4.286565

0.298

AB

AB

BB

BB

BB

BB

BB

BB

BB

BB

1708039

12

SNP_A-

rs1861584

5578079

5.578079

0.702

AA

AA

AB

AB

AB

AB

AA

AB

AB

AB

1727428

12

SNP_A-

rs4883241

9384549

9.384549

0.369

AA

AA

AB

AB

AB

AB

AA

AA

AB

AB

1708085

12

SNP_A-

rs560444

9940542

9.940542

0.321

BB

AB

BB

BB

BB

BB

BB

BB

BB

BB

1709352

12

SNP_A-

rs1009954

11789366

11.789366

0.333

BB

BB

AB

AB

AB

AB

BB

BB

BB

BB

1667917

12

SNP_A-

rs10505774

13327672

13.327672

0.714

AA

AB

AA

AA

AA

AA

BB

BB

AA

AA

1749536

12

SNP_A-

rs10492150

14935164

14.935164

0.333

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1696855

12

SNP_A-

rs4366546

18267461

18.267461

0.75

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1680095

12

SNP_A-

rs10505845

19976927

19.976927

0.714

AA

AA

AA

AA

AA

AA

BB

BB

BB

AB

1714486

12

SNP_A-

rs4131935

20632200

20.6322

0.738

BB

BB

AA

AA

AA

AA

AB

AB

BB

AB

1729086

12

SNP_A-

rs2417981

21483114

21.483114

0.5

BB

BB

AB

BB

AB

AB

AA

AA

AA

AA

1673313

12

SNP_A-

rs3884510

24249990

24.24999

0.512

AA

AA

AB

BB

AB

AB

AB

AB

AA

AA

1645425

12

SNP_A-

rs10505945

24803300

24.8033

0.381

BB

AB

BB

BB

BB

BB

BB

BB

BB

BB

1672243

12

SNP_A-

rs10505972

25379461

25.379461

0.393

BB

AB

AB

AA

AB

AB

AB

AB

BB

AB

1692085

12

SNP_A-

rs9300175

27617467

27.617467

0.417

BB

BB

BB

BB

BB

BB

BB

BB

AA

AB

1674778

12

SNP_A-

rs148898

29606383

29.606383

0.691

AA

AA

AA

AA

AA

AA

AA

AB

AA

AB

1649795

12

SNP_A-

rs10506065

30342307

30.342307

0.417

BB

AB

BB

BB

BB

BB

BB

BB

BB

BB

1658781

12

SNP_A-

rs7979386

30966129

30.966129

0.464

AA

AB

AA

BB

BB

AB

AA

AB

AA

AA

1722521

12

SNP_A-

rs2593998

32333520

32.33352

0.714

AA

AA

AA

AA

AA

AA

AA

AB

AA

AB

1705996

12

SNP_A-

rs1905428

33450742

33.450742

0.512

AA

AA

AA

AA

AA

AA

BB

AB

BB

AB

1644085

12

SNP_A-

rs2389276

33989158

33.989158

0.595

AA

AB

BB

AA

AA

AB

BB

AB

BB

AB

1711331

12

SNP_A-

rs10506124

37305503

37.305503

0.571

BB

AB

AA

BB

BB

AB

AA

AB

AA

AA

1692149

12

SNP_A-

rs7969928

39561348

39.561348

0.393

AA

AA

BB

BB

BB

BB

BB

BB

BB

AB

1720482

12

SNP_A-

rs7309345

40585255

40.585255

0.75

BB

BB

AA

AA

AA

AA

AA

AA

AA

AA

1659791

12

SNP_A-

rs1369610

41755818

41.755818

0.369

AA

AB

AA

BB

AB

AB

BB

AB

AA

AB

1754513

12

SNP_A-

rs1506678

43535759

43.535759

0.631

AA

AB

AA

AA

AA

AA

AA

AA

AA

AA

1693494

12

SNP_A-

rs7310869

44951653

44.951653

0.536

AA

AB

BB

BB

BB

BB

AA

AA

BB

BB

1702318

12

SNP_A-

rs10506292

49031020

49.03102

0.381

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1748898

12

SNP_A-

rs7968810

52445260

52.44526

0.738

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1733843

12

SNP_A-

rs10506393

56672989

56.672989

0.691

AA

AB

BB

AA

AA

AB

BB

BB

BB

AB

1712318

12

SNP_A-

rs3913094

57197682

57.197682

0.655

AA

AA

AA

BB

BB

AB

AA

AA

AA

AB

1657234

12

SNP_A-

rs10506408

58834234

58.834234

0.512

AA

AB

AA

AA

AA

AA

BB

AB

AA

AB

1662747

12

SNP_A-

rs7308021

61145687

61.145687

0.571

BB

AB

AA

BB

BB

AB

AA

AA

BB

BB

1688045

12

SNP_A-

rs513203

62226007

62.226007

0.56

BB

BB

BB

AA

AA

AB

AB

AB

AB

AB

1749010

12

SNP_A-

rs1596727

63609374

63.609374

0.583

AA

AA

AA

AA

AA

AA

BB

BB

AA

AA

1730271

12

SNP_A-

rs8756

64646019

64.646019

0.595

AA

AA

BB

BB

BB

BB

BB

BB

AB

AB

1716970

12

SNP_A-

rs10506514

65583191

65.583191

0.298

AB

AB

BB

BB

BB

BB

BB

BB

AA

AA

1721334

12

SNP_A-

rs7313431

66378203

66.378203

0.631

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1646303

12

SNP_A-

rs710779

68249633

68.249633

0.476

AB

AB

BB

AA

AA

AB

AB

AB

BB

BB

1695666

12

SNP_A-

rs2567134

69233806

69.233806

0.31

BB

BB

BB

BB

BB

BB

AB

AB

BB

BB

1700862

12

SNP_A-

rs7960254

70109323

70.109323

0.405

AB

AB

BB

AA

AA

AB

BB

BB

BB

BB

1757570

12

SNP_A-

rs10506645

70671767

70.671767

0.31

BB

BB

BB

AA

AA

AB

AB

AB

BB

BB

1676631

12

SNP_A-

rs7964705

72103027

72.103027

0.31

AA

AA

BB

AA

AA

AB

AB

AB

BB

BB

1743470

12

SNP_A-

rs1396226

73586112

73.586112

0.429

BB

BB

AA

BB

BB

AB

AB

AB

AB

AB

1660536

12

SNP_A-

rs1275643

74439702

74.439702

0.393

AB

AB

BB

AA

AA

AB

AB

AB

AA

AA

1662713

12

SNP_A-

rs310877

75889008

75.889008

0.274

BB

BB

BB

BB

BB

BB

BB

BB

AB

AB

1667227

12

SNP_A-

rs7315131

76389953

76.389953

0.381

AB

AB

AA

AA

AA

AA

AA

AB

AA

AA

1732426

12

SNP_A-

rs1796135

77491016

77.491016

0.524

BB

BB

BB

AA

AA

AB

AA

AB

AB

AB

1667491

12

SNP_A-

rs1244908

79104469

79.104469

0.631

AA

AA

BB

BB

BB

BB

AA

AB

AB

AB

1643877

12

SNP_A-

rs10506839

79948071

79.948071

0.31

AA

AA

BB

BB

BB

BB

AA

AA

AB

AB

1737202

12

SNP_A-

rs10506846

80609736

80.609736

0.655

AA

AA

AA

BB

BB

AB

AA

AB

AB

AB

1700433

12

SNP_A-

rs892540

81919943

81.919943

0.667

AB

AB

BB

AA

AA

AB

AA

AA

AA

AA

1738317

12

SNP_A-

rs7960510

82715458

82.715458

0.274

AB

AB

BB

BB

BB

BB

BB

BB

AB

AB

1688895

12

SNP_A-

rs839159

85096176

85.096176

0.726

AB

AB

BB

BB

BB

BB

AA

AA

AB

AB

1675076

12

SNP_A-

rs2635067

85762474

85.762474

0.571

AB

AB

AB

AA

AA

AB

AA

AA

BB

BB

1663055

12

SNP_A-

rs1019206

87893500

87.8935

0.333

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1727255

12

SNP_A-

rs2731240

89061896

89.061896

0.31

BB

BB

BB

BB

BB

BB

AA

AB

AA

AA

1657981

12

SNP_A-

rs924328

91753976

91.753976

0.31

BB

BB

BB

BB

BB

BB

AA

AA

BB

BB

1696519

12

SNP_A-

rs4761590

93076279

93.076279

0.655

BB

BB

AA

AA

AA

AA

BB

AB

AB

AB

1747554

12

SNP_A-

rs759572

95985503

95.985503

0.524

BB

BB

AB

AA

AB

AB

AB

AB

BB

BB

1701918

12

SNP_A-

rs1394380

97055132

97.055132

0.75

AA

AA

AA

AA

AA

AA

AB

AB

AA

AA

1734475

12

SNP_A-

rs10492276

97699500

97.6995

0.691

AA

AA

AB

BB

AB

AB

AA

AA

AB

AB

1690482

12

SNP_A-

rs1718312

101743655

101.743655

0.393

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1704900

12

SNP_A-

rs10507166

102367680

102.36768

0.369

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1698694

12

SNP_A-

rs7954946

103966503

103.966503

0.333

BB

BB

AA

AA

AA

AA

AA

AA

AA

AA

1731482

12

SNP_A-

rs10507197

104564170

104.56417

0.583

AA

AA

AA

AA

AA

AA

BB

BB

AB

AB

1689283

12

SNP_A-

rs1444581

105816718

105.816718

0.488

BB

BB

AA

AA

AA

AA

AA

AA

BB

BB

1723539

12

SNP_A-

rs715447

107449185

107.449185

0.464

BB

BB

AB

AB

AB

AB

BB

BB

AB

AB

1676727

12

SNP_A-

rs10507234

108519202

108.519202

0.714

AB

AB

AA

AA

AA

AA

AB

AB

AA

AA

1742456

12

SNP_A-

rs4767550

116413870

116.41387

0.595

AA

AA

AB

AB

AB

AB

AA

AA

AB

AB

1655216

12

SNP_A-

rs1726392

117061645

117.061645

0.321

BB

AB

AB

AB

AB

AB

BB

BB

BB

BB

1673501

12

SNP_A-

rs3858710

118701913

118.701913

0.573

AA

AB

AA

AA

AA

AA

AA

AA

AB

AB

1748666

12

SNP_A-

rs1558062

124778387

124.778387

0.524

AA

AB

AB

AB

AB

AB

AA

AB

AA

AA

1708029

12

SNP_A-

rs345676

126581103

126.581103

0.643

AA

AB

BB

BB

BB

BB

BB

AB

AA

AA

1716508

12

SNP_A-

rs1983314

129393207

129.393207

0.333

BB

AB

BB

BB

BB

BB

AB

AB

BB

BB

1664795

13

SNP_A-

rs7985257

18787997

18.787997

0.524

BB

BB

AA

AA

AA

AA

BB

AB

AA

AA

1652867

13

SNP_A-

rs535233

20445317

20.445317

0.321

AB

AB

BB

BB

BB

BB

BB

BB

AA

AB

1686943

13

SNP_A-

rs2862901

23933239

23.933239

0.571

AB

AB

AA

AA

AA

AA

BB

AB

AA

AA

1745741

13

SNP_A-

rs10507349

25679528

25.679528

0.274

BB

BB

AA

AA

AA

AB

BB

BB

AB

AB

1642868

13

SNP_A-

rs1161470

28322644

28.322644

0.31

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1702806

13

SNP_A-

rs213611

30348913

30.348913

0.705

AA

AA

AA

AA

AA

AA

AB

AB

AB

AB

1664657

13

SNP_A-

rs206079

31818618

31.818618

0.417

BB

BB

BB

BB

BB

BB

AB

AB

AB

AB

1658585

13

SNP_A-

rs4941700

32383381

32.383381

0.262

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1685897

13

SNP_A-

rs1538001

33683068

33.683068

0.274

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1664201

13

SNP_A-

rs6563348

35588714

35.588714

0.397

AA

AA

BB

BB

BB

BB

AB

AB

BB

BB

1742432

13

SNP_A-

rs2224655

36217500

36.2175

0.298

BB

BB

BB

BB

BB

BB

AB

AB

AA

AA

1709846

13

SNP_A-

rs1359214

36774982

36.774982

0.452

AB

AB

AA

AA

AA

AA

AB

AB

AB

AB

1719156

13

SNP_A-

rs10507466

37361657

37.361657

0.75

AA

AA

AA

AA

AA

AA

AB

AB

AB

AB

1699940

13

SNP_A-

rs2197879

38143188

38.143188

0.286

AB

AB

BB

BB

BB

BB

BB

BB

AA

AA

1757710

13

SNP_A-

rs4566029

39136387

39.136387

0.691

AA

AA

AA

AA

AA

AA

AB

AB

AA

AA

1725889

13

SNP_A-

rs7322754

40220977

40.220977

0.31

BB

BB

BB

AB

AB

AB

BB

BB

BB

BB

1648291

13

SNP_A-

rs1409075

42143450

42.14345

0.5

AB

AB

AB

AB

AB

AB

AA

AA

AA

AA

1644487

13

SNP_A-

rs9316020

42892291

42.892291

0.274

BB

BB

AB

AB

AB

AB

BB

BB

BB

BB

1692131

13

SNP_A-

rs9285153

43710570

43.71057

0.536

BB

BB

BB

BB

BB

BB

AB

AB

AB

AB

1683729

13

SNP_A-

rs10507544

46298746

46.298746

0.286

BB

BB

BB

BB

BB

BB

AB

AB

AB

AB

1675092

13

SNP_A-

rs1983805

48609971

48.609971

0.655

AA

AA

AA

AA

AA

AA

BB

AB

AA

AA

1706220

13

SNP_A-

rs1359613

49664241

49.664241

0.381

AA

AB

AA

AA

AA

AA

BB

BB

AB

AB

1656586

13

SNP_A-

rs9316513

50452286

50.452286

0.643

AA

AB

AA

AA

AA

AA

BB

AB

AA

AA

1687875

13

SNP_A-

rs1891948

52537146

52.537146

0.429

BB

BB

AA

AA

AA

AA

AA

AB

BB

BB

1699260

13

SNP_A-

rs9316642

53093973

53.093973

0.571

AA

AB

BB

BB

BB

BB

BB

BB

BB

BB

1670827

13

SNP_A-

rs1010947

53921670

53.92167

0.702

AA

AB

AA

AA

AA

AA

AA

AA

AA

AA

1664927

13

SNP_A-

rs10507599

54585799

54.585799

0.286

AA

AB

BB

BB

BB

BB

BB

BB

BB

BB

1686045

13

SNP_A-

rs2253408

55216697

55.216697

0.75

AA

AA

AB

AB

AB

AB

BB

AB

BB

BB

1686285

13

SNP_A-

rs959745

56718869

56.718869

0.274

BB

BB

BB

BB

BB

BB

BB

AB

BB

BB

1668215

13

SNP_A-

rs10492603

57769822

57.769822

0.679

AA

AA

BB

BB

BB

BB

AA

AA

AA

AA

1706400

13

SNP_A-

rs2786664

59574054

59.574054

0.417

BB

BB

BB

BB

BB

BB

BB

BB

AA

AA

1695368

13

SNP_A-

rs3102221

60652316

60.652316

0.488

AA

AB

AB

AB

AB

AB

AA

AB

AA

AA

1690895

13

SNP_A-

rs7323089

61693413

61.693413

0.56

AA

AA

AA

AA

AA

AA

AA

AB

AA

AA

1731184

13

SNP_A-

rs2134898

62767058

62.767058

0.25

BB

BB

AA

AA

AA

AA

BB

AB

BB

BB

1697063

13

SNP_A-

rs9317406

63717021

63.717021

0.417

BB

AB

BB

BB

BB

BB

BB

BB

AB

AB

1707522

13

SNP_A-

rs7321823

65570977

65.570977

0.679

BB

BB

AA

AA

AA

AA

AA

AA

AA

AA

1645393

13

SNP_A-

rs10492592

66385683

66.385683

0.714

AA

AB

AB

AB

AB

AB

AA

AA

AB

AB

1726077

13

SNP_A-

rs176343

68069259

68.069259

0.702

AA

AB

AA

AA

AA

AA

AA

AA

AA

AA

1650731

13

SNP_A-

rs2782448

68801734

68.801734

0.643

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1705084

13

SNP_A-

rs3909263

71753222

71.753222

0.321

BB

BB

AB

AB

AB

AB

AA

AA

BB

BB

1715042

13

SNP_A-

rs10507812

72886773

72.886773

0.75

AA

AA

AB

AB

AB

AB

BB

BB

AA

AA

1732673

13

SNP_A-

rs9318226

73391987

73.391987

0.419

BB

BB

AA

AA

AA

AA

AA

AA

BB

BB

1713643

13

SNP_A-

rs9318324

74649787

74.649787

0.658

AA

AA

BB

BB

BB

BB

AA

AA

AB

AB

1756880

13

SNP_A-

rs10507835

75353682

75.353682

0.691

AA

AA

AA

AA

AA

AA

BB

AB

AA

AA

1685215

13

SNP_A-

rs1952548

76037205

76.037205

0.333

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1679595

13

SNP_A-

rs7326108

77781442

77.781442

0.393

AB

AB

AA

AA

AA

AA

BB

BB

AB

AB

1687191

13

SNP_A-

rs3903388

78802822

78.802822

0.393

BB

BB

AB

AB

AB

AB

AA

AA

BB

BB

1680379

13

SNP_A-

rs1215462

79594011

79.594011

0.536

BB

BB

AB

AB

AB

AB

AB

AB

BB

BB

1664955

13

SNP_A-

rs1744600

80158809

80.158809

0.631

AB

AB

AB

AB

AB

AB

BB

BB

AA

AA

1727874

13

SNP_A-

rs10507917

80741431

80.741431

0.488

AA

AA

AA

AA

AA

AA

BB

BB

AB

AB

1710116

13

SNP_A-

rs9318868

81947326

81.947326

0.643

AB

AB

AA

AA

AA

AA

AA

AA

AB

AB

1663633

13

SNP_A-

rs9319022

83601961

83.601961

0.345

BB

BB

AB

AB

AB

AB

AB

AB

AB

AB

1693530

13

SNP_A-

rs1331567

84793816

84.793816

0.56

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1706422

13

SNP_A-

rs995475

87558036

87.558036

0.357

AB

AB

BB

BB

BB

BB

AB

AB

BB

BB

1733077

13

SNP_A-

rs1113478

88908389

88.908389

0.417

AA

AA

AB

AA

AB

AB

AB

AB

AB

AB

1679861

13

SNP_A-

rs665530

90571947

90.571947

0.726

AA

AA

AA

AA

AA

AA

AB

AB

AA

AA

1649205

13

SNP_A-

rs1926489

91465990

91.46599

0.524

AB

AB

AA

AA

AA

AA

AA

AA

AB

AB

1726887

13

SNP_A-

rs913005

92275844

92.275844

0.607

AB

AB

BB

BB

BB

BB

AA

AA

AA

AA

1714183

13

SNP_A-

rs9301876

92819688

92.819688

0.56

AA

AA

BB

BB

BB

BB

AA

AA

AA

AA

1701716

13

SNP_A-

rs1412938

93661657

93.661657

0.726

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1681625

13

SNP_A-

rs9302001

94261393

94.261393

0.274

AA

AA

BB

BB

BB

BB

AB

AB

BB

BB

1648409

13

SNP_A-

rs7324781

95032754

95.032754

0.405

AB

AB

BB

BB

AB

AB

BB

BB

BB

BB

1741482

13

SNP_A-

rs4603415

96610639

96.610639

0.631

AB

AB

AA

AA

AA

AA

AB

AB

AA

AB

1661319

13

SNP_A-

rs285067

97536416

97.536416

0.691

AA

AB

BB

BB

AB

AB

AA

AA

AA

AA

1664929

13

SNP_A-

rs1886553

98448739

98.448739

0.486

BB

BB

AA

AA

AB

AB

AA

AA

BB

AB

1709292

13

SNP_A-

rs2760306

99841672

99.841672

0.298

BB

BB

BB

BB

BB

BB

AB

AB

BB

BB

1749428

13

SNP_A-

rs10508075

101237184

101.237184

0.464

AA

AB

AA

AA

AB

AB

AB

AB

AA

AA

1703098

13

SNP_A-

rs1015795

102023701

102.023701

0.488

AA

AB

BB

BB

BB

BB

AA

AA

BB

BB

1680317

13

SNP_A-

rs279927

102539019

102.539019

0.643

AA

AA

AA

AA

AA

AA

AA

AA

BB

AB

1704124

13

SNP_A-

rs1033147

103460337

103.460337

0.333

AA

AA

BB

BB

BB

BB

AB

AB

BB

BB

1752530

13

SNP_A-

rs9300981

104440279

104.440279

0.286

BB

AB

BB

BB

BB

BB

AB

AB

BB

AB

1654228

13

SNP_A-

rs7318881

105459909

105.459909

0.671

BB

BB

AA

AA

AA

AA

BB

BB

BB

BB

1715354

13

SNP_A-

rs7327250

106243682

106.243682

0.329

BB

AB

BB

BB

BB

BB

BB

AB

BB

BB

1645715

13

SNP_A-

rs1320446

106965333

106.965333

0.679

BB

BB

BB

BB

AB

AB

BB

AB

AA

AA

1756346

13

SNP_A-

rs231604

107524007

107.524007

0.381

AA

AA

BB

BB

BB

BB

BB

BB

BB

BB

1732084

13

SNP_A-

rs4772985

108080882

108.080882

0.25

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1681321

13

SNP_A-

rs10492480

108947427

108.947427

0.333

BB

BB

AA

AA

AA

AA

AA

AA

BB

BB

1648777

13

SNP_A-

rs2183850

110513987

110.513987

0.714

BB

BB

AA

AA

AA

AA

BB

BB

AA

AA

1654860

14

SNP_A-

rs1952805

19586195

19.586195

0.345

BB

BB

BB

BB

BB

BB

BB

BB

AB

AB

1733261

14

SNP_A-

rs1923

22511019

22.511019

0.429

BB

AB

AA

AA

AA

AA

AB

AB

AA

AA

1702470

14

SNP_A-

rs4983041

24495978

24.495978

0.595

BB

AB

AB

AA

BB

AB

AA

AA

AB

AB

1645139

14

SNP_A-

rs10483331

26546808

26.546808

0.417

AB

AB

BB

BB

BB

BB

AB

AB

AA

AA

1676969

14

SNP_A-

rs4981658

27234585

27.234585

0.732

AA

AA

AA

AA

AA

AA

AB

AB

AA

AA

1680111

14

SNP_A-

rs2333423

28146939

28.146939

0.381

AB

AB

BB

BB

BB

BB

BB

BB

BB

BB

1734437

14

SNP_A-

rs10483350

28885906

28.885906

0.738

AA

AA

BB

BB

BB

BB

AA

AA

AA

AA

1669916

14

SNP_A-

rs225842

29622687

29.622687

0.441

AB

AB

BB

BB

BB

BB

AB

AB

AB

AB

1732697

14

SNP_A-

rs1278891

31464813

31.464813

0.595

AA

AA

AB

AA

AB

AB

BB

BB

AB

AB

1656700

14

SNP_A-

rs9322929

33377471

33.377471

0.345

AB

AB

AB

BB

AB

AB

BB

BB

BB

BB

1740154

14

SNP_A-

rs799493

34621626

34.621626

0.691

AB

AB

AB

BB

AB

AB

AA

AA

AA

AA

1757044

14

SNP_A-

rs847498

35546428

35.546428

0.607

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1676887

14

SNP_A-

rs1950361

36101975

36.101975

0.329

AB

AB

BB

BB

BB

BB

AB

AB

AB

AB

1665507

14

SNP_A-

rs4901596

37659956

37.659956

0.667

AB

AB

AA

AA

AA

AA

AB

AB

BB

BB

1705178

14

SNP_A-

rs6571869

38248210

38.24821

0.679

AA

AA

AB

AB

AB

AB

AB

AB

AA

AA

1654996

14

SNP_A-

rs10483511

39587714

39.587714

0.571

AB

AB

AB

AB

AB

AB

AB

AB

AB

AB

1708854

14

SNP_A-

rs10498360

40670723

40.670723

0.476

AB

AB

BB

BB

BB

BB

BB

BB

AB

AB

1653001

14

SNP_A-

rs1951874

41387217

41.387217

0.345

AA

AA

AB

AB

AB

AB

BB

BB

AA

AA

1753660

14

SNP_A-

rs2010338

45895631

45.895631

0.655

AA

AA

BB

BB

BB

BB

AA

AA

AA

AA

1653419

14

SNP_A-

rs10483573

46932227

46.932227

0.357

BB

BB

AA

AA

AA

AA

AA

AA

AB

AB

1663303

14

SNP_A-

rs698340

47611853

47.611853

0.585

AB

AB

AA

AA

AA

AA

AA

AA

BB

BB

1664801

14

SNP_A-

rs7146291

48172131

48.172131

0.274

BB

BB

BB

BB

BB

BB

BB

BB

AB

AB

1722201

14

SNP_A-

rs8006972

48690753

48.690753

0.31

BB

BB

AB

AB

AA

AB

AA

AA

AB

AB

1650017

14

SNP_A-

rs10498420

49483793

49.483793

0.476

AB

AB

AB

AB

BB

AB

AB

AB

BB

BB

1720778

14

SNP_A-

rs963626

50157439

50.157439

0.691

AA

AA

AA

AA

AA

AA

AB

AB

AA

AA

1743320

14

SNP_A-

rs1956574

51163026

51.163026

0.655

AA

AA

AA

AA

AA

AA

AA

AA

AB

AB

1641756

14

SNP_A-

rs7151306

52273870

52.27387

0.607

AB

AB

BB

BB

BB

BB

AA

AA

AB

AB

1669704

14

SNP_A-

rs877018

52892776

52.892776

0.451

BB

BB

AB

AB

AA

AB

AB

AB

AB

AB

1748272

14

SNP_A-

rs1382978

55788938

55.788938

0.536

AA

AA

BB

BB

BB

BB

AA

AB

AA

AA

1714357

14

SNP_A-

rs10483679

56503799

56.503799

0.61

BB

AB

AB

AB

AA

AB

AA

AA

AB

AB

1714205

14

SNP_A-

rs238376

57129665

57.129665

0.357

AA

AB

BB

BB

BB

BB

AA

AB

AB

AB

1654106

14

SNP_A-

rs10498488

58658876

58.658876

0.451

BB

BB

AB

AB

BB

AB

AA

AA

AA

AA

1690578

14

SNP_A-

rs9323353

59240800

59.2408

0.619

AA

AA

AB

AB

AA

AB

AA

AA

AA

AA

1690058

14

SNP_A-

rs2296274

60986931

60.986931

0.75

BB

AB

AA

AA

AA

AA

AA

AA

AB

AB

1671347

14

SNP_A-

rs9285590

61521469

61.521469

0.417

AA

AA

AA

AA

AA

AA

BB

AB

BB

BB

1755551

14

SNP_A-

rs1271582

64634456

64.634456

0.441

BB

BB

AA

AA

AA

AA

BB

BB

BB

BB

1707294

14

SNP_A-

rs10483805

67325404

67.325404

0.329

BB

AB

AB

AB

BB

AB

BB

BB

AB

AB

1648725

14

SNP_A-

rs1956528

67858721

67.858721

0.631

BB

BB

AA

AA

AA

AA

BB

AB

AB

AB

1699466

14

SNP_A-

rs749397

69414068

69.414068

0.262

BB

BB

AA

AA

AA

AA

BB

BB

BB

BB

1682431

14

SNP_A-

rs2215132

71545542

71.545542

0.262

AA

AB

BB

BB

BB

BB

AA

AA

AB

AB

1674164

14

SNP_A-

rs2803971

72182227

72.182227

0.713

AA

AA

AA

AA

AA

AA

AA

AA

AB

AB

1672631

14

SNP_A-

rs1028258

75447775

75.447775

0.726

AA

AA

AB

AB

BB

AB

AA

AA

AA

AA

1648423

14

SNP_A-

rs7152153

76265708

76.265708

0.286

BB

BB

BB

BB

BB

BB

AA

AA

BB

BB

1700204

14

SNP_A-

rs7156671

76991628

76.991628

0.7

AA

AA

AB

AB

BB

AB

AA

AA

BB

BB

1701478

14

SNP_A-

rs10483905

78043978

78.043978

0.429

BB

BB

AA

AA

AA

AA

BB

BB

BB

BB

1706776

14

SNP_A-

rs997842

78614233

78.614233

0.679

AA

AA

AA

AA

AA

AA

AA

AB

AB

AB

1667157

14

SNP_A-

rs2049826

79383063

79.383063

0.345

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1722889

14

SNP_A-

rs2372083

81860288

81.860288

0.452

AB

AB

AA

AA

AA

AA

BB

AB

AB

AB

1645339

14

SNP_A-

rs2372424

83017248

83.017248

0.438

AA

AA

BB

BB

BB

BB

AA

AA

BB

BB

1704748

14

SNP_A-

rs8003423

83533541

83.533541

0.643

BB

BB

AB

AB

AA

AB

AA

AA

AA

AA

1757272

14

SNP_A-

rs1530325

84781909

84.781909

0.702

AB

AB

AA

AA

AA

AA

AA

AB

AB

AB

1644835

14

SNP_A-

rs10498604

86238836

86.238836

0.298

BB

BB

BB

BB

BB

BB

BB

BB

AB

AB

1680733

14

SNP_A-

rs8018273

86867956

86.867956

0.524

AA

AA

BB

BB

BB

BB

AA

AA

AA

AA

1702796

14

SNP_A-

rs429923

87481126

87.481126

0.405

BB

BB

AA

AA

AA

AA

AA

AA

BB

BB

1687761

14

SNP_A-

rs1742083

90256423

90.256423

0.321

AB

AB

AB

AB

AB

AB

AB

AB

AB

AB

1725723

14

SNP_A-

rs10498627

91041872

91.041872

0.583

AA

AA

BB

BB

BB

BB

AA

AA

AB

AB

1661389

14

SNP_A-

rs2148567

93244403

93.244403

0.286

BB

BB

BB

BB

BB

BB

AA

AA

BB

BB

1705392

14

SNP_A-

rs1456988

97557760

97.55776

0.679

AB

AB

AA

AA

AA

AA

AA

AA

BB

BB

1734665

14

SNP_A-

rs200331

98457298

98.457298

0.488

AB

AB

AA

AA

AA

AA

AB

AB

AA

AA

1684765

14

SNP_A-

rs3918051

99023837

99.023837

0.61

BB

AB

AA

AA

AA

AA

AB

AB

AA

AA

1682935

14

SNP_A-

rs10484072

102695759

102.695759

0.631

AA

AA

AB

AB

AB

AB

BB

BB

AB

AB

1734911

14

SNP_A-

rs1048257

104475429

104.475429

0.667

AA

AA

AB

AB

AB

AB

BB

BB

AB

AB

1659209

15

SNP_A-

rs1405186

21306806

21.306806

0.441

BB

AB

BB

BB

BB

BB

BB

BB

BB

BB

1669336

15

SNP_A-

rs2169637

25517776

25.517776

0.262

BB

BB

AA

AA

AA

AA

BB

BB

BB

BB

1690082

15

SNP_A-

rs10519635

27330404

27.330404

0.607

BB

BB

AB

AB

AB

AB

BB

AB

BB

AB

1643639

15

SNP_A-

rs4779462

28026287

28.026287

0.598

BB

BB

AB

AB

AB

AB

AA

AA

AA

AA

1740804

15

SNP_A-

rs2219507

29646927

29.646927

0.691

AA

AA

AA

AA

AA

AA

BB

AB

AA

AA

1722463

15

SNP_A-

rs10519737

30756749

30.756749

0.381

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1730684

15

SNP_A-

rs1343900

31431890

31.43189

0.667

AA

AA

AB

AB

AB

AB

AA

AB

BB

BB

1648795

15

SNP_A-

rs10519956

32849133

32.849133

0.345

AB

AB

BB

BB

BB

BB

BB

BB

AA

AB

1755583

15

SNP_A-

rs1948650

33827340

33.82734

0.738

AA

AA

AA

AA

AA

AA

AB

AB

AA

AB

1699406

15

SNP_A-

rs10518868

34381353

34.381353

0.655

AA

AA

AB

AB

AB

AB

AB

AB

AA

AA

1645977

15

SNP_A-

rs471122

41345866

41.345866

0.3

AA

AA

BB

BB

BB

BB

BB

BB

AA

AB

1665819

15

SNP_A-

rs10519044

44169166

44.169166

0.381

BB

BB

AB

AB

AB

AB

BB

BB

BB

BB

1673073

15

SNP_A-

rs493728

48678247

48.678247

0.441

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1740676

15

SNP_A-

rs1478200

51948279

51.948279

0.357

BB

AB

BB

BB

BB

BB

AB

AB

BB

BB

1709940

15

SNP_A-

rs2553222

52657040

52.65704

0.691

BB

BB

AA

AA

AA

AA

AB

AB

AA

AB

1720532

15

SNP_A-

rs4534776

55408068

55.408068

0.463

AA

AA

AB

AB

AB

AB

AB

BB

BB

AB

1654466

15

SNP_A-

rs1550574

56000660

56.00066

0.536

AA

AA

BB

BB

BB

BB

AA

AA

AA

AB

1752856

15

SNP_A-

rs2033721

58609267

58.609267

0.714

AA

AB

AB

AB

AB

AB

AA

AA

AA

AB

1735597

15

SNP_A-

rs3935962

59611593

59.611593

0.536

AA

AB

AA

AA

AA

AA

AA

AA

AA

AB

1642536

15

SNP_A-

rs10519148

60507655

60.507655

0.25

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1726387

15

SNP_A-

rs2652824

61207054

61.207054

0.286

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1750348

15

SNP_A-

rs10518707

65152676

65.152676

0.488

AA

AB

AB

AB

AB

AB

AA

AA

AA

AA

1741266

15

SNP_A-

rs305002

67928959

67.928959

0.595

AA

AA

AA

AA

AA

AA

BB

BB

BB

BB

1739192

15

SNP_A-

rs2128112

69973340

69.97334

0.262

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1677047

15

SNP_A-

rs3898352

74308825

74.308825

0.631

BB

AB

AB

AB

AA

AB

BB

BB

AA

AA

1698770

15

SNP_A-

rs1446312

75199244

75.199244

0.738

AA

AA

AA

AA

AA

AA

AB

AB

AA

AB

1654378

15

SNP_A-

rs7163689

76352533

76.352533

0.488

AA

AB

AB

AB

AA

AB

AB

AB

BB

BB

1657306

15

SNP_A-

rs1001460

77291934

77.291934

0.56

AA

AA

AB

AB

BB

AB

AB

AB

AA

AB

1701268

15

SNP_A-

rs1320323

79128502

79.128502

0.59

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1689635

15

SNP_A-

rs1846911

80255705

80.255705

0.329

AA

AA

BB

BB

BB

BB

AB

AB

BB

BB

1749864

15

SNP_A-

rs10520585

83462510

83.46251

0.286

BB

AB

AB

AB

AA

AB

BB

BB

BB

AB

1714319

15

SNP_A-

rs1961601

84030610

84.03061

0.31

BB

BB

AB

AB

AA

AB

BB

BB

BB

AB

1654264

15

SNP_A-

rs1122907

84708371

84.708371

0.691

AA

AA

AB

AB

BB

AB

AA

AA

AA

AA

1650691

15

SNP_A-

rs10520655

85887415

85.887415

0.595

BB

AB

AA

AA

AA

AA

AA

AA

AA

AB

1665669

15

SNP_A-

rs3817428

87216251

87.216251

0.75

AA

AA

AA

AA

AA

AA

AB

AB

AA

AA

1694944

15

SNP_A-

rs1079537

89675287

89.675287

0.452

AB

AB

AB

AB

AA

AB

BB

BB

BB

BB

1683397

15

SNP_A-

rs10520710

90688998

90.688998

0.287

BB

BB

BB

BB

BB

BB

BB

AB

BB

AB

1752072

15

SNP_A-

rs1989269

91611056

91.611056

0.305

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1731798

15

SNP_A-

rs10520754

92760413

92.760413

0.548

AA

AA

AA

AA

AA

AA

AA

AA

AA

AA

1728656

15

SNP_A-

rs4321143

93957372

93.957372

0.262

BB

BB

BB

BB

BB

BB

BB

BB

BB

BB

1700188

15

SNP_A-

rs1551466

99344619

99.344619

0.345

AB

AB

AB

AB

AB

AB

BB

BB

AB

AB

1686439

15

SNP_A-

rs352716

100155950

100.15595

0.31

AA

AA

BB

BB

BB

BB

BB

AB

AA

AA

1647533

The results show heterozygosity of derived phESC lines and displays changes in genotype by comparison with the related donor genotype. Portions of heterozygous segments of the donor genome became homozygous in phESC. Chromosome-chromosome number; RS ID-RS number in dbSNP database; Base pair-base

# pair distance as recorded by Affimetrix GeneChip; Freq A in Cauc-the frequency of A allele in Caucasian population.

In prior research, parthenogenetic activation of mouse oocytes has resulted in homozygous embryonic stem cell lines (Lin et al., Stem Cells (2003) 21:152). In human oocytes, the suppression of the second meiotic division after oocyte parthenogenetic activation and the generation of diploid embryos does not lead to the derivation of wholly homozygous hES cells.

Based on the HLA-typing results, differentiated cells derived from all phESC lines should be wholly histocompatible with the oocyte donors, making this a method to create cells of therapeutic use (Table 19).

TABLE 19
HLA-typing for phESC cell lines
	MHC I	MHC II
	HLA-A	HLA-B	HLA-C	DRB1	DQB1	DQA1
phESC-1	A*01	B*15(63)	Cw*04	DRB1*12	DQB1*06	DQA1*01
	A*02	B*35	Cw*0708	DRB1*13	DQB1*03	DQA1*0505
phESC-1	A*01	B*15(63)	Cw*04	DRB1*12	DQB1*06	DQA1*01
donor	A*02	B*35	Cw*0708	DRB1*13	DQB1*03	DQA1*0505
phESC-3, 4, 5	A*02	B*52	Cw*03	DRB1*01	DQB1*05	DQA1*0101
	A*03	B*22	Cw*04	DRB1*03	DQB1*02	DQA1*05
phESC-3, 4, 5	A*02	B*52	Cw*03	DRB1*01	DQB1*05	DQA1*0101
donor	A*03	B*22	Cw*04	DRB1*03	DQB1*02	DQA1*05
phESC-6	A*02	B*07	Cw*04	DRB1*04	DQB1*06	DQA1*01
	A*03	B*27	Cw*07	DRB1*15	DQB1*03	DQA1*03
phESC-6	A*02	B*07	Cw*04	DRB1*04	DQB1*06	DQA1*01
donor	A*03	B*27	Cw*07	DRB1*15	DQB1*03	DQA1*03
phESC-7	A*01	B*38	Cw*06	DRB1*13	DQB1*06	DQA1*0106
	A*02	B*57	Cw*12	DRB1*14	DQB1*06	DQA1*0103
phESC-7	A*01	B*38	Cw*06	DRB1*13	DQB1*06	DQA1*0106
donor	A*02	B*57	Cw*12	DRB1*14	DQB1*06	DQA1*0103
NSF	A*25	B*15(62)	Cw*12	DRB1*04	DQB1*06	DQA1*01
	A*32	B*18	Cw*12	DRB1*15	DQB1*03	DQA1*03

DNA-profiling of the genetic material derived from the human fibroblasts used as feeder cells revealed no contamination of the phESC cell lines with material from the human fibroblasts (Table 19).

The phESC-1 line remained undifferentiated during ten months of culture, spanning 35 passages. The other cell lines were successfully cultivated over at least 21 passages. The cells from all phESC lines formed cystic embryoid bodies in suspension culture and gave rise to derivatives of all three germ layers: ectoderm, mesoderm, and endoderm, after differentiation in vitro (FIG. 4). Approximately 5% of embryoid bodies from the phESC-1 line gave rise to beating cells five days following plating. The phESC-6 line produced pigmented epithelial-like cells (FIG. 41, K). Ectoderm differentiation is presented by positive immunocytochemical staining for neuron specific markers neurofiliment 68 (FIG. 4A), NCAM (FIG. 4B), beta III-tubulin (FIG. 4C) and the glial cell marker GFAP (FIGS. 4D, M). Differentiated cells were positive for mesoderm markers including alpha-actinin (FIG. 4G) and desmin (FIG. 4J), which are muscle specific markers, and the endothelial markers PECAM-1 (FIG. 4E) and VE-Cadherin (FIG. 4F). Endoderm differentiation is presented by positive staining of differentiated derivatives for alpha-fetoprotein. These data demonstrate that phESC can be differentiated into the three germ layers that lead to all cell types of a human body.

The altered karyotype of phESC-7 may be a reason to exclude it form clinical use. Alterations of genomic imprinting in human embryos can contribute to the development of disorders linked to maternally or paternally expressed genes (Gabriel et al., Proc Natl Acad Sci USA (1998) 95:14857). In order to investigate other characteristics of the phESC lines, and to determine their suitability for use in cell therapy, imprinting analysis was performed.

Northern blots were made and screened with DNA probes SNRPN, Peg1_—2, Peg1_A, H19, and GAPDH (as an internal control) as outlined above. Blotted nucleic acids were obtained from NSF, neonatal skin fibroblasts; hES, human embryonic stem cell line derived from fertilized oocytes; 1, phESC-1; 2, phESC-3, 3, phESC-4, 4, phESC-5; 5, phESC-6; 6 phESC-7. NSF RT-, hES RT-, 1 RT- are negative controls. FIG. 3 shows the results of the imprinting blot.

The maternal imprinting gene, Peg1_A shows strong binding in all of the cell lines tested. Weaker (relative to Peg1_A), but consistent binding was observed in all of the cell lines for the maternal imprinting gene H19. SNRPN shows binding predominantly in NSF, hES, phESC-4, and phESC-6. Peg1_—2 shows binding predominantly in NSF, hES, phESC-1 (weaker signal), phESC-3, phESC-5, and phESC-6. GAPDH binding confirmed similar loading of RNA in all lanes.

Although the invention has been described with reference to the above examples, it will be understood that modifications and variations are encompassed within the spirit and scope of the invention. Accordingly, the invention is limited only by the following claims.

REFERENCES

• 1. J. Cibelli et al., Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells. US Patent Application No. 20030232430, Dec. 18, 2003.
• 2. H. Lin et al., Multilineage potential of homozygous stem cells derived from metaphase II oocytes. Stem Cells (2003) 21:153-161
• 3. K. E. Vrana et al., Nonhuman primate parthenogenetic stem cells. PNAS (2003) 100 (Suppl 1):11911-11916.
• 4. J. P. M. Dumoulin et al., Effect of oxygen concentration on human in vitro fertilization and embryo culture. Human Reproduction. (1999) 14(2):465-469.
• 5. B.Fischer and B. D. Bavister, Oxygen tension in the oviduct and uterus of rhesus monkeys, hamsters and rabbits. J Reprod Fertil (1993) 99:673-679.
• 6. D. I. Kaufman and J. A. Mitchell, Intauterine oxygen tension during oestrous cycle in the hamster: patterns of change. Comp Biochem Physiol Comp Physiol (1994) 107(4): 673-678.
• 7. F. D. Houghton et al., Oxygen consumption and energy metabolism of the early mouse embryo. Mol Reprod Dev (1996) 44:476-485.
• 8. A. Van Soom et al., Prevalence of apoptosis and inner cell allocation in bovine embryos cultured under different oxygen tension with or without cysteine addition. Theriogenology (2002) 57(5):1453-1465.

Claims

1. A method of producing human stem cells comprising: a) parthenogenetically activating a human oocyte, wherein activating comprises: i) contacting the oocyte with an ionophore at high O2 tension and ii) contacting the oocyte with a serine-threonine kinase inhibitor under low O2 tension; b) cultivating the activated oocyte of step (a) at low O2 tension until blastocyst formation; c) transferring the blastocyst to a layer of feeder cells, and culturing the transferred blastocyst under high O2 tension; d) mechanically isolating an inner cell mass (ICM) from trophectoderm of the blastocyst of step (c); and e) culturing the cells of the ICM of step (d) on a layer of feeder cells, wherein culturing step (e) is carried out under high O2 tension.

2. The method of claim 1, wherein low O2 tension is maintained by incubation in a gas mixture environment comprising an O2 concentration of about 2% O2 to about 5% O2.

3. The method of claim 2, wherein the gas mixture environment further comprises about 5% CO2 and about 90% N2 to 93% N2.

4. The method of claim 1, wherein high O2 tension is maintained by incubation in a gas mixture environment comprising about 5% CO2 and about 20% O2.

5. The method of claim 1, wherein the ionophore is selected from the group consisting of ionomycin and A23187.

6. The method of claim 1, wherein the serine-threonine kinase inhibitor is selected from the group consisting of staurosporine, 2-aminopurine, sphingosine, and 6-dimethylaminopurine (DMAP).

7. The method of claim 1, wherein the activating, isolating, and culturing steps are carried out under defined media conditions for therapeutic applications.

8. The method of claim 7, wherein the media comprises human umbilical cord serum.

9. The method of claim 8, wherein the media comprises about 10% human umbilical cord serum.

10. The method of claim 1, wherein the layer of feeder cells comprises human fibroblasts.

11. The method of claim 10, wherein the fibroblasts are postnatal human dermal fibroblasts.

12. The method of claim 10, wherein the feeder cells are inactivated with an antibiotic.

13. The method of claim 12, wherein the antibiotic is mitomycin C.

14. An isolated stem cell prepared by the method of claim 1.

15. A method of activating a human metaphase II oocyte comprising; a) incubating a human metaphase II oocyte in in vitro fertilization (IVF) media; b) incubating the cell of step (a) in IVF media comprising an ionophore; c) incubating the cell of step (b) in IVF media comprising a serine-threonine kinase inhibitor; and d) incubating the cells of step (c) in fresh IVF medium until blastocyst formation, wherein the incubating steps (a) and (b) are carried out under high O2 tension, and wherein an inner cell mass (ICM) obtained from the blastocyst at step (d) produce culturable stem cells.

16. The method of claim 15, wherein the O2 tension for incubating steps (c) and (d) is maintained by incubating the cells in a gas mixture environment comprising an O2 concentration of about 2% O2 to 5% O2.

17. The method of claim 16, wherein the gas mixture environment further comprises about 5% CO2 and about 90% N2 to 93% N2.

18. The method of claim 15, further comprising incubating the oocytes with hyaluronidase.

19. The method of claim 15, wherein incubating step (a) is carried out for about 2 hours at about 37° C.

20. The method of claim 15, wherein incubating step (b) is carried out for about 5 minutes at about 37° C.

21. The method of claim 15, wherein incubating step (c) is carried out for about 4 hours at about 37° C.

22. The method of claim 15, wherein incubating step (d) is carried out for about 24 hours at about 37° C.

23. The method of claim 15, wherein the IVF media is free of non-human products.

24. The method of claim 23, wherein the ionophore is selected from the group consisting of ionomycin and A23187.

25. The method of claim 24, wherein the ionophore is ionomycin.

26. The method of claim 23, wherein the serine-threonine kinase inhibitor is selected from the group consisting of staurosporine, 2-aminopurine, sphingosine, and 6-dimethylaminopurine (DMAP).

27. The method of claim 26, wherein the serine-threonine kinase inhibitor is DMAP.

28. An isolated oocyte prepared by the method of claim 15.

29. An isolated inner cell mass (ICM) prepared from the oocyte of claim 28.

30. A method for producing human stem cells from a cryopreserved oocyte or parthenote, comprising: (a) microinjecting into the cytoplasm of the oocyte or parthenote a cryopreservation agent; (b) freezing the oocyte or parthenote to a cryogenic temperature to cause the oocyte or parthenote to enter a dormant state; (c) storing the oocyte or parthenote in the dormant state; (d) thawing the oocyte or parthenote; (e) parthenogenetically activating the oocyte from step (d) comprising i) contacting the oocyte with an ionophore at high O2 tension and ii) contacting the oocyte with a serine-threonine kinase inhibitor under low O2 tension; (f) cultivating the parthenote of step (d) or oocyte of step (e) at low O2 tension until blastocyst formation; (g) isolating an inner cell mass (ICM) from trophectoderm of the blastocyst; and (h) culturing the cells of the ICM of step (g) on a layer of feeder cells or extracellular matrix (ECM) substrate, wherein culturing step (g) is carried out under high O2 tension.

31. The method of claim 30, wherein the feeder cells are from a human source.

32. The method of claim 30, wherein the cryopreservation agent (i) comprises a sugar, (ii) is substantially non-permeating with respect to mammalian cell membranes, and (iii) maintains the viability of the oocyte or parthenote such that it can be stored in a temporarily dormant state and substantially restored to an active state.

33. The method of claim 28, further comprising contacting the oocyte or parthenote with an extracellular cryopreservation agent that is substantially non-permeating with respect to mammalian cell membranes and that stabilizes the cell membrane of the oocyte or parthenote.

34. The method of claim 30, wherein the cryopreservation agent comprises at least one sugar selected from the group consisting of sucrose, trehalose, fructose, dextran, and raffinose.

35. The method of claim 30, wherein the cryopreservation agent comprises at least one sugar selected from the group consisting of glucose, sorbitol, mannitol, lactose, maltose, and stachyose.

36. The method of claim 30, wherein the oocyte or parthenote is plunge frozen.

37. The method of claim 30, wherein the cryopreservation agent comprises Na+ low/K+ high media.

38. The method of claim 30, wherein the cryopreservation agent comprises an organic buffer.

39. The method of claim 38, wherein the organinc buffer is HEPES.

40. The method of claim 30, wherein the cryopreservation agent comprises a moiety that inhibits apoptotic proteins.

41. The method of claim 30, wherein the moiety is a capase.

42. The method of claim 36, wherein the oocyte or parthenote is cooled at a rate between about 0.3 and 6° C. per minute to a final temperature that is at least about −50° C.

43. The method of claim 42, wherein the oocyte or parthenote is cooled at a rate between about 0.3 and 3° C. per minute to a final temperature that is between about −50 and −10° C.

44. The method of claim 30, wherein step (b) comprises drying the oocyte or parthenote to a level sufficient to permit dry storage.

45. The method of claim 30, wherein step (b) comprises freeze drying the oocyte or parthenote.

46. The method of claim 30, wherein step (b) comprises vacuum or convective drying the oocyte or parthenote.

47. The method of claim 30, wherein step (d) comprises rehydrating the oocyte or parthenote.

48. An autologous stem cell, wherein the stem cell is derived from a parthenogenetically activated oocyte from a human donor.

49. The stem cell of claim 48, wherein the stem cell possesses a substantially identical haplotype as the donor oocyte.

50. The stem cell of claim 48, wherein the cell (i) will proliferate in an in vitro culture for over one year, (ii) maintains the potential to differentiate to derivatives of endoderm, mesoderm, and ectoderm tissues throughout the culture, and (iii) is inhibited from differentiation when cultured on a fibroblast feeder layer.

51. The stem cell of claim 50, wherein the cell maintains a karyotype in which the chromosomes are euploid and not altered through prolonged culture.

52. The stem cell of claim 48, wherein the stem cell is substantially identical genetically to the donor oocyte.

53. The stem cell of claim 52, wherein the stem cell possesses a 46, XX karyotype.

54. The stem cell of claim 52, wherein the stem cell is identified as a full sibling of the donor according to single nucleotide polymorphism (SNP) markers.

55. The stem cell of claim 52, wherein the stem cell is histocompatible with the donor.

56. The stem cell of claim 48, wherein the stem cell is genomically imprinted according to donor origin.

57. The stem cell of claim 56, wherein the stem cell expresses one or more genes selected from the group consisting of SNRPN, Peg1—2, Peg—1A, XIST, and H19.

58. The stem cell of claim 48, wherein the stem cell expresses one or more markers selected from the group consisting of SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, and OCT-4.

59. The stem cell of claim 48, wherein the stem cell comprises homoplasmic mitochondrial DNA (mtDNA).

60. A differentiated cell derived from a stem cell obtained from a parthenogenetically activated oocyte from a human donor.

61. The differentiated cell of claim 60, wherein the differentiated cell is histocompatible with the oocyte donor.

62. The differentiated cell of claim 60, wherein the differentiated cell is selected from the group consisting of a neuronal cell, cardiac cell, smooth muscle cell, striated muscle cell, endothelial cell, osteoblast, oligodendrocyte, hematopoietic cell, adipose cell, stromal cell, chondrocyte, astrocyte, dendritic cell, keratinocyte, pancreatic islet, lymphoid precursor cell, mast cell, mesodermal cell, and endodermal cell.

63. The differentiated cell of claim 62, wherein the cell expresses neurofiliment 68, NCAM, beta III-tubulin, GFAP, or a combination thereof.

64. The differentiated cell of claim 62, wherein the cell expresses alpha-actinin, desmin, or a combination thereof.

65. The differentiated cell of claim 62, wherein the cell expresses PECAM-1, VE-Cadherin, or a combination thereof.

66. The differentiated cell of claim 62, wherein the cell expresses alpha-fetoprotein.

67. The differentiated cell of claim 62, wherein the cell comprises homoplasmic mitochondrial DNA (mtDNA).

68. A cell line comprising autologous stem cells, wherein the stem cells are derived from parthenogenically activated oocytes from a human donor.

69. The cell line of claim 68, wherein each cell possesses a 46, XX karyotype.

70. The cell line of claim 68, wherein each cell is substantially identical genetically to the donor oocyte.

71. The cell line of claim 68, wherein each cell is genetically imprinted according to donor origin.

72. The cell line of claim 68, wherein the cells do not express SSEA-1.

73. The cell line of claim 68, wherein the cells give rise to ectoderm, mesoderm, and endoderm germ lines.

74. The cell line of claim 68, wherein cells of each separate cell line comprise homoplasmic mitochondrial DNA (mtDNA).

75. A library of stem cells comprising autologous stem cells, wherein the stem cells are derived from parthenogenetically activated oocytes from one or more human donors.

76. The library of claim 75, wherein each library member is identified as a full sibling, half sibling, or unrelated according to single nucleotide polymorphism (SNP) markers.

77. The library of claim 75, wherein the oocyte donor is histocompatible with a member of the library.

78. The library of claim 75, wherein a member of the library is genomically imprinted according to the oocyte donor origin.

79. The library of claim 75, wherein each member is homozygous for at least one MHC allele present in a human population.

80. The library of claim 75, wherein each member is homozygous for a different combination of MHC alleles than the other members of the library.

81. The library of claim 75, wherein each member is at least homozygous for one or more HLA class I genes and HLA class II genes.

82. The library of claim 81, wherein the HLA class I genes are selected from HLA A*, HLA B*, HLA and Cw* haplotype combinations.

83. The library of claim 81, wherein the HLA class II genes are selected from HLA DRB1*, DRB3*, DRB4*, DRB5*, DQA1*, and DQB1* haplotype combinations.

84. The library of claim 75, wherein each member (i) will proliferate in an in vitro culture for over one year, (ii) maintains the potential to differentiate to derivatives of one or all of endoderm, mesoderm, and ectoderm tissues throughout the culture, and (iii) is inhibited from differentiation when cultured on a fibroblast feeder layer.

85. The library of claim 84, wherein each member maintains a karyotype in which the chromosomes are euploid and not altered through prolonged culture.

86. The library of claim 75, wherein each member can differentiate into to ectoderm, mesoderm, and endoderm germ line cells.

87. A cell bank comprising cryopreserved parthenotes, wherein the parthenotes are derived from parthenogenetically activated oocytes from one or more human donors.

88. The cell bank of claim 87, wherein the parthenotes have been cultivated under low O2 tension until blastocyst formation.

89. A cell bank comprising cryopreserved autologous stem cells, wherein the stem cells are derived from parthenogenetically activated oocytes from one or more human donors.

90. A method of treating a subject in need thereof, comprising administering a cellular composition comprising differentiated cells, wherein the differentiated cells are derived from a stem cell obtained from a parthenogenetically activated oocyte from a human donor.

91. The method according to claim 90, wherein the differentiated cell is selected from the group consisting of a neuronal cell, cardiac cell, smooth muscle cell, striated muscle cell, endothelial cell, osteoblast, oligodendrocyte, hematopoietic cell, adipose cell, stromal cell, chondrocyte, astrocyte, dendritic cell, keratinocyte, pancreatic islet, lymphoid precursor cell, mast cell, mesodermal cell, and endodermal cell.

92. The method according to claim 90, wherein the subject presents a disease selected from the group consisting of Parkinson's disease, Huntington's disease, Alzheimer's disease, ALS, spinal cord defects or injuries, multiple sclerosis, muscular dystrophy, cystic fibrosis, liver disease, diabetes, heart disease, macular degeneration, cartilage defects or injuries, burns, foot ulcers, vascular disease, urinary tract disease, AIDS, and cancer.

93. A method of generating cloned human embryonic stem cell lines comprising: a) removing a first pro-nuclei from a previously fertilized human oocyte; b) transferring a second pro-nuclei into the enucleated oocyte of step (a) wherein the second pro-nuclei is derived from: i) a donor oocyte or an oocyte from the mother of the donor, or ii) a parthenogenetically activated oocyte, wherein the pro-nuclei of the oocyte has been replaced by the nucleus of a donor somatic cell prior to activation; and c) cultivating the resulting oocyte of step (b) until blastocyst formation, wherein an inner cell mass from the blastocyst contains the embryonic stem cells.